0001683168-19-003232.txt : 20191011 0001683168-19-003232.hdr.sgml : 20191011 20191011125052 ACCESSION NUMBER: 0001683168-19-003232 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 39 CONFORMED PERIOD OF REPORT: 20190831 FILED AS OF DATE: 20191011 DATE AS OF CHANGE: 20191011 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PATRIOT SCIENTIFIC CORP CENTRAL INDEX KEY: 0000836564 STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794] IRS NUMBER: 841070278 STATE OF INCORPORATION: DE FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-22182 FILM NUMBER: 191147682 BUSINESS ADDRESS: STREET 1: 2038 CORTE DEL NOGAL, SUITE 141 CITY: CARLSBAD STATE: CA ZIP: 92011-1478 BUSINESS PHONE: 760-795-8517 MAIL ADDRESS: STREET 1: 2038 CORTE DEL NOGAL, SUITE 141 CITY: CARLSBAD STATE: CA ZIP: 92011-1478 FORMER COMPANY: FORMER CONFORMED NAME: PATRIOT FINANCIAL CORP DATE OF NAME CHANGE: 19920521 10-Q 1 patriotsci_q1-20190831.htm FORM 10-Q

 

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

[X]QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended August 31, 2019

 

OR

 

[_]TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ___________ to _______________

 

Commission File Number 0-22182

 

PATRIOT SCIENTIFIC CORPORATION

(Exact name of registrant as specified in its charter)

 

Delaware

(State or other jurisdiction of

incorporation or organization)

84-1070278

(I.R.S. Employer Identification No.)

 

2038 Corte Del Nogal, Suite 141, Carlsbad, California

(Address of principal executive offices)

92011

(Zip Code)

 

(Registrant’s telephone number, including area code): (760) 795-8517

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol   Name of each exchange on which registered
None   None   None

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES [X ] NO [_]

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 229.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). YES [X] NO [_]

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer [_] Accelerated filer [_]
Non-accelerated filer [_]  Smaller reporting company [X]
Emerging growth company [_]  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [_]

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES [_]  NO [X]

 

On October 10, 2019, 401,392,948 shares of common stock, par value $0.00001 per share were outstanding.

 

 

 

 

   

 

 

INDEX

 

 

 

 

 

Page

PART I. FINANCIAL INFORMATION  
ITEM 1. Financial Statements  
Condensed consolidated Balance Sheets as of August 31, 2019 (unaudited) and May 31, 2019 3
Condensed consolidated Statements of Operations for the three months ended August 31, 2019 and August 31, 2018 (unaudited) 4
Condensed consolidated Statements of Cash Flows for the three months ended August 31, 2019 and August 31, 2018 (unaudited) 5
Condensed consolidated Statements of Stockholders’ Equity for the three months ended August 31, 2019 and August 31, 2018 (unaudited) 6
Notes to condensed consolidated Financial Statements (unaudited) 7-17
ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 18-26
ITEM 3. Quantitative and Qualitative Disclosures About Market Risk 27
ITEM 4. Controls and Procedures 27

 

PART II. OTHER INFORMATION

 
ITEM 1. Legal Proceedings 28
ITEM 1A. Risk Factors 28
ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds 28
ITEM 3. Defaults Upon Senior Securities 28
ITEM 4. Mine Safety Disclosures 28
ITEM 5. Other Information 28
ITEM 6. Exhibits 29
   
SIGNATURES 30

 

 

 

 

 

 

 

 

 

 

 

 

 

 2 

 

 

 

PART I- FINANCIAL INFORMATION

 

Item 1. Financial Statements

Patriot Scientific Corporation

Condensed Consolidated Balance Sheets

 

   August 31, 2019   May 31, 2019 
    (Unaudited)      
ASSETS          
Current assets:          
Cash and cash equivalents  $738,660   $787,086 
Restricted cash and cash equivalents   177,247    198,843 
Investments in marketable securities   500,000    750,000 
Prepaid expenses and other current assets   85,880    28,003 
Total current assets   1,501,787    1,763,932 
           
Property and equipment, net   692    814 
Deferred income taxes   52,156    52,156 
Investment in affiliated company   63,549    107,861 
Total assets  $1,618,184   $1,924,763 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
Current liabilities:          
Accounts payable  $19,779   $8,868 
Accrued expenses and other   243,512    219,344 
Income taxes payable   1,600     
Total current liabilities   264,891    228,212 
Total liabilities   264,891    228,212 
           
Commitments and contingencies        
           
Stockholders’ equity:          
Preferred stock, $0.00001 par value; 5,000,000 shares authorized: none outstanding        
Common stock, $0.00001 par value: 600,000,000 shares authorized: 438,242,618 shares issued and 401,392,948 shares outstanding at August 31, 2019 and May 31, 2019   4,382    4,382 
Additional paid-in capital   77,444,062    77,444,062 
Accumulated deficit   (61,469,283)   (61,126,025)
Common stock held in treasury, at cost – 36,849,670 shares at August 31, 2019 and May 31, 2019   (14,625,868)   (14,625,868)
Total stockholders’ equity   1,353,293    1,696,551 
Total liabilities and stockholders’ equity  $1,618,184   $1,924,763 

 

See accompanying notes to unaudited condensed consolidated financial statements

 

 

 

 3 

 

 

Patriot Scientific Corporation

Condensed Consolidated Statements of Operations

(Unaudited)

 

   Three months ended 
   August 31, 2019   August 31, 2018 
Operating expenses:          
Selling, general and administrative  $303,037   $203,481 
Total operating expenses   303,037    203,481 
           
Other income (expense):          
Interest income   5,691    6,943 
Equity in loss of affiliated company   (44,312)   (14,780)
Total other expense, net   (38,621)   (7,837)
           
Loss before income taxes   (341,658)   (211,318)
           
Provision for income taxes   1,600    1,600 
           
Net loss  $(343,258)  $(212,918)
           
Basic and diluted loss per common share  $   $ 
           
Weighted average number of common shares outstanding – basic   398,548,318    398,548,318 
           
Weighted average number of common shares outstanding – diluted   398,548,318    398,548,318 

 

See accompanying notes to unaudited condensed consolidated financial statements

 

 

 

 

 

 

 

 

 4 

 

 

Patriot Scientific Corporation

Condensed Consolidated Statements of Cash Flows

(Unaudited)

 

   Three months ended 
   August 31, 2019   August 31, 2018 
Operating activities:          
Net loss  $(343,258)  $(212,918)
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation   122    122 
Equity in loss of affiliated company   44,312    14,780 
Changes in operating assets and liabilities:          
Prepaid expenses and other current assets   (57,877)   (55,813)
Income taxes payable   1,600    1,600 
Accounts payable, accrued expenses and other   35,079    (8,096)
Net cash used in operating activities   (320,022)   (260,325)
           
Investing activities:          
Proceeds from sales of marketable securities   500,000     
Purchases of marketable securities   (250,000)    
Net cash provided by investing activities   250,000     
           
Net decrease in cash, cash equivalents, and restricted cash and cash equivalents   (70,022)   (260,325)
Cash, cash equivalents, and restricted cash and cash equivalents, beginning of period   985,929    2,319,449 
Cash, cash equivalents, and restricted cash and cash equivalents, end of period  $915,907   $2,059,124 
           
Reconciliation of cash, cash equivalents, and restricted cash and cash equivalents at end of period:          

Cash and cash equivalents

  $738,660   $2,037,537 
Restricted cash and cash equivalents   177,247    21,587 
   $915,907   $2,059,124 

 

See accompanying notes to unaudited condensed consolidated financial statements.

 

 

 

 5 

 

 

Patriot Scientific Corporation

Condensed Consolidated Statements of Stockholders’ Equity

(Unaudited)

 

 

For the three months ended August 31, 2018                    
   Common Stock   Additional
Paid-in
   Accumulated   Treasury   Total
Stockholders’
 
   Shares   Amounts   Capital   Deficit   Stock   Equity 
Balance, May 31, 2018   401,392,948   $4,382   $77,444,062   $(60,327,562)  $(14,625,868)  $2,495,014 
Net loss               (212,918)       (212,918)
Balance, August 31, 2018   401,392,948   $4,382   $77,444,062   $(60,540,480)  $(14,625,868)  $2,282,096 

 

 

 

 

For the three months ended August 31, 2019                    
   Common Stock   Additional
Paid-in
   Accumulated   Treasury   Total
Stockholders’
 
   Shares   Amounts   Capital   Deficit   Stock   Equity 
Balance, May 31, 2019   401,392,948   $4,382   $77,444,062   $(61,126,025)  $(14,625,868)  $1,696,551 
Net loss               (343,258)       (343,258)
Balance, August 31, 2019   401,392,948   $4,382   $77,444,062   $(61,469,283)  $(14,625,868)  $1,353,293 

 

See accompanying notes to unaudited condensed consolidated financial statements.

 

 

 

 

 

 

 

 6 

 

 

Patriot Scientific Corporation

Notes to Unaudited Condensed Consolidated Financial Statements

 

1. Basis of Presentation and Summary of Significant Accounting Policies

 

The unaudited condensed consolidated financial statements of Patriot Scientific Corporation (the “Company”, “PTSC”, “Patriot”, “we”, “us” or “our”) presented herein have been prepared pursuant to the rules of the Securities and Exchange Commission (“SEC”) for quarterly reports on Form 10-Q and do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America. These unaudited condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements and notes thereto included in our Report on Form 10-K for our fiscal year ended May 31, 2019.

 

The accompanying condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern. In the opinion of management, the interim condensed consolidated financial statements reflect all adjustments of a normal recurring nature necessary for a fair presentation of the results for the interim period presented. Operating results for the three month period ended August 31, 2019 are not necessarily indicative of the results that may be expected for the year ending May 31, 2020.

 

Basis of Consolidation

 

The condensed consolidated balance sheets at August 31, 2019 and May 31, 2019 include our accounts and those of our inactive subsidiary Patriot Data Solutions Group, Inc. (“PDSG”) which includes Crossflo Systems, Inc. (“Crossflo”). The condensed consolidated statements of operations, cash flows and stockholders’ equity for the three months ended August 31, 2019 and 2018 include our accounts and those of our inactive subsidiaries: PDSG and Plasma Scientific Corporation (“Plasma”). We dissolved Plasma in March 2018. All significant intercompany accounts and transactions have been eliminated.

 

Liquidity and Management’s Plans

 

The accompanying condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern. At August 31, 2019, the Company has an accumulated deficit of $61,469,283, and has incurred recurring losses and used significant amounts of cash in its operations. As of August 31, 2019, the Company had cash and cash equivalents and marketable securities of approximately $1,239,000 and working capital of approximately $1,237,000. Our only significant potential source of cash is PDS. PDS has not generated significant license revenues since September 2013. Therefore, our ability to continue and expand our operations is highly dependent on the amount of cash and cash equivalents and marketable securities on hand combined with our ability to raise additional capital to fund future operations. We anticipate, based on currently proposed plans and assumptions that our cash on hand will not satisfy our operational and capital requirements through twelve months from the date of filing on this Form 10-Q.

 

Cash shortfalls currently experienced by PDS will have an adverse effect on our liquidity. To date, we have determined that it is in the best interests of the Moore Microprocessor Patent (“MMP”) licensing program that we provide our 50% share of capital to provide for PDS expenses including legal retainers and litigation related payments in the event license revenues received by PDS are insufficient to meet these needs. We believe contributions to PDS to fund working capital may be required.

 

PDS had been incurring significant third-party costs for legal fees, expert testimony, depositions and other related litigation costs. We could be required to make capital contributions to PDS for any future litigation related costs in the event that PDS does not receive sufficient licensing revenues to pay these expenses.

 

 

 

 7 

 

 

Patriot Scientific Corporation

Notes to Unaudited Condensed Consolidated Financial Statements

 

PDS is currently pursuing a litigation strategy, which includes the filing, on September 6, 2019, a petition for a writ of certiorari with the Supreme Court of the United States in regards to a decision by the United States Court of Appeals for the Federal Circuit, stemming from litigation in U.S. District Court against multiple companies alleged to be infringers of the MMP portfolio. We continue to believe that the significant investment in legal effort and costs incurred to date at PDS is necessary for the protection of our interests in the MMP portfolio and its future success, although to date it has generated mixed results.

 

On March 20, 2013, TPL filed a petition under Chapter 11 of the United States Bankruptcy Code. On March 5, 2018, TPL’s Motion for Entry of Final Decree Closing Chapter 11 was granted. In the event we are required to provide funding to PDS that is not reciprocated by TPL, our ownership percentage in PDS will increase and we will have a controlling financial interest in PDS, in which case, we will consolidate PDS in our consolidated financial statements.

 

On April 12, 2019, we entered into an agreement with Artius Bioconsulting LLC, (“Artius”), to evaluate the potential of establishing a company that develops a platform that could be implemented throughout the drug development process utilizing blockchain technologies. We are anticipating receiving shortly a feasibility report with its analysis. In the event the next steps in the development of a blockchain based business are undertaken, it is expected that funding from external sources will be required.

 

There are a number of uncertainties associated with our financial projections that could increase our projected expenses, which would further accelerate cash usage. Additionally, if we are unable to realize satisfactory cash from operations in the near future, we will be required to seek additional financing to continue our operations. We will also require additional financing to develop or acquire new lines of business. We have no current arrangements with respect to any additional financing. Consequently, there can be no assurance that any additional financing on commercially reasonable terms, or at all, will be available when needed. The inability to obtain additional capital may reduce our ability to continue to conduct business operations. Any additional equity financing may involve substantial dilution to our then existing stockholders. The above matters raise substantial doubt regarding our ability to continue as a going concern.

 

Investment in Affiliated Companies

 

We have a 50% interest in PDS. We account for our investment using the equity method of accounting since the investment provides us the ability to exercise significant influence, but not control, over the investee. Significant influence is generally deemed to exist if we have an ownership interest in the voting stock of the investee of between 20% and 50%, although other factors, such as representation on the investee’s Board of Directors, are considered in determining whether the equity method of accounting is appropriate. Under the equity method of accounting, the investment, originally recorded at cost, is adjusted to recognize our share of net earnings or losses of the investee and is recognized in the condensed consolidated statements of operations in the caption “Equity in earnings (loss) of affiliated company” and also is adjusted by contributions to and distributions from PDS.

 

PDS, as an unconsolidated equity investee, recognizes revenue from technology license agreements at the time a contract is entered into, the license method is determined (paid-in-advance or on-going royalty), performance obligations under the license agreement are satisfied, and the realization of revenue is assured which is generally upon the receipt of the license proceeds. PDS may at times enter into license agreements whereby contingent revenues are recognized as one or more contractual milestones are met.

 

We review our investment in PDS to determine whether events or changes in circumstances indicate that the carrying amount may not be recoverable. The primary factors we consider in our determination are the financial condition, operating performance and near term prospects of PDS. If the decline in value is deemed to be other than temporary, we would recognize an impairment loss.

 

We own 100% of the preferred stock of Holocom (see Note 3). Prior to impairment, this investment was accounted for at cost since we do not have the ability to exercise significant influence over the operating and financial policies of Holocom.

 

 

 

 8 

 

 

Patriot Scientific Corporation

Notes to Unaudited Condensed Consolidated Financial Statements

 

Income (Loss) Per Share

 

Basic income (loss) per share includes no dilution and is computed by dividing income (loss) available to common stockholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share reflect the potential dilution of securities that could share in the earnings of an entity.

 

At August 31, 2019 and 2018, potential common shares of 1,600,000 related to our outstanding options were not included in the calculation of diluted loss per share as we recorded a loss. Had we reported net income for the three months ended August 31, 2019 and 2018, no shares of common stock would have been included in the calculation of diluted income per share using the treasury stock method.

 

In connection with our acquisition of Crossflo, which became a part of PDSG, we issued 2,844,630 escrow shares that are contingent upon certain representations and warranties made by Crossflo at the time of the merger agreement (see Note 6). We exclude these escrow shares from the basic income (loss) per share calculations and would have included the escrowed shares in the diluted income per share calculations if we reported net income.

 

Income Taxes

 

We follow authoritative guidance in accounting for uncertainties in income taxes. This authoritative guidance prescribes a recognition threshold and measurement requirement for the financial statement recognition of a tax position that has been taken or is expected to be taken on a tax return and also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. Under this guidance we may only recognize tax positions that meet a “more likely than not” threshold.

 

We follow authoritative guidance to evaluate whether a valuation allowance should be established against our deferred tax assets based on the consideration of all available evidence using a “more likely than not” standard. In making such judgments, significant weight is given to evidence that can be objectively verified. We assess our deferred tax assets annually under more likely than not scenarios in which they may be realized through future income.

 

With the exception for refundable alternative minimum tax (“AMT”) credits, we have determined that it was more likely than not that all of our deferred tax assets will not be realized in the future due to our continuing pre-tax and taxable losses. As a result of this determination, and with the exception for the aforementioned refundable tax credits, we have recorded a full valuation allowance against our deferred tax assets.

 

On December 22, 2017, the United States Government passed the Tax Cuts and Jobs Act (“Tax Cuts Act”) that, among other provisions, has lowered the corporate tax rate from 35% to 21%. In addition to applying the new lower corporate tax rate in 2018 and thereafter to any taxable income we may have, the legislation affects the way we can use and carryforward net operating losses previously accumulated and results in a revaluation of deferred tax assets and liabilities recorded on our condensed consolidated balance sheet. The Securities and Exchange Commission staff issued Staff Accounting Bulletin No. 118 (“SAB 118”) which provides guidance regarding accounting for the income tax effects of the Tax Cuts Act, including the impact of the Tax Cuts Act on deferred tax assets and liabilities for financial statements issued in the reporting period that includes the enactment date of December 22, 2017. Given that our current deferred tax assets, with the exception of those representing certain refundable tax credits, are offset by a full valuation allowance, these changes had no net impact on our condensed consolidated balance sheet. However, if we become profitable, we will receive a reduced benefit from such deferred tax assets.

 

Assessment of Contingent Liabilities

 

We are involved in various legal matters, disputes, and patent infringement claims which arise in the ordinary course of our business. We accrue for any estimated losses at the time when we can make a reliable estimate of such loss and it is probable that it has been incurred. By their very nature, contingencies are difficult to estimate. We continually evaluate information related to all contingencies to determine that the basis on which we have recorded our estimated exposure is appropriate.

 

 

 

 9 

 

 

Patriot Scientific Corporation

Notes to Unaudited Condensed Consolidated Financial Statements

 

Intellectual Property Rights

 

PDS, our investment in affiliated company, relies on a combination of patents, trademarks, copyrights, trade secret laws, confidentiality procedures and licensing arrangements to protect our intellectual property rights. We have seven U.S., nine European, and three Japanese patents all of which expired between August 2009 and October 2016. These patents, while expired, may have certain retrospective statutory benefits that will fully diminish six years after the patent expiration dates. The patent useful life for purposes of negotiating licenses is finite and these patents are subject to legal challenges, which in combination with the limited life, could adversely impact the stream of revenues. A successful challenge to the ownership of the technology or the proprietary nature of the intellectual property would materially damage business prospects. Any issued patent may be challenged and invalidated.

 

Recent Accounting Pronouncements

 

In February 2016, the FASB issued ASU No. 2016-02, “Leases (Topic 842)”, as amended ("ASC 842"), which modifies lease accounting for lessees to increase transparency and comparability by recording lease assets and liabilities for operating leases and disclosing key information about leasing arrangements. ASU 2018-13 is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2018. The Company adopted ASC 842 effective June 1, 2019 using a modified retrospective method and will not restate comparative periods. As permitted under the transition guidance, the Company will carry forward the assessment of whether its contracts contain or are leases, classification of its leases and remaining lease terms. Implementation of this guidance did not have a material impact on the Company’s consolidated financial statements. We have elected the short-term lease recognition exemption for all applicable classes of underlying assets. Short-term leases include only those leases with a term greater than one month and twelve months or less. Short-term leases are not recorded on the consolidated balance sheet, and lease expense on short-term leases is recognized on a straight-line basis over the lease term. The Company elected the “practical expedient package” as permitted under ASC 842. Therefore, the Company has not reassessed whether any expired or existing contracts are, or contain, leases; the Company has not reassessed the lease classification for any expired or existing leases; and the Company has not reassessed initial direct costs for any expired or existing leases. The Company currently leases office space on a month-to-month basis.

 

In August 2018, the FASB issued ASU No. 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement” (“ASU 2018-13”), which removes, modifies, and adds various disclosure requirements on fair value measurements in Topic 820. ASU 2018-13 is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2019. The amendments on changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. Early adoption is permitted upon issuance of this update. An entity is permitted to early adopt any removed or modified disclosures upon issuance of this update and delay adoption of the additional disclosures until their effective date. The Company does not expect a significant impact from adopting this update on its consolidated financial statements.

 

2. Cash, Cash Equivalents and Restricted Cash

 

We follow authoritative guidance to account for our marketable securities as held-to-maturity. Under this authoritative guidance we are required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. We determine fair value based on quoted prices when available or through the use of alternative approaches, such as discounting the expected cash flows using market interest rates commensurate with the credit quality and duration of the investment or valuations by third party professionals. The three levels of inputs that we may use to measure fair value are:

 

Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;

 

Level 2: Quoted prices in markets that are not active or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; and

 

Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e. supported by little or no market activity).

 

 

 

 10 

 

 

Patriot Scientific Corporation

Notes to Unaudited Condensed Consolidated Financial Statements

 

The following tables detail the fair value measurements within the fair value hierarchy of our cash, cash equivalents and investments in marketable securities:

 

       Fair Value Measurements at August 31, 2019 Using 
   Fair Value at
August 31,
2019
   Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
   Significant Other
Observable
Inputs
(Level 2)
   Significant
Unobservable
Inputs
(Level 3)
 
Cash and cash equivalents:                    
Cash  $46,048   $46,048   $   $ 
Money market funds   692,612    692,612         
Restricted cash and cash equivalents   177,247    177,247         
Investments in marketable securities:                    
Certificates of deposit   500,000        500,000     
Total  $1,415,907   $915,907   $500,000   $ 

 

 

       Fair Value Measurements at May 31, 2019 Using 
   Fair Value at
May 31,
2019
   Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
   Significant Other
Observable
Inputs
(Level 2)
   Significant
Unobservable
Inputs
(Level 3)
 
Cash and cash equivalents:                    
Cash  $49,149   $49,149   $   $ 
Money market funds   237,937    237,937         
Certificates of deposit   500,000        500,000     
Restricted cash and cash equivalents   198,843    198,843         
Investments in marketable securities:                    
Certificates of deposit   750,000        750,000     
Total  $1,735,929   $485,929   $1,250,000   $ 

 

 

 

 

 11 

 

 

Patriot Scientific Corporation

Notes to Unaudited Condensed Consolidated Financial Statements

 

We purchase certificates of deposit with varying maturity dates. The following tables summarize the purchase date maturities, gross unrealized gains or losses and fair value of the certificates of deposit as of August 31, 2019 and May 31, 2019:

 

  

August 31, 2019

(Unaudited)

 
   Cost   Gross Unrealized Gains/(Losses)   Fair
Value
 
Maturity            
Due in greater than three months  $500,000   $   $500,000 

 

 

   May 31, 2019 
   Cost   Gross Unrealized Gains/(Losses)   Fair
Value
 
Maturity            
Due in three months or less  $500,000   $   $500,000 
Due in greater than three months   750,000        750,000 
   $1,250,000   $   $1,250,000 

 

3. Investment in Affiliated Companies

 

Phoenix Digital Solutions, LLC

 

On June 7, 2005, we entered into a Master Agreement (the “Master Agreement”) with TPL, and Charles H. Moore (“Moore”), the co-inventor of the technology which is the subject of the MMP portfolio of microprocessor patents, pursuant to which the parties resolved all legal disputes between them. Pursuant to the Master Agreement, we and TPL entered into the Limited Liability Company Operating Agreement of PDS (the “LLC Agreement”) into which we and Moore contributed our rights to certain of our technologies.

 

We and TPL each own 50% of the membership interests of PDS, and each member has the right to appoint one member of the three-member management committee. The two appointees are required to select a mutually acceptable third member of the management committee. There had not been a third management committee member since May 2010; however, as a result of our initiation of arbitration seeking the appointment of a third member, on December 16, 2014, an independent manager to the PDS management committee was selected by the arbitrator. Pursuant to the LLC Agreement, we and TPL initially agreed to establish a working capital fund for PDS of $4,000,000, of which our contribution was $2,000,000. The working capital fund was increased to a maximum of $8,000,000 as license revenues are achieved. We and TPL are obligated to fund future working capital requirements at the discretion of the management committee of PDS in order to maintain working capital of not more than $8,000,000. If the management committee determines that additional capital is required, neither we nor TPL are required to contribute more than $2,000,000 in any fiscal year. No such contributions were made during the three months ended August 31, 2019 and 2018. Distributable cash and allocation of profits and losses have been allocated to the members in the priority defined in the LLC Agreement.

 

On July 11, 2012, we entered into the Program Agreement with PDS, TPL, and Alliacense, and an Agreement (the “TPL Agreement”) with TPL. Pursuant to the Program Agreement, PDS engaged Alliacense to negotiate MMP portfolio licenses and to pursue claims against violators of the MMP portfolio on behalf of PDS, TPL, and the Company. The Program Agreement continued through the useful life of the MMP portfolio patents. Pursuant to the TPL Agreement, we and TPL agreed to certain allocations of obligations in connection with the engagement of Alliacense. On July 24, 2014, the Program Agreement was amended with PDS and Alliacense entering into the Amended Alliacense Services and Novation Agreement (the “Novation Agreement”). Pursuant to the Novation Agreement certain performance goals and incentives were established for Alliacense. The Novation Agreement also provided for the addition of a second licensing company, which was engaged on October 10, 2014, to complement the MMP licensing commercialization. However, Alliacense fulfilled only a portion of its obligations under the Novation Agreement associated with the deployment of the second licensing company and on May 11, 2015, Alliacense was terminated by PDS.

 

 

 

 12 

 

 

Patriot Scientific Corporation

Notes to Unaudited Condensed Consolidated Financial Statements

 

On August 10, 2016, PDS entered into an agreement with Alliacense and MMP Licensing, LLC to settle matters relating to Alliacense’s non-performance under terms of the Novation Agreement. The August 10, 2016 agreement required Alliacense to provide PDS’s second licensing company, Dominion Harbor Group (“DHG”), with certain materials and to cooperate with reasonable discovery requests relating to infringement litigation in the U.S. District Court for the Northern District of California. MMP Licensing, LLC will provide commercialization services to PDS for the MMP portfolio with respect to certain companies. PDS and Alliacense have agreed to cause the arbitration between the parties to be dismissed with prejudice. The August 10, 2016 agreement, and the agreement retaining DHG as PDS’s second licensing company, will both expire on October 4, 2022. Terms of the settlement agreement required PDS to pay Alliacense $84,000 within 24 hours after delivery of materials to PDS’s second licensing agent and to pay Alliacense $84,000 out of subsequent recoveries. PDS paid Alliacense $84,000 on each of August 11, 2016 and October 3, 2016.

 

During January 2013, TPL and Moore settled their litigation. Terms of the settlement included the payment by PDS to Moore of a consulting fee of $250,000 for four years or until the completion of all outstanding MMP litigation whichever came first. Per terms of the agreement, PDS paid Moore $150,000 on the settlement date and paid Moore $16,667 per month from August 2013 through January 2014 and $20,833 per month beginning February 2014 through January 2017.

  

Based on our analysis of current authoritative accounting guidance with respect to our investment in PDS, we continue to account for our investment in PDS under the equity method of accounting, and accordingly have recorded our share of PDS’s net loss during the three months ended August 31, 2019 and 2018 of $44,312 and $14,780, respectively, as a decrease in our investment as “Equity in loss of affiliated company” in the accompanying condensed consolidated statements of operations.

 

On March 20, 2013, TPL filed a petition under Chapter 11 of the United States Bankruptcy Code. On March 5, 2018, TPL’s Motion for Entry of Final Decree Closing Chapter 11 was granted. In the event we are required to provide funding to PDS that is not reciprocated by TPL, our ownership percentage in PDS will increase and we will have a controlling financial interest in PDS, in which case, we will consolidate PDS in our condensed consolidated financial statements. If we determine that it is appropriate to consolidate PDS, we would measure the assets, liabilities and noncontrolling interests of PDS at their fair values at the date that we have the controlling financial interest.

 

PDS’s balance sheets at August 31, 2019 and May 31, 2019 and statements of operations for the three months ended August 31, 2019 and 2018 are as follows:

 

Balance Sheets

 

Assets:

 

   August 31, 2019   May 31, 2019 
    (Unaudited)      
           
Cash  $234,758   $237,655 
Total assets  $234,758   $237,655 

 

 

 

 13 

 

 

Patriot Scientific Corporation

Notes to Unaudited Condensed Consolidated Financial Statements

 

Liabilities and Members’ Equity:

 

    August 31, 2019    May 31, 2019 
    (Unaudited)      
           
Payables  $107,661   $21,933 
Members’ equity   127,097    215,722 
Total liabilities and members’ equity  $234,758   $237,655 

 

Statements of Operations

 

  

Three Months Ended

August 31,

 
   2019   2018 
   (Unaudited)   (Unaudited) 
           
Expenses  $88,625   $29,559 
Net loss  $(88,625)   (29,559)

 

We review our investment in PDS to determine whether events or changes in circumstances indicate that the carrying amount may not be recoverable. The primary factors we consider in our determination are the financial condition, operating performance and near term prospects of PDS. If a decline in value is deemed to be other than temporary, we would recognize an impairment loss.

 

Holocom, Inc.

 

We currently own 2,100,000 shares of preferred stock, equivalent to an approximate 46% ownership interest on an after converted basis, in Holocom, Inc. (“Holocom”), a California corporation that manufactures products that protect information transmitted over secure networks. The shares are convertible at our option into shares of Holocom’s common stock on a one-to-one basis. The preferred stock entitles us to receive non-cumulative dividends at the per annum rate of $0.04 per share, when and if declared by the Board of Directors of Holocom, as well as a liquidation preference of $0.40 per share, plus an amount equal to all declared but unpaid dividends.

 

In 2010, we determined that the inability of Holocom to meet its business plan, raise capital, and the general economic environment were indicators of impairment on our investment and we wrote-off our cost basis investment in Holocom. At August 31, 2019 and May 31, 2019, our investment in Holocom was valued at $0.

 

4. Income Taxes

 

On December 22, 2017, the United States Government passed the Tax Cuts and Jobs Act (“Tax Cuts Act”) that, among other provisions, has lowered the corporate tax rate from 35% to 21%. In addition to applying the new lower corporate tax rate in 2018 and thereafter to any taxable income we may have, the legislation affects the way we can use and carryforward net operating losses previously accumulated and results in a revaluation of deferred tax assets and liabilities recorded on our condensed consolidated balance sheet. The Securities and Exchange Commission staff issued Staff Accounting Bulletin No. 118 (“SAB 118”) which provides guidance regarding accounting for the income tax effects of the Tax Cuts Act, including the impact of the Tax Cuts Act on deferred tax assets and liabilities for financial statements issued in the reporting period that includes the enactment date of December 22, 2017. Given that our current deferred tax assets, with the exception of those representing certain refundable tax credits, are offset by a full valuation allowance, these changes had no net impact on our condensed consolidated balance sheet. However, if we become profitable, we will receive a reduced benefit from such deferred tax assets.

 

 

 

 14 

 

 

Patriot Scientific Corporation

Notes to Unaudited Condensed Consolidated Financial Statements

 

5. Stockholders’ Equity

 

Share-based Compensation

 

Summary of Assumptions and Activity

 

The fair value of share-based awards to employees and directors is calculated using the Black-Scholes option pricing model, even though this model was developed to estimate the fair value of freely tradable, fully transferable options without vesting restrictions, which differ significantly from our stock options.

 

The Black-Scholes model also requires subjective assumptions, including future stock price volatility and expected time to exercise, which greatly affect the calculated values. The expected term of options granted is derived from historical data on employee exercises and post-vesting employment termination behavior. The risk-free rate selected to value any particular grant is based on the U.S. Treasury rate that corresponds to the pricing term of the grant effective as of the date of the grant. The expected volatility is based on the historical volatilities of our common stock. These factors could change in the future, affecting the determination of share-based compensation expense in future periods.

 

A summary of option activity as of August 31, 2019 and changes during the three months then ended, is presented below:

 

   Shares   Weighted Average Exercise Price   Weighted Average Remaining Contractual Term (Years)   Aggregate Intrinsic Value 
Options outstanding at June 1, 2019   1,600,000   $0.03           
Options granted      $           
Options exercised      $           
Options forfeited/expired      $           
Options outstanding at August 31, 2019   1,600,000   $0.03    0.68   $ 
Options vested and expected to vest at August 31, 2019   1,600,000   $0.03    0.68   $ 
Options exercisable at August 31, 2019   1,600,000   $0.03    0.68   $ 

 

The aggregate intrinsic value represents the differences in market price at the close of the quarter ($0.004 per share on August 31, 2019) and the exercise price of outstanding, in-the-money options (those options with exercise prices below $0.004 per share) on August 31, 2019.

 

6. Commitments and Contingencies

 

Litigation

 

Patent Litigation

 

We, TPL, and PDS (collectively referred to as “Plaintiffs”) are Plaintiffs in ongoing proceedings in the U.S. District Court for the Northern District of California where the Plaintiffs allege infringement of the US 5,809,336 patent (the “‘336 patent”) by: Huawei Technologies Co. Ltd., LG Electronics, Nintendo Co. Ltd., Samsung Electronics Co. Ltd., and ZTE Corporation (collectively referred to as the “Defendants”). This litigation is proceeding in front of District Court Judge Vince Chhabria.

 

 

 

 15 

 

 

Patriot Scientific Corporation

Notes to Unaudited Condensed Consolidated Financial Statements

 

These ongoing proceedings relate to the proceedings filed by the Plaintiffs in February 2008 in the U.S. District Court for the Northern District of California alleging infringement of the US 5,440,749 patent (the “‘749 patent”), the US 5,530,890 patent (the “‘890 patent”) and the ‘336 patent against Amazon.com Inc., Barnes & Noble Inc., Garmin Ltd., Huawei Technologies Co. Ltd., Kyocera Corporation, LG Electronics, Nintendo Co. Ltd., Novatel Wireless Inc., Samsung Electronics Co. Ltd., Sierra Wireless Inc., and ZTE Corporation. We have settled with all defendants except those named in the first paragraph to this footnote. On September 18, 2015, a Markman hearing was held before U.S. Magistrate Judge Grewal and, on September 22, 2015, he issued a claim construction report and recommendation. On September 25, 2015, as a result of the claim construction report and recommendation, Plaintiffs and defendants, with the exception of Huawei Technologies Co. Ltd., (“Huawei”) agreed to stay all proceedings pending resolution of Plaintiffs’ objections to the claim construction report and recommendation. Plaintiffs further stipulated that, under the claim construction provided by the report and recommendation, defendants’ products do not infringe the ‘336 patent, and, in the event that the Court does not materially modify the claim construction, Plaintiffs and defendants ask that the Court enter a final judgment of non-infringement. After Plaintiffs and Huawei filed opposing letter briefs with the Court, U.S. Magistrate Judge Grewal stayed the action against Huawei pending resolution of Plaintiffs’ objections to the claim construction. On October 6, 2015, Plaintiffs filed objections to the claim construction with District Court Judge Chhabria. Judge Chhabria rejected those objections on November 9, 2015. Based on that order, the parties stipulated to a judgment of non-infringement as to the ‘336 patent and such judgment was entered on November 13, 2015.

 

On December 7, 2015, Plaintiffs filed notices of appeal with the U.S. Federal Circuit appealing the district court’s claim construction. Plaintiffs filed their opening appellate brief on March 10, 2016. Defendants filed their response brief on May 23, 2016, with Plaintiffs filing their reply brief on June 23, 2016. On March 3, 2017, the U.S. Court of Appeals for the Federal Circuit rendered its decision modifying the claim construction that was issued in September 2016 by the U.S. District Court for the Northern District of California and has remanded the matter to the District Court for further proceedings.

 

On May 23, 2017, a case management conference was held in front of District Court Judge Chhabria, who ordered that Plaintiffs amend their infringement contentions on or before June 16, 2017. Judge Chhabria further ordered that Defendants submit any motion for summary judgment based on the amended infringement contentions and the modified claim construction by August 1, 2017. On June 5, 2017, the law firm of Banys, P.C., who had served as local counsel for PDS, withdrew as counsel. PDS continued to be represented by the law firm of Nelson Bumgardner, P.C. On June 16, 2017, Plaintiffs timely amended their infringement contentions. On July 13, 2017, all remaining counsel for each of Patriot, TPL, and PDS moved to withdraw as counsel and further moved to extend all currently pending case deadlines by 60 days for Plaintiffs to seek new counsel.

 

On September 13, 2017, the law firm of Bunsow De Mory LLP was entered before the U.S. District Court for the Northern District of California as successor counsel in representation of Patriot, PDS, and TPL.

 

The Defendants moved for summary judgment of non-infringement on September 29, 2017, and the Court held a hearing on Defendants’ motion on November 30, 2017. The Court granted Defendants’ motion and entered judgment of non-infringement on December 13, 2017.

 

Defendant Samsung submitted a bill of costs seeking $30,170 in taxable costs in the underlying district court proceedings; Plaintiffs filed an objection to significant portions of that request. On March 1, 2018, the Clerk of the District Court taxed costs in the amount $829.

 

Plaintiffs filed notices of appeal in these district court matters on January 5, 2018. The appeals were docketed and consolidated under lead case No. 18-1439, captioned as Technology Properties Limited v. Huawei Technologies Co., Ltd in the United States Court of Appeals for the Federal Circuit. Oral argument proceeded on February 4, 2019. The Court affirmed the lower court’s determination without written opinion pursuant to Federal Circuit Rule 36 on February 6, 2019. Plaintiffs filed a Petition for Rehearing En Banc on March 8, 2019 which was denied by the Court on April 10, 2019.

 

On September 6, 2019, Plaintiffs filed a petition for a writ of certiorari with the Supreme Court of the United States as a result of the United States Court of Appeals outcome.

 

 

 

 16 

 

 

Patriot Scientific Corporation

Notes to Unaudited Condensed Consolidated Financial Statements

 

Employment Contracts

 

In connection with Mr. Flowers’ appointment as the Chief Financial Officer, and commencing on September 17, 2007, we entered into an employment agreement with Mr. Flowers for an initial 120-day term if not terminated pursuant to the agreement, with an extension period of one year and on a continuing basis thereafter. On December 30, 2016, we entered into an amended and restated employment agreement with Mr. Flowers. Pursuant to the amended December 30, 2016 agreement, if Mr. Flowers is terminated without cause or resigns with good reason any time after two years of continuous employment, he is entitled to receive an amount equal to 1.25 times his annual base salary. Mr. Flowers is also entitled to certain payments upon a change of control of the Company if the surviving corporation does not retain him. All such payments are conditional upon the execution of a general release. Mr. Flowers resigned effective October 1, 2019 (see Note 7).

 

Guarantees and Indemnities

 

We have made certain guarantees and indemnities, under which we may be required to make payments to a guaranteed or indemnified party. We indemnify our directors, officers, employees and agents to the maximum extent permitted under the laws of the State of Delaware. The duration of the guarantees and indemnities varies, and in many cases is indefinite. These guarantees and indemnities do not provide for any limitation of the maximum potential future payments we could be obligated to make. Historically, we have not been obligated to make any payments for these obligations and no liabilities have been recorded for these guarantees and indemnities in the accompanying condensed consolidated balance sheets.

 

Escrow Shares

 

On August 31, 2009 we gave notice to the former shareholders of Crossflo and Union Bank of California (the “Escrow Agent”) under Section 2.5 of the Agreement and Plan of Merger between us and Crossflo (the “Agreement”), outlining damages incurred by us in conjunction with the acquisition of Crossflo, and seeking the return of 2,844,630 shares of our common stock held by the Escrow Agent. Subsequently, former shareholders of Crossflo representing a majority of the escrowed shares responded in protest to our claim, delaying the release of the escrowed shares until a formal resolution is reached. In the event we fail to prevail in our claim against the escrowed shares, we may be obligated to deposit into escrow approximately $256,000 of cash consideration due to the decline in our average stock price over the one year escrow period, calculated in accordance with the Section 2.5 of the Agreement. We have evaluated the potential for loss regarding our claim and believe that it is probable that the resolution of this issue will not result in a material obligation to the Company, although there is no assurance of this. Accordingly, we have not recorded a liability for this matter.

 

7. Subsequent Events

 

Mr. Clifford L. Flowers, Chief Financial Officer, Secretary, Treasurer and member of the Company’s Board of Directors, resigned his positions effective October 1, 2019. On October 3, 2019, our Board appointed Mr. Carlton Johnson Jr. as the Interim Chief Financial Officer on an interim basis. There were no known disagreements with Mr. Flowers regarding our operations, policies or practices.

 

In connection with his departure, Mr. Flowers entered into a Separation Agreement and General Release of All Claims as of with the Company (the “Release”). Pursuant to the Release, Mr. Flowers is entitled to receive severance payments equal to $327,750, less all appropriate federal and state tax withholding, which will be made in seven equal installments on the 30th of each month commencing on October 30, 2019 and ending April 30, 2020. The payments under the Release are in lieu of any rights under the employment agreement between Mr. Flowers and the Company. The Release also contains a mutual general release, confidentiality, non-disparagement and other covenants and agreements.

 

 

 

 17 

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

THE FOLLOWING DISCUSSION AND THE REST OF THIS QUARTERLY REPORT ON FORM 10-Q INCLUDES FORWARD-LOOKING STATEMENTS WITH RESPECT TO OUR FUTURE FINANCIAL PERFORMANCE. ACTUAL RESULTS MAY DIFFER MATERIALLY FROM THOSE CURRENTLY ANTICIPATED AND FROM HISTORICAL RESULTS DEPENDING UPON A VARIETY OF FACTORS, INCLUDING THOSE DESCRIBED BELOW UNDER THE SUB-HEADING, "RISK FACTORS". SEE ALSO OUR ANNUAL REPORT ON FORM 10-K FOR THE YEAR ENDED MAY 31, 2019.

 

Overview

 

In June 2005, we entered into a series of agreements with TPL and others to facilitate the pursuit of unlicensed users of our intellectual property. Over the years we, TPL and TPL’s affiliate, Alliacense, have entered into various agreements regarding licensing and litigation of the MMP portfolio. Pursuant to a July 2014 Novation Agreement with Alliacense PDS engaged a second licensing agent for the MMP portfolio in October 2014 and on May 11, 2015, PDS terminated Alliacense as licensing agent due to the inability of Alliacense to fulfill its obligations under the Novation Agreement. In August 2016, PDS and Alliacense entered into an agreement which requires Alliacense to: cooperate with reasonable discovery requests, provide support to litigation counsel, and deliver certain materials to PDS’s second licensing agent. Pursuant to the August 2016 agreement, MMP Licensing, LLC will provide MMP portfolio commercialization services to PDS for certain companies. PDS is currently pursuing a litigation strategy, which includes the filing of a petition for a writ of certiorari with the Supreme Court of the United States in regards to a decision by the United States Court of Appeals for the Federal Circuit, stemming from litigation in U.S. District Court against multiple companies alleged to be infringers of the MMP portfolio. We continue to believe that the significant investment in legal effort and costs incurred to date at PDS is necessary for the protection of our interests in the MMP portfolio.

 

Management expects to continue to incur significant legal expenses for the continued operation of PDS. PDS has been incurring significant costs pursuant to its litigation activity. We could be required to make capital contributions to PDS for any future litigation related costs in the event that PDS does not receive sufficient licensing revenues to pay these expenses.

 

On April 12, 2019, we entered into an agreement with Artius Bioconsulting LLC (“Artius”), to evaluate the potential of establishing a systems integration company that develops a blockchain based technology platform that could be implemented throughout the drug development process. We believe there is an opportunity to improve drug development through the use of blockchain, and believe blockchain technologies have the potential to be uniquely suited for creating efficiencies to improve how drugs are tested and developed, while ultimately leading to reduced costs. Pursuant to the agreement, Artius is performing research, analysis and reporting its findings in exchange for $151,000. We are anticipating receiving shortly a feasibility report with its analysis.

 

In the event we are required to provide funding to PDS that is not reciprocated by our joint venture partner TPL, our ownership percentage in PDS will increase and we will have a controlling financial interest in PDS, in which case, we will consolidate PDS in our condensed consolidated financial statements.

 

To the extent MMP portfolio license proceeds are insufficient; we expect working capital contributions may need to be made to PDS in the future. Cash shortfalls currently experienced by PDS will have an adverse effect on our liquidity. To date, we have determined that it is in the best interests of the MMP licensing program that we contribute our 50% share of additional capital to PDS in the event license revenues received by PDS are insufficient.

 

On October 10, 2019, PDS’s cash balance was $71,009. Management’s plans for the continued operation of PDS rely on the ability of PDS to obtain license agreements to cover its operational costs. PDS has experienced a decline in licensing revenues and has not obtained significant license revenues since September 2013 and it is unclear when any additional licensing revenues may be generated.

 

 

 

 18 

 

 

Critical Accounting Policies and Estimates

 

Our condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America, which require us to make estimates and judgments that significantly affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. Actual results could differ from those estimates, and such differences could affect the results of operations reported in future periods. We believe the following critical accounting policies affect our most significant estimates and judgments used in the preparation of our condensed consolidated financial statements.

  

1.Investments in Marketable Securities

 

We classify our investments in marketable securities in certificates of deposit at the time of purchase as held-to-maturity and reevaluate such classifications at each balance sheet date. Held-to-maturity investments consist of securities that we have the intent and ability to retain until maturity. These securities are recorded at cost and adjusted for the amortization of premiums and discounts, which approximates fair value. Cash inflows and outflows related to the sale and purchase of investments are classified as investing activities in our condensed consolidated statements of cash flows.

 

2.Investment in Affiliated Companies

 

We have a 50% interest in PDS. We account for our investment using the equity method of accounting since the investment provides us the ability to exercise significant influence, but not control, over the investee. Significant influence is generally deemed to exist if we have an ownership interest in the voting stock of the investee of between 20% and 50%, although other factors, such as representation on the investee’s Board of Directors, are considered in determining whether the equity method of accounting is appropriate. Under the equity method of accounting, the investment, originally recorded at cost, is adjusted to recognize our share of net earnings or losses of the investee and is recognized in the condensed consolidated statements of operations in the caption “Equity in loss of affiliated company” and also is adjusted by contributions to and distributions from PDS.

 

PDS, as an unconsolidated equity investee, recognizes revenue from technology license agreements at the time a contract is entered into, the license method is determined (paid-in-advance or on-going royalty), performance obligations under the license agreement are satisfied, and the realization of revenue is assured, which is generally upon the receipt of the license proceeds. PDS may at times enter into license agreements whereby contingent revenues are recognized as one or more contractual milestones are met.

 

We review our investment in PDS to determine whether events or changes in circumstances indicate that the carrying amount may not be recoverable. The primary factors we consider in our determination are the financial condition, operating performance and near term prospects of PDS. If a decline in value is deemed to be other than temporary, we would recognize an impairment loss.

 

We own 100% of the preferred stock of Holocom. Prior to impairment, this investment was accounted for at cost since we did not have the ability to exercise significant influence over the operating and financial policies of Holocom.

 

3.Income Taxes

 

We follow authoritative guidance in accounting for uncertainties in income taxes. This authoritative guidance prescribes a recognition threshold and measurement requirement for the financial statement recognition of a tax position that has been taken or is expected to be taken on a tax return and also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. Under this guidance we may only recognize tax positions that meet a “more likely than not” threshold.

 

We follow authoritative guidance to evaluate whether a valuation allowance should be established against our deferred tax assets based on the consideration of all available evidence using a “more likely than not” standard. In making such judgments, significant weight is given to evidence that can be objectively verified. We are assessing our deferred tax assets under more likely than not scenarios in which they may be realized through future income.

 

 

 

 19 

 

 

With the exception for refundable alternative minimum tax (“AMT”) credits, we have determined that it was more likely than not that all of our deferred tax assets will not be realized in the future due to our continuing pre-tax and taxable losses. As a result of this determination, and with the exception for the aforementioned refundable tax credits, we have recorded a full valuation allowance against our deferred tax assets.

 

On December 22, 2017, the United States Government passed new tax legislation that, among other provisions, lowered the corporate tax rate from 35% to 21%. In addition to applying the new lower corporate tax rate in 2018 and thereafter to any taxable income we may have, the legislation affects the way we can use and carryforward net operating losses previously accumulated and results in a revaluation of deferred tax assets and liabilities recorded on our condensed consolidated balance sheet. Given that our current deferred tax assets, with the exception of those representing certain refundable tax credits, are offset by a full valuation allowance, these changes had no net impact on our condensed consolidated balance sheet. However, if we become profitable, we will receive a reduced benefit from such deferred tax assets.

  

4.Assessment of Contingent Liabilities

 

We are involved in various legal matters, disputes, and patent infringement claims which arise in the ordinary course of our business. We accrue for any estimated losses at the time when we can make a reliable estimate of such loss and it is probable that it has been incurred. By their very nature, contingencies are difficult to estimate. We continually evaluate information related to all contingencies to determine that the basis on which we have recorded our estimated exposure is appropriate.

 

Results of Operations

 

Comparison of the Three Months Ended August 31, 2019 and Three Months Ended August 31, 2018.

 

   Three months ended 
   August 31, 2019   August 31, 2018 
Selling, general and administrative  $303,037   $203,481 

 

Selling, general and administrative expenses increased from approximately $203,000 for the three months ended August 31, 2018 to approximately $303,000 for the three months ended August 31, 2019. The increase consisted primarily of approximately $93,000 attributable to the Artius feasibility study.

 

   Three months ended 
   August 31, 2019   August 31, 2018 
Other income (expense):          
Interest income  $5,691   $6,943 
Equity in loss of affiliated company   (44,312)   (14,780)
Total other expense, net  $(38,621)  $(7,837)

 

Other income and expense for the three months ended August 31, 2019 and 2018, which includes equity in the loss of affiliated company, PDS, was approximately $(39,000) and $(8,000), respectively. Our investment in PDS is accounted for in accordance with the equity method of accounting for investments. The increase in the equity in the loss of PDS is due to the increase in PDS legal costs associated with the filing of the writ of certiorari with the Supreme Court of the United States.

 

   Three months ended 
   August 31, 2019   August 31, 2018 
Loss before income taxes  $(341,658)  $(211,318)

 

Loss before income taxes increased from approximately $(211,000) for the three months ended August 31, 2018 to approximately $(342,000) for the three months ended August 31, 2019 due to increases in both “Selling, general and administrative” and “Total other expense, net” as discussed above.

 

 

 

 20 

 

 

Provision for income taxes

 

During the each of the three months ended August 31, 2019 and August 31, 2018, we recorded a provision for income taxes related to California taxes of $1,600.

 

Net loss

 

Net loss increased from approximately $(213,000) for the three months ended August 31, 2018 to approximately $(343,000) for the three months ended August 31, 2019 due to increases in “Selling, general and administrative” and “Total other expense, net”, as discussed above.

 

Liquidity and Capital Resources

 

Liquidity

 

Our cash and cash equivalents and marketable security balances decreased from approximately $1,537,000 as of May 31, 2019 to approximately $1,239,000 as of August 31, 2019. We also have restricted cash of approximately $199,000 and $177,000 as of May 31, 2019 and August 31, 2019, respectively. Total current assets decreased from approximately $1,764,000 as of May 31, 2019 to approximately $1,502,000 as of August 31, 2019. Total current liabilities were approximately $228,000 and $265,000 as of May 31, 2019 and August 31, 2019, respectively. The change in our working capital position as of August 31, 2019 as compared with May 31, 2019 is primarily due to the inability of PDS to generate revenues and provide partnership distributions sufficient to cover our operating expenses.

  

Cash shortfalls currently experienced by PDS will have an adverse effect on our liquidity. To date, we have determined that it is in the best interests of the Moore Microprocessor Patent (“MMP”) licensing program that we provide our 50% share of capital to provide for PDS expenses including legal retainers and litigation related payments in the event license revenues received by PDS are insufficient to meet these needs. We believe contributions to PDS to fund working capital may be required.

 

PDS had been incurring significant third-party costs for legal fees, expert testimony, depositions and other related litigation costs. We could be required to make capital contributions to PDS for any future litigation related costs in the event that PDS does not receive sufficient licensing revenues to pay these expenses.

 

PDS is currently pursuing a litigation strategy, which includes the filing on September 6, 2019 a petition for a writ of certiorari with the Supreme Court of the United States in regards to a decision by the United States Court of Appeals for the Federal Circuit, stemming from litigation in U.S. District Court against multiple companies alleged to be infringers of the MMP portfolio. We continue to believe that the significant investment in legal effort and costs incurred to date at PDS is necessary for the protection of our interests in the MMP portfolio and its future success, although to date it has generated mixed results.

 

On March 20, 2013, TPL filed a petition under Chapter 11 of the United States Bankruptcy Code. On March 5, 2018, TPL’s Motion for Entry of Final Decree Closing Chapter 11 was granted. In the event we are required to provide funding to PDS that is not reciprocated by TPL, our ownership percentage in PDS will increase and we will have a controlling financial interest in PDS, in which case, we will consolidate PDS in our consolidated financial statements.

 

On April 12, 2019, we entered into an agreement with Artius Bioconsulting LLC, (“Artius”), to evaluate the potential of establishing a company that develops a platform that could be implemented throughout the drug development process utilizing blockchain technologies. We are anticipating receiving shortly a feasibility report with its analysis. In the event the next steps in the development of a blockchain based business are undertaken, it is expected that funding from external sources will be required.

 

There are a number of uncertainties associated with our financial projections that could increase our projected expenses, which would further accelerate cash usage. Additionally, if we are unable to realize satisfactory cash from operations in the near future, we will be required to seek additional financing to continue our operations. We will also require additional financing to develop or acquire new lines of business. We have no current arrangements with respect to any additional financing. Consequently, there can be no assurance that any additional financing on commercially reasonable terms, or at all, will be available when needed. The inability to obtain additional capital may reduce our ability to continue to conduct business operations. Any additional equity financing may involve substantial dilution to our then existing stockholders. The above matters raise substantial doubt regarding our ability to continue as a going concern.

 

 

 

 21 

 

 

Cash Flows From Operating Activities

 

Cash used in operating activities was approximately $320,000 and $260,000 for the three months ended August 31, 2019 and 2018, respectively. The principal components of the current period amount were a net loss of approximately $343,000, and an increase in prepaid expenses and other current assets of approximately $58,000, offset by the equity in loss of affiliated company of approximately $44,000 and an increase in accounts payable and accrued expenses of approximately $35,000. The principal components of the prior period were a net loss of approximately $213,000, and an increase in prepaid expenses and other current assets of approximately $56,000 and a decrease in accounts payable and accrued expenses of approximately $8,000, offset by the equity in loss of affiliated company of approximately $15,000.

 

Cash Flows From Investing Activities

 

Cash provided by investing activities for the three months ended August 31, 2019 was $250,000, attributable to the net sale of marketable securities. No cash was provided or used in investing activities for the three months ended August 31, 2018.

 

Capital Resources

 

The condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern. At August 31, 2019, the Company has an accumulated deficit of $61,469,283, and has incurred recurring losses and used significant amounts of cash in its operations. As of August 31, 2019, the Company had cash and cash equivalents and marketable securities of approximately $1,239,000 and working capital of approximately $1,237,000. Our only significant potential source of cash is PDS. PDS has not generated significant license revenues since September 2013. Therefore, our ability to continue and expand our operations is highly dependent on the amount of cash and cash equivalents and marketable securities on hand combined with our ability to raise additional capital to fund future operations. We anticipate, based on currently proposed plans and assumptions that our cash on hand will not satisfy our operational and capital requirements through twelve months from the date of filing on this Form 10-Q.

 

Recent Accounting Pronouncements

 

In February 2016, the FASB issued ASU No. 2016-02, “Leases (Topic 842)”, as amended ("ASC 842"), which modifies lease accounting for lessees to increase transparency and comparability by recording lease assets and liabilities for operating leases and disclosing key information about leasing arrangements. ASU 2018-13 is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2018. The Company adopted ASC 842 effective June 1, 2019 using a modified retrospective method and will not restate comparative periods. As permitted under the transition guidance, the Company will carry forward the assessment of whether its contracts contain or are leases, classification of its leases and remaining lease terms. Implementation of this guidance did not have a material impact on the Company’s consolidated financial statements. We have elected the short-term lease recognition exemption for all applicable classes of underlying assets. Short-term leases include only those leases with a term greater than one month and twelve months or less. Short-term leases are not recorded on the consolidated balance sheet, and lease expense on short-term leases is recognized on a straight-line basis over the lease term. The Company elected the “practical expedient package” as permitted under ASC 842. Therefore, the Company has not reassessed whether any expired or existing contracts are, or contain, leases; the Company has not reassessed the lease classification for any expired or existing leases; and the Company has not reassessed initial direct costs for any expired or existing leases. The Company currently leases office space on a month-to-month basis.

 

In August 2018, the FASB issued ASU No. 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement” (“ASU 2018-13”), which removes, modifies, and adds various disclosure requirements on fair value measurements in Topic 820. ASU 2018-13 is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2019. The amendments on changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. Early adoption is permitted upon issuance of this update. An entity is permitted to early adopt any removed or modified disclosures upon issuance of this update and delay adoption of the additional disclosures until their effective date. The Company does not expect a significant impact from adopting this update on its consolidated financial statements.

 

 

 

 22 

 

 

Risk Factors

 

We urge you to carefully consider the following discussion of risks as well as other information regarding our common stock. We believe the following to be our most significant risk factors as of the date this report is being filed. The risks and uncertainties described below are not the only ones we face. Please refer to our risk factors contained in our Form 10-K for the year ended May 31, 2019 for additional risk factors.

 

We May Be Required To Fund Our Joint Venture’s Legal Costs.

 

PDS has incurred significant legal costs in ongoing matters before the U.S. District Court and the U.S. Court of Appeals for the Federal Circuit, and may ultimately be involved in proceedings before the Supreme Court of the United States. If PDS does not receive sufficient licensing revenues to pay these expenses, we may be required to pay these expenses. In the event the cost of legal actions exceeds our ability to fund these efforts, our options for additional sources of financing may be limited.

 

We Have Reported Licensing Income In Prior Fiscal Years Which May Not Be Indicative Of Our Future Income.

 

We have entered into license agreements through our joint venture with TPL and have reported income from the joint venture for the fiscal years 2006 to 2011, 2013 to 2014 and 2016 to 2017. However, the joint venture has not generated significant licensing revenues since September 2013. Because of the uncertain nature of the negotiations that lead to license revenues, pending litigation with companies which we allege have infringed on our patent portfolio, the possibility of legislative action regarding patent rights, the possible effect of new judicial interpretations of patent laws, and delays in obtaining information necessary for the successful deployment of licensing companies to represent the MMP Portfolio, we may not receive revenues from such agreements in the future consistent with amounts received in the past, and we may not receive future revenues from license agreements at all.

  

We Are Dependent Upon A Joint Venture For Substantially All Of Our Income.

 

In June 2005, we entered into the PDS joint venture with TPL, which as a result of agreements entered into in June 2005, July 2012 and July 2014, TPL and its licensing company affiliate Alliacense had been responsible for the licensing and enforcement of our microprocessor patent portfolio. This joint venture has been the source of substantially all of our income since June 2005. Therefore, in light of the absence of significant revenue from other sources we should be regarded as highly dependent on the success or failure of licensing and settlements occurring in conjunction with existing litigation efforts.

 

We Have Been Involved In Multiple Disputes With Our Joint Venture Partner.

 

We have been involved in multiple disputes with our joint venture partner TPL and its affiliate Alliacense. During times when there are only two appointed managers of the joint venture, a deadlock can exist on important issues that may not be resolved quickly. In the event of a protracted deadlock, the joint venture may not be able to take actions when appropriate or necessary. Previously we have had to initiate formal arbitration proceedings seeking the appointment of an independent manager to the management committee of the joint venture. An independent manager is currently not in place, which may have a negative impact on the licensing program and PDS’s business.

 

We May Be Unsuccessful In Our Search For New Business Opportunities

 

We are currently in the process of evaluating the potential of establishing a systems integration company that develops a blockchain based technology platform, as well as also reviewing collaboration discussions in the arena of artificial intelligence, with early indications of potential strong synergies between these two technologies. At this stage there is no assurance this opportunity will become fully developed or be beneficial to the Company and its results of operations.

 

Our Joint Venture Is At Risk For Going Concern And An Inability To Meet Certain Obligations.

 

PDS, our joint venture with TPL, which received a going concern opinion since its May 31, 2011 financial statements, has experienced significant declines in revenues while at the same time incurring significant legal costs associated with pending litigation with companies which we allege have infringed on our patent portfolio.

 

 

 

 23 

 

 

PDS’s licensing revenues have declined over recent years to a point where PDS’s ability to make future payments is in substantial doubt unless licensing revenues substantially increase in the near term. In the event that PDS does not have the funds to pay one or more of the aforementioned costs, we and TPL must decide whether to contribute additional capital to PDS to fund such payments. In the event TPL is unwilling or unable to contribute additional capital, we may be required to pay these expenses without any contribution from TPL. In the event we are required to provide funding to PDS that is not reciprocated by TPL, our ownership percentage in PDS will increase and we will have a controlling financial interest in PDS; in which case, we will consolidate PDS in our consolidated financial statements

 

Our auditors have expressed substantial doubt about our ability to continue as a going concern.

 

The Report of Independent Registered Public Accounting Firm on our May 31, 2019 consolidated financial statements includes an explanatory paragraph stating that the recurring losses and negative cash flows from operations, combined with our substantial reliance on cash generated by PDS, raise substantial doubt about our ability to continue as a going concern. The condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

If we are unable to obtain additional funding, we may have to reduce or discontinue our business operations.

 

As of August 31, 2019, the Company had cash and cash equivalents and marketable securities of approximately $1,239,000 and working capital of approximately $1,237,000. Therefore, our ability to continue and expand our operations is highly dependent on the amount of cash and cash equivalents and marketable securities on hand combined with our ability to raise additional capital to fund future operations. We anticipate, based on currently proposed plans and assumptions that our cash on hand will not satisfy our operational and capital requirements through twelve months from the date of filing on this Form 10-Q. There are a number of uncertainties associated with our financial projections that could increase our projected expenses, which would further accelerate cash usage. Additionally, if we are unable to realize satisfactory cash from operations in the near future, we will be required to seek additional financing to continue our operations. We will also require additional financing to develop or acquire new lines of business. We have no current arrangements with respect to any additional financing. Consequently, there can be no assurance that any additional financing on commercially reasonable terms, or at all, will be available when needed. The inability to obtain additional capital may reduce our ability to continue to conduct business operations. Any additional equity financing may involve substantial dilution to our then existing stockholders. The uncertainties surrounding our future cash inflows have raised substantial doubt regarding our ability to continue as a going concern.

  

We Have Identified A Significant Deficiency In Internal Control Over Financial Reporting, If We Fail To Maintain Effective Internal Controls Over Financial Reporting, The Price Of Our Common Stock May Be Adversely Affected.

 

We are required to establish and maintain appropriate internal controls over financial reporting. Failure to establish those controls, or any failure of those controls once established, could adversely impact our public disclosures regarding our business, financial condition or results of operations. Any failure of these controls could also prevent us from maintaining accurate accounting records and discovering accounting errors and financial fraud. 

 

In the course of completing its assessment of internal control over financial reporting as of May 31, 2019, management did not identify any material weaknesses but did identify a significant deficiency in the number of personnel available to serve the Company’s accounting function. Specifically, management believes that we may not be able to adequately segregate responsibility over financial transaction processing and reporting. A significant deficiency is a deficiency, or a combination of deficiencies, in internal control over financial reporting, that is less severe than a material weakness yet important enough to merit attention by those responsible for oversight of the Company’s financial reporting. Although we are unable to remediate the significant deficiency with current personnel, we are mitigating its potential impact, primarily through greater involvement of our Board of Directors in the review and monitoring of financial transaction processing and reporting.

 

Our Microprocessor Patents Have Expired.

 

We have seven U.S., nine European, and three Japanese patents that expired between August 2009 and October 2016. While expired patents may have certain retrospective statutory benefits, their value as assets for licensing and cash generation is significantly diminished. Licensing revenues from these patents are our sole source of income.

 

 

 

 24 

 

 

A Successful Challenge To Our Intellectual Property Rights Could Have A Significant And Adverse Effect On Us.

 

A successful challenge to our ownership of our technology or the proprietary nature of our intellectual property could materially damage our business prospects. We rely on a combination of patents, trademarks, copyrights, trade secret laws, confidentiality procedures and licensing arrangements to protect our intellectual property rights. With respect to our core technologies, our patents have expired. Any issued patent may be challenged and invalidated. Any claims allowed from existing patents may not be of sufficient scope or strength to provide significant protection. Our competitors may also be able to design around our patents.

 

Vigorous protection and pursuit of intellectual property rights or positions characterize the fiercely competitive semiconductor industry, which has resulted in significant and often protracted and expensive litigation. Therefore, our competitors and others may assert that our technologies infringe on their patents or proprietary rights. Persons we believe are infringing our patents are likely to vigorously defend their actions and assert that our patents are invalid. Problems with patents or other rights could result in significant costs, and limit future license revenue. If infringement claims against us are deemed valid or if our infringement claims are successfully opposed, we may not be able to obtain appropriate licenses on acceptable terms or at all. Litigation could be costly and time-consuming but may be necessary to protect our future patent and/or technology license positions or to defend against infringement claims. From time to time parties have petitioned the USPTO to re-examine certain of our patents. An adverse decision in litigation or in the re-examination process could have a very significant and adverse effect on our business.

 

We are party to a lawsuit regarding the MMP portfolio and have had mixed results in our litigation efforts to date. See Note 6 to our condensed consolidated financial statements and Part II, Item 1. “Legal Proceedings” in this Report on Form 10-K for more information.

 

In the event that the lawsuit regarding the MMP portfolio is not resolved in our favor, PDS may be liable for the opposing party’s attorneys’ fees and such outcome (or lack of an outcome) could weaken the MMP portfolio which would have a negative effect on PDS's ability to procure future license revenues and, therefore, adversely affect PDS’s and our cash flows.

  

Changes In U.S. Patent Law Could Diminish The Value Of Patents In General, Thereby Impairing Our Ability To Protect And Assert Our Patents.

 

The United States has enacted the America Invents Act of 2011, wide-ranging patent reform legislation. The United States Supreme Court has ruled on several patent cases in recent years, either narrowing the scope of patent protection available in certain circumstances or weakening the rights of patent owners in certain situations. This combination of events has created uncertainty with respect to the value of patents, once obtained. Depending on decisions by the U.S. Congress, the federal courts, and the USPTO, the laws and regulations governing patents could change in unpredictable ways that would weaken our ability to enforce our existing patents and patents that we might obtain in the future.

 

We Are Dependent On A Single Law Firm To Defend And Enforce Our Intellectual Property Rights.

 

A single law firm has been engaged to defend and enforce our intellectual property rights. Any significant interruption in their services, or the loss of their services for any reason, would have a material adverse effect on our ability to defend and prosecute such lawsuits and, therefore, have a material adverse effect on our business, financial condition and result of operations. The law firm’s services could be disrupted for a variety of reasons, and any disruption would have a material adverse effect on our business. Our inability to engage the services of a new law firm in a timely manner could have a substantial negative effect on our business.

 

A Change In Our Relationship With PDS Could Change The Way We Account For Our Interest In The Future.

 

Our investment in PDS is accounted for under the equity method, we record as part of other income or expense our share of the increase or decrease in the equity of this company in which we have invested. It is possible that, in the future, our relationships and/or our interests in or with this equity method investee could change. Such potential future changes could result in consolidation of such entity which could result in changes in our reported results.

 

 

 

 25 

 

 

We May Issue Preferred Stock, And The Terms Of Such Preferred Stock May Reduce The Value Of Our Common Stock.

 

We are authorized to issue up to a total of 5,000,000 shares of preferred stock in one or more series. Our Board of Directors may determine whether to issue shares of preferred stock without further action by holders of our Common Stock. If we issue shares of preferred stock, it could affect the rights or reduce the value of our Common Stock. In particular, specific rights granted to future holders of preferred stock could be used to restrict our ability to merge with or sell our assets to a third party. These terms may include voting rights, preferences as to dividends and liquidation, conversion and redemption rights, and sinking fund provisions. If we seek capital for our business, such capital may be raised through the issuance of preferred stock.

 

If A Large Number Of Our Shares Are Sold All At Once Or In Blocks, The Market Price Of Our Shares Would Most Likely Decline.

 

Most of our shareholders are not restricted in the price at which they can sell their shares. Shares sold at a price below the current market price at which our Common Stock is trading may cause the market price of our Common Stock to decline.

 

Our Common Stock Is Quoted On The OTC Pink Current Information, Which Could Adversely Affect The Market Price And Liquidity Of Our Common Stock.

 

Our common stock is quoted on OTC Pink Current Information. The quotation of our shares on such marketplace may result in a less liquid market available for existing and potential stockholders to trade shares of our common stock, could depress the trading price of our common stock and could have a long-term adverse impact on our ability to raise capital in the future.

 

There can be no assurance that there will be an active market for our shares of common stock either now or in the future or that stockholders will be able to liquidate their investment or liquidate it at a price that reflects the value of the business. As a result, our stockholders may not find purchasers for our securities should they to desire to sell them.

  

 

The Market For Our Stock Is Subject To Rules Relating To Low-Priced Stock (“Penny Stock”) Which May Limit Our Ability To Raise Capital.

 

Our Common Stock is currently subject to the “penny stock rules” adopted pursuant to Section 15(g) of the Exchange Act. In general, the penny stock rules apply to non-NASDAQ or non-national stock exchange companies whose common stock trades at less than $5.00 per share or which have tangible net worth of less than $5,000,000 ($2,000,000 if the company has been operating for three or more years). Such rules require, among other things, that brokers who trade “penny stock” on behalf of persons other than “established customers” complete certain documentation, make suitability inquiries of investors and provide investors with certain information concerning trading in the security, including a risk disclosure document, quote information, broker’s commission information and rights and remedies available to investors in penny stocks. Many brokers have decided not to trade “penny stock” because of the requirements of the penny stock rules, and as a result, the number of broker-dealers willing to act as market makers in such securities is limited. The “penny stock rules,” therefore, may have an adverse impact on the market for our Common Stock and may affect our ability to raise additional capital if we decide to do so.

 

Our Share Price Could Decline As A Result Of Short Sales.

 

When an investor sells stock that he does not own, it is known as a short sale. The seller, anticipating that the price of the stock will go down, intends to buy stock to cover his sale at a later date. If the price of the stock goes down, the seller will profit to the extent of the difference between the price at which he originally sold it less his later purchase price. Short sales enable the seller to profit in a down market. Short sales could place significant downward pressure on the price of our Common Stock. Penny stocks which do not trade on an exchange, such as our Common Stock, are particularly susceptible to short sales.

 

 

 

 26 

 

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

Not applicable.

 

Item 4. Controls and Procedures

 

As required by Rule 13a-15(b) under the Exchange Act, as of August 31, 2019, the end of the period to which this quarterly report relates, we have carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures. This evaluation was carried out under the supervision and with the participation of our management, including our Interim Chief Executive Officer and our former Chief Financial Officer.

 

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed under the Exchange Act is accumulated and communicated to management, including the Interim Chief Executive Officer and Chief Financial Officer as appropriate, to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives, and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.  Based on the evaluation of our disclosure controls and procedures as of August 31, 2019, our management, with the participation of our Interim Chief Executive Officer and former Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective.

 

Changes in Internal Control over Financial Reporting

 

There were no significant changes to our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during our most recently completed fiscal quarter that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

 

 

 

 

 

 

 

 27 

 

 

PART II- OTHER INFORMATION

 

Item 1. Legal Proceedings

 

Patent Litigation

 

Our patent litigation with TPL and PDS in the United States District Court for the Northern District of California against Huawei Technologies Co. Ltd., LG Electronics, Nintendo Co. Ltd., Samsung Electronics Co. Ltd., and ZTE Corporation, as described in Item 3 – “Legal Proceedings” in our Annual Report on Form 10-K for the year ended May 31, 2018, is still ongoing. The U.S. Court of Appeals affirmed the District Court’s determination of non-infringement without written opinion pursuant to Federal Circuit Rule 36 on February 6, 2019. Plaintiffs filed with the Appellate Court a Petition for Rehearing En Banc on March 8, 2019 which was denied by the Court on April 10, 2019. On September 6, 2019, Plaintiffs filed a petition for a writ of certiorari with the Supreme Court of the United States as a result of the United States Court of Appeals outcome.

 

Item 1A. Risk Factors

 

Please see Part I, Item 2, above, for our risk factors.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

None.

 

Item 3. Defaults Upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosures

 

None.

 

Item 5. Other Information

 

None.

 

 

 

 

 

 28 

 

 

Item 6. Exhibits

 

Those exhibits marked with an asterisk (*) refer to exhibits filed herewith. The other exhibits are incorporated herein by reference, as indicated in the following list.

 

Those exhibits marked with a cross (†) refer to management contracts or compensatory plans or arrangements.

 

Exhibit No. Document
   
31.1* Certification of Carlton M. Johnson Jr., Interim CEO, pursuant to Rule 13a-15(e) or Rule 15d-15(e)
   
31.2* Certification of Carlton M. Johnson Jr., Interim CFO, pursuant to Rule 13a-15(e) or Rule 15d-15(e)
   
32.1* Certification of Carlton M. Johnson Jr., Interim CEO and Interim CFO, pursuant to 18 U.S.C. Section 1350
   
   
101.INS XBRL Instance Document
   
101.SCH XBRL Schema Document
   
101.CAL XBRL Calculation Linkbase Document
   
101.DEF XBRL Definition Linkbase Document
   
101.LAB XBRL Label Linkbase Document
   
101.PRE XBRL Presentation Linkbase Document

 

* Filed herewith.

 

 

 

 

 29 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

DATED:  October 11, 2019

PATRIOT SCIENTIFIC CORPORATION

 

/S/ CARLTON M. JOHNSON JR.                           

Carlton M. Johnson Jr. Interim Chief Executive Officer and Interim Chief Financial Officer

(Duly Authorized and Principal Financial Officer) 

 

 

 

 

 

 

 

 

 

 

 

 30 

 

EX-31.1 2 patriotsci_ex3101.htm CERTIFICATION OF CARLTON M. JOHNSON JR., INTERIM CEO

Exhibit 31.1

 

CERTIFICATION PURSUANT TO RULE 13A-14 OF THE SECURITIES EXCHANGE ACT OF 1934

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Carlton M. Johnson Jr., Interim Chief Executive Officer of the registrant, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q for the fiscal quarter ended August 31, 2019 of Patriot Scientific Corporation, a Delaware corporation (the “Registrant”);

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

 

4. The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;

 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) Evaluated the effectiveness of the Registrant's disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d) Disclosed in this report any change in the Registrant's internal control over financial reporting that occurred during the Registrant's most recent fiscal quarter (the Registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and

 

5. The Registrant’s other certifying officer and I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the Registrant's auditors and the audit committee of the Registrant's board of directors (or persons performing the equivalent functions):

 

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant's ability to record, process, summarize and report financial information; and

 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant's internal control over financial reporting.

 

Date: October 11, 2019

 

    /s/ CARLTON M. JOHNSON JR.
   

Carlton M. Johnson Jr.

Interim Chief Executive Officer

Principal Executive Officer

 

EX-31.2 3 patriotsci_ex3102.htm CERTIFICATION OF CARLTON M. JOHNSON JR., INTERIM CFO

Exhibit 31.2

 

CERTIFICATION PURSUANT TO RULE 13A-14 OF THE SECURITIES EXCHANGE ACT OF 1934

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Carlton M. Johnson Jr., Interim Chief Financial Officer of the registrant, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q for the fiscal quarter ended August 31, 2019 of Patriot Scientific Corporation, a Delaware corporation (the “Registrant”);

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

 

4. The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;

 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) Evaluated the effectiveness of the Registrant's disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d) Disclosed in this report any change in the Registrant's internal control over financial reporting that occurred during the Registrant's most recent fiscal quarter (the Registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the Registrant's auditors and the audit committee of the Registrant's board of directors (or persons performing the equivalent functions):

 

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant's ability to record, process, summarize and report financial information; and

 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant's internal control over financial reporting.

 

Date: October 11, 2019

 

 

 

    /s/ CARLTON M. JOHNSON JR.
   

Carlton M. Johnson Jr.

Interim Chief Financial Officer

and Principal Financial Officer

 

EX-32.1 4 patriotsci_ex3201.htm CERTIFICATION OF CARLTON M. JOHNSON JR., INTERIM CEO AND INTERIM CFO

Exhibit 32.1

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q of Patriot Scientific Corporation, a Delaware corporation (the “Company”) for the fiscal quarter ended August 31, 2019, as filed with the Securities and Exchange Commission on October 11, 2019 (the “Report”), the undersigned officer of the Company does hereby certify, pursuant to Title 18 of the United States Code Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: October 11, 2019

 

 

    /s/ CARLTON M. JOHNSON JR.    
   

Carlton M. Johnson Jr.

Interim Chief Executive Officer

and Principal Executive Officer

Interim Chief Financial Officer

and Principal Financial Officer

   

 

 

A signed original of this written statement required by Section 906 has been provided to Patriot Scientific Corporation and will be retained by Patriot Scientific Corporation and furnished to the Securities and Exchange Commission or its staff upon request.

 

This Certification is being furnished pursuant to Rule 15(d) and shall not be deemed “filed” for purposes of Section 18 of the Exchange Act (15 U.S.C. 78r), or otherwise subject to the liability of that section. This Certification shall not be deemed to be incorporated by reference into any filing under the Securities Act or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.

 

 

EX-101.INS 5 ptsc-20190831.xml XBRL INSTANCE FILE 0000836564 2019-06-01 2019-08-31 0000836564 2019-10-10 0000836564 2018-08-31 0000836564 2019-08-31 0000836564 us-gaap:CommonStockMember 2018-08-31 0000836564 us-gaap:CommonStockMember 2019-08-31 0000836564 us-gaap:AdditionalPaidInCapitalMember 2018-08-31 0000836564 us-gaap:AdditionalPaidInCapitalMember 2019-08-31 0000836564 us-gaap:RetainedEarningsMember 2018-08-31 0000836564 us-gaap:RetainedEarningsMember 2019-08-31 0000836564 us-gaap:TreasuryStockMember 2018-08-31 0000836564 us-gaap:TreasuryStockMember 2019-08-31 0000836564 us-gaap:FairValueInputsLevel1Member 2019-08-31 0000836564 us-gaap:FairValueInputsLevel2Member 2019-08-31 0000836564 us-gaap:FairValueInputsLevel3Member 2019-08-31 0000836564 2018-06-01 2018-08-31 0000836564 PTSC:DueInThreeMonthsOrLessMember 2019-08-31 0000836564 us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2019-08-31 0000836564 PTSC:MembersEquityMember 2019-08-31 0000836564 us-gaap:CashMember 2019-08-31 0000836564 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2019-08-31 0000836564 us-gaap:StockOptionMember 2019-08-31 0000836564 us-gaap:StockOptionMember 2019-06-01 2019-08-31 0000836564 us-gaap:RetainedEarningsMember 2018-06-01 2018-08-31 0000836564 us-gaap:RetainedEarningsMember 2019-06-01 2019-08-31 0000836564 PTSC:PDSMember 2019-06-01 2019-08-31 0000836564 PTSC:PDSMember 2018-06-01 2018-08-31 0000836564 PTSC:PDSMember 2019-08-31 0000836564 us-gaap:StockOptionMember 2019-06-01 2019-08-31 0000836564 us-gaap:StockOptionMember 2018-06-01 2018-08-31 0000836564 PTSC:CrossfloMember 2019-08-31 0000836564 PTSC:HolocomMember 2019-08-31 0000836564 PTSC:HolocomMember us-gaap:PreferredStockMember 2019-08-31 0000836564 PTSC:HolocomMember 2018-08-31 0000836564 PTSC:DueInGreaterThanThreeMonthsMember 2019-08-31 0000836564 us-gaap:CommonStockMember 2018-05-31 0000836564 us-gaap:AdditionalPaidInCapitalMember 2018-05-31 0000836564 us-gaap:RetainedEarningsMember 2018-05-31 0000836564 us-gaap:TreasuryStockMember 2018-05-31 0000836564 2018-05-31 0000836564 us-gaap:CommonStockMember 2019-05-31 0000836564 us-gaap:AdditionalPaidInCapitalMember 2019-05-31 0000836564 us-gaap:RetainedEarningsMember 2019-05-31 0000836564 us-gaap:TreasuryStockMember 2019-05-31 0000836564 2019-05-31 0000836564 us-gaap:FairValueInputsLevel1Member 2019-05-31 0000836564 us-gaap:FairValueInputsLevel2Member 2019-05-31 0000836564 us-gaap:FairValueInputsLevel3Member 2019-05-31 0000836564 PTSC:DueInThreeMonthsOrLessMember 2019-05-31 0000836564 PTSC:DueInGreaterThanThreeMonthsMember 2019-05-31 0000836564 us-gaap:CashMember 2019-05-31 0000836564 us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2019-05-31 0000836564 PTSC:MembersEquityMember 2019-05-31 0000836564 us-gaap:OperatingExpenseMember 2019-06-01 2019-08-31 0000836564 us-gaap:OperatingExpenseMember 2018-06-01 2018-08-31 0000836564 PTSC:NetLossMember 2019-06-01 2019-08-31 0000836564 PTSC:NetLossMember 2018-06-01 2018-08-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure PATRIOT SCIENTIFIC CORP 0000836564 10-Q 2019-08-31 false --05-31 Yes Non-accelerated Filer Q1 2020 401392948 0.00001 0.00001 5000000 5000000 0 0 0 0 0.00001 0.00001 600000000 600000000 438242618 438242618 401392948 401392948 36849670 36849670 1250000 0 500000 500000 750000 234758 107661 127097 237655 21933 215722 234758 234758 0 237655 237655 1600000 1600000 1600000 0.03 0.03 0.03 1600000 1600000 46048 46048 0 0 49149 49149 0 0 692612 692612 0 0 237937 237937 0 0 1250000 500000 500000 500000 750000 63549 0 0 107861 0 0 0 0 0 0.50 0.46 0 0 0 0 0 2100000 2844630 0 0 0 true false 000-22182 DE 21587 177247 177247 0 0 198843 198843 0 0 2282096 1353293 4382 4382 77444062 77444062 -60540480 -61469283 -14625868 -14625868 4382 77444062 -60327562 -14625868 2495014 4382 77444062 -61126025 -14625868 1696551 401392948 401392948 401392948 401392948 2059124 915907 2319449 985929 1415907 915907 500000 0 1735929 485929 1250000 0 P8M5D P8M5D P8M5D Yes 500000 0 500000 0 750000 0 750000 0 2037537 738660 787086 500000 750000 85880 28003 1501787 1763932 692 814 52156 52156 1618184 1924763 19779 8868 243512 219344 264891 228212 264891 228212 0 0 4382 4382 77444062 77444062 -61469283 -61126025 14625868 14625868 1618184 1924763 303037 203481 303037 203481 5691 6943 -44312 -14780 -44312 -14780 -38621 -7837 -341658 -211318 1600 1600 -343258 -212918 -212918 -343258 0.00 0.00 398548318 398548318 398548318 398548318 122 122 57877 55813 1600 1600 35079 -8096 -320022 -260325 500000 0 250000 0 250000 0 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>1. Basis of Presentation and Summary of Significant Accounting Policies</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The unaudited condensed consolidated financial statements of Patriot Scientific Corporation (the &#8220;Company&#8221;, &#8220;PTSC&#8221;, &#8220;Patriot&#8221;, &#8220;we&#8221;, &#8220;us&#8221; or &#8220;our&#8221;) presented herein have been prepared pursuant to the rules of the Securities and Exchange Commission (&#8220;SEC&#8221;) for quarterly reports on Form 10-Q and do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America. These unaudited condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements and notes thereto included in our Report on Form 10-K for our fiscal year ended May 31, 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern. In the opinion of management, the interim condensed consolidated financial statements reflect all adjustments of a normal recurring nature necessary for a fair presentation of the results for the interim period presented. Operating results for the three month period ended August 31, 2019 are not necessarily indicative of the results that may be expected for the year ending May 31, 2020.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Basis of Consolidation</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The condensed consolidated balance sheets at August 31, 2019 and May 31, 2019 include our accounts and those of our inactive subsidiary Patriot Data Solutions Group, Inc. (&#8220;PDSG&#8221;) which includes Crossflo Systems, Inc. (&#8220;Crossflo&#8221;). The condensed consolidated statements of operations, cash flows and stockholders&#8217; equity for the three months ended August 31, 2019 and 2018 include our accounts and those of our inactive subsidiaries: PDSG and Plasma Scientific Corporation (&#8220;Plasma&#8221;). We dissolved Plasma in March 2018. All significant intercompany accounts and transactions have been eliminated.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Liquidity and Management&#8217;s Plans</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern. At August 31, 2019, the Company has an accumulated deficit of $61,469,283, and has incurred recurring losses and used significant amounts of cash in its operations. As of August 31, 2019, the Company had cash and cash equivalents and marketable securities of approximately $1,239,000 and working capital of approximately $1,237,000. Our only significant potential source of cash is PDS. PDS has not generated significant license revenues since September 2013. Therefore, our ability to continue and expand our operations is highly dependent on the amount of cash and cash equivalents and marketable securities on hand combined with our ability to raise additional capital to fund future operations. We anticipate, based on currently proposed plans and assumptions that our cash on hand will not satisfy our operational and capital requirements through twelve months from the date of filing on this Form 10-Q.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cash shortfalls currently experienced by PDS will have an adverse effect on our liquidity. To date, we have determined that it is in the best interests of the Moore Microprocessor Patent (&#8220;MMP&#8221;) licensing program that we provide our 50% share of capital to provide for PDS expenses including legal retainers and litigation related payments in the event license revenues received by PDS are insufficient to meet these needs. We believe contributions to PDS to fund working capital may be required.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">PDS had been incurring significant third-party costs for legal fees, expert testimony, depositions and other related litigation costs. We could be required to make capital contributions to PDS for any future litigation related costs in the event that PDS does not receive sufficient licensing revenues to pay these expenses.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">PDS is currently pursuing a litigation strategy, which includes the filing, on September 6, 2019, a petition for a writ of certiorari with the Supreme Court of the United States in regards to a decision by the United States Court of Appeals for the Federal Circuit, stemming from litigation in U.S. District Court against multiple companies alleged to be infringers of the MMP portfolio. We continue to believe that the significant investment in legal effort and costs incurred to date at PDS is necessary for the protection of our interests in the MMP portfolio and its future success, although to date it has generated mixed results.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 20, 2013, TPL filed a petition under Chapter 11 of the United States Bankruptcy Code. On March 5, 2018, TPL&#8217;s Motion for Entry of Final Decree Closing Chapter 11 was granted. In the event we are required to provide funding to PDS that is not reciprocated by TPL, our ownership percentage in PDS will increase and we will have a controlling financial interest in PDS, in which case, we will consolidate PDS in our consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 12, 2019, we entered into an agreement with Artius Bioconsulting LLC, (&#8220;Artius&#8221;), to evaluate the potential of establishing a company that develops a platform that could be implemented throughout the drug development process utilizing blockchain technologies. We are anticipating receiving shortly a feasibility report with its analysis. In the event the next steps in the development of a blockchain based business are undertaken, it is expected that funding from external sources will be required.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are a number of uncertainties associated with our financial projections that could increase our projected expenses, which would further accelerate cash usage. Additionally, if we are unable to realize satisfactory cash from operations in the near future, we will be required to seek additional financing to continue our operations. We will also require additional financing to develop or acquire new lines of business. We have no current arrangements with respect to any additional financing. Consequently, there can be no assurance that any additional financing on commercially reasonable terms, or at all, will be available when needed. The inability to obtain additional capital may reduce our ability to continue to conduct business operations. Any additional equity financing may involve substantial dilution to our then existing stockholders. The above matters raise substantial doubt regarding our ability to continue as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Investment in Affiliated Companies</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have a 50% interest in PDS. We account for our investment using the equity method of accounting since the investment provides us the ability to exercise significant influence, but not control, over the investee. Significant influence is generally deemed to exist if we have an ownership interest in the voting stock of the investee of between 20% and 50%, although other factors, such as representation on the investee&#8217;s Board of Directors, are considered in determining whether the equity method of accounting is appropriate. Under the equity method of accounting, the investment, originally recorded at cost, is adjusted to recognize our share of net earnings or losses of the investee and is recognized in the condensed consolidated statements of operations in the caption &#8220;Equity in earnings (loss) of affiliated company&#8221; and also is adjusted by contributions to and distributions from PDS.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">PDS, as an unconsolidated equity investee, recognizes revenue from technology license agreements at the time a contract is entered into, the license method is determined (paid-in-advance or on-going royalty), performance obligations under the license agreement are satisfied, and the realization of revenue is assured which is generally upon the receipt of the license proceeds. PDS may at times enter into license agreements whereby contingent revenues are recognized as one or more contractual milestones are met.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We review our investment in PDS to determine whether events or changes in circumstances indicate that the carrying amount may not be recoverable. The primary factors we consider in our determination are the financial condition, operating performance and near term prospects of PDS. If the decline in value is deemed to be other than temporary, we would recognize an impairment loss.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We own 100% of the preferred stock of Holocom (see Note 3). Prior to impairment, this investment was accounted for at cost since we do not have the ability to exercise significant influence over the operating and financial policies of Holocom.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Income (Loss) Per Share</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Basic income (loss) per share includes no dilution and is computed by dividing income (loss) available to common stockholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share reflect the potential dilution of securities that could share in the earnings of an entity.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At August 31, 2019 and 2018, potential common shares of 1,600,000 related to our outstanding options were not included in the calculation of diluted loss per share as we recorded a loss. Had we reported net income for the three months ended August 31, 2019 and 2018, no shares of common stock would have been included in the calculation of diluted income per share using the treasury stock method.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with our acquisition of Crossflo, which became a part of PDSG, we issued 2,844,630 escrow shares that are contingent upon certain representations and warranties made by Crossflo at the time of the merger agreement (see Note 6). We exclude these escrow shares from the basic income (loss) per share calculations and would have included the escrowed shares in the diluted income per share calculations if we reported net income.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Income Taxes</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We follow authoritative guidance in accounting for uncertainties in income taxes. This authoritative guidance prescribes a recognition threshold and measurement requirement for the financial statement recognition of a tax position that has been taken or is expected to be taken on a tax return and also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. Under this guidance we may only recognize tax positions that meet a &#8220;more likely than not&#8221; threshold.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We follow authoritative guidance to evaluate whether a valuation allowance should be established against our deferred tax assets based on the consideration of all available evidence using a &#8220;more likely than not&#8221; standard. In making such judgments, significant weight is given to evidence that can be objectively verified. We assess our deferred tax assets annually under more likely than not scenarios in which they may be realized through future income.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With the exception for refundable alternative minimum tax (&#8220;AMT&#8221;) credits, we have determined that it was more likely than not that all of our deferred tax assets will not be realized in the future due to our continuing pre-tax and taxable losses. As a result of this determination, and with the exception for the aforementioned refundable tax credits, we have recorded a full valuation allowance against our deferred tax assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 22, 2017, the United States Government passed the Tax Cuts and Jobs Act (&#8220;Tax Cuts Act&#8221;) that, among other provisions, has lowered the corporate tax rate from 35% to 21%. In addition to applying the new lower corporate tax rate in 2018 and thereafter to any taxable income we may have, the legislation affects the way we can use and carryforward net operating losses previously accumulated and results in a revaluation of deferred tax assets and liabilities recorded on our condensed consolidated balance sheet. The Securities and Exchange Commission staff issued Staff Accounting Bulletin No. 118 (&#8220;SAB 118&#8221;) which provides guidance regarding accounting for the income tax effects of the Tax Cuts Act, including the impact of the Tax Cuts Act on deferred tax assets and liabilities for financial statements issued in the reporting period that includes the enactment date of December 22, 2017. Given that our current deferred tax assets, with the exception of those representing certain refundable tax credits, are offset by a full valuation allowance, these changes had no net impact on our condensed consolidated balance sheet. However, if we become profitable, we will receive a reduced benefit from such deferred tax assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Assessment of Contingent Liabilities</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are involved in various legal matters, disputes, and patent infringement claims which arise in the ordinary course of our business. We accrue for any estimated losses at the time when we can make a reliable estimate of such loss and it is probable that it has been incurred. By their very nature, contingencies are difficult to estimate. We continually evaluate information related to all contingencies to determine that the basis on which we have recorded our estimated exposure is appropriate.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Intellectual Property Rights</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">PDS, our investment in affiliated company, relies on a combination of patents, trademarks, copyrights, trade secret laws, confidentiality procedures and licensing arrangements to protect our intellectual property rights. We have seven U.S., nine European, and three Japanese patents all of which expired between August 2009 and October 2016. These patents, while expired, may have certain retrospective statutory benefits that will fully diminish six years after the patent expiration dates. The patent useful life for purposes of negotiating licenses is finite and these patents are subject to legal challenges, which in combination with the limited life, could adversely impact the stream of revenues. A successful challenge to the ownership of the technology or the proprietary nature of the intellectual property would materially damage business prospects. Any issued patent may be challenged and invalidated.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Recent Accounting Pronouncements </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In February 2016, the FASB issued ASU No. 2016-02, &#8220;Leases (Topic 842)&#8221;, as amended (&#34;ASC 842&#34;), which modifies lease accounting for lessees to increase transparency and comparability by recording lease assets and liabilities for operating leases and disclosing key information about leasing arrangements. ASU 2018-13 is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2018. The Company adopted ASC 842 effective June 1, 2019 using a modified retrospective method and will not restate comparative periods. As permitted under the transition guidance, the Company will carry forward the assessment of whether its contracts contain or are leases, classification of its leases and remaining lease terms. Implementation of this guidance did not have a material impact on the Company&#8217;s consolidated financial statements. We have elected the short-term lease recognition exemption for all applicable classes of underlying assets. Short-term leases include only those leases with a term greater than one month and twelve months or less. Short-term leases are not recorded on the consolidated balance sheet, and lease expense on short-term leases is recognized on a straight-line basis over the lease term. The Company elected the &#8220;practical expedient package&#8221; as permitted under ASC 842. Therefore, the Company has not reassessed whether any expired or existing contracts are, or contain, leases; the Company has not reassessed the lease classification for any expired or existing leases; and the Company has not reassessed initial direct costs for any expired or existing leases. The Company currently leases office space on a month-to-month basis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In August 2018, the FASB issued ASU No. 2018-13, &#8220;Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement&#8221; (&#8220;ASU 2018-13&#8221;), which removes, modifies, and adds various disclosure requirements on fair value measurements in Topic 820. ASU 2018-13 is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2019. The amendments on changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. Early adoption is permitted upon issuance of this update. An entity is permitted to early adopt any removed or modified disclosures upon issuance of this update and delay adoption of the additional disclosures until their effective date. The Company does not expect a significant impact from adopting this update on its consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>2. Cash, Cash Equivalents and Restricted Cash </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We follow authoritative guidance to account for our marketable securities as held-to-maturity. Under this authoritative guidance we are required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. We determine fair value based on quoted prices when available or through the use of alternative approaches, such as discounting the expected cash flows using market interest rates commensurate with the credit quality and duration of the investment or valuations by third party professionals. The three levels of inputs that we may use to measure fair value are:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 2: Quoted prices in markets that are not active or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; and</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e. supported by little or no market activity).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following tables detail the fair value measurements within the fair value hierarchy of our cash, cash equivalents and investments in marketable securities:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Fair Value Measurements at August&#160;31,&#160;2019 Using</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Fair Value at<br /> August 31, <br /> 2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Quoted Prices<br /> in Active<br /> Markets for<br /> Identical Assets <br /> (Level 1)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Significant Other<br /> Observable <br /> Inputs <br /> (Level 2)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Significant<br /> Unobservable <br /> Inputs<br /> (Level 3)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Cash and cash equivalents:</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 40%; padding-left: 5pt">Cash</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">46,048</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">46,048</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 5pt">Money market funds</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">692,612</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">692,612</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td> <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#8211;</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Restricted cash and cash equivalents</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">177,247</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">177,247</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td> <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#8211;</td><td style="font-weight: bold; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Investments in marketable securities:</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5pt">Certificates of deposit</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">500,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">500,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt; padding-left: 10pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,415,907</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">915,907</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">500,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Fair Value Measurements at May&#160;31,&#160;2019 Using</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Fair Value at<br /> May 31, <br /> 2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Quoted Prices<br /> in Active<br /> Markets for<br /> Identical Assets <br /> (Level 1)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Significant Other<br /> Observable <br /> Inputs <br /> (Level 2)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Significant<br /> Unobservable <br /> Inputs<br /> (Level 3)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Cash and cash equivalents:</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5pt; width: 40%">Cash</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">49,149</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">49,149</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 5pt">Money market funds</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">237,937</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">237,937</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td> <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#8211;</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5pt">Certificates of deposit</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">500,000</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">500,000</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Restricted cash and cash equivalents</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">198,843</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">198,843</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td> <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#8211;</td><td style="font-weight: bold; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Investments in marketable securities:</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 5pt">Certificates of deposit</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">750,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">750,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; padding-left: 10pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,735,929</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">485,929</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,250,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We purchase certificates of deposit with varying maturity dates. The following tables summarize the purchase date maturities, gross unrealized gains or losses and fair value of the certificates of deposit as of August 31, 2019 and May 31, 2019:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td colspan="10" style="text-align: center; border-bottom: Black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>August&#160;31, 2019 </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Unaudited)</b></p></td><td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Cost</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Gross Unrealized Gains/(Losses)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Fair<br /> Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Maturity</td><td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 55%; text-align: left">Due in greater than three months</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">500,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">500,000</td><td style="width: 1%; text-align: left">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">May&#160;31, 2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Cost</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Gross Unrealized Gains/(Losses)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Fair<br /> Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Maturity</td><td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 55%; text-align: left">Due in three months or less</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">500,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">500,000</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Due in greater than three months</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">750,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">750,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,250,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,250,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Fair Value Measurements at August&#160;31,&#160;2019 Using</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Fair Value at<br /> August 31, <br /> 2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Quoted Prices<br /> in Active<br /> Markets for<br /> Identical Assets <br /> (Level 1)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Significant Other<br /> Observable <br /> Inputs <br /> (Level 2)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Significant<br /> Unobservable <br /> Inputs<br /> (Level 3)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Cash and cash equivalents:</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 40%; padding-left: 5pt">Cash</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">46,048</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">46,048</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 5pt">Money market funds</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">692,612</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">692,612</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td> <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#8211;</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Restricted cash and cash equivalents</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">177,247</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">177,247</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td> <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#8211;</td><td style="font-weight: bold; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Investments in marketable securities:</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5pt">Certificates of deposit</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">500,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">500,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt; padding-left: 10pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,415,907</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">915,907</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">500,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Fair Value Measurements at May&#160;31,&#160;2019 Using</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Fair Value at<br /> May 31, <br /> 2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Quoted Prices<br /> in Active<br /> Markets for<br /> Identical Assets <br /> (Level 1)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Significant Other<br /> Observable <br /> Inputs <br /> (Level 2)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Significant<br /> Unobservable <br /> Inputs<br /> (Level 3)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Cash and cash equivalents:</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5pt; width: 40%">Cash</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">49,149</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">49,149</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 5pt">Money market funds</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">237,937</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">237,937</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td> <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#8211;</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5pt">Certificates of deposit</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">500,000</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">500,000</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Restricted cash and cash equivalents</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">198,843</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">198,843</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td> <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#8211;</td><td style="font-weight: bold; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Investments in marketable securities:</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 5pt">Certificates of deposit</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">750,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">750,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; padding-left: 10pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,735,929</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">485,929</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,250,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td colspan="10" style="text-align: center; border-bottom: Black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>August&#160;31, 2019 </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Unaudited)</b></p></td><td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Cost</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Gross Unrealized Gains/(Losses)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Fair<br /> Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Maturity</td><td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 55%; text-align: left">Due in greater than three months</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">500,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">500,000</td><td style="width: 1%; text-align: left">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">May&#160;31, 2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Cost</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Gross Unrealized Gains/(Losses)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Fair<br /> Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Maturity</td><td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 55%; text-align: left">Due in three months or less</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">500,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">500,000</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Due in greater than three months</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">750,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">750,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,250,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,250,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Assets:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">August 31, 2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">May 31, 2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 46%">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td> <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 13%; font-weight: bold; text-align: center"><font style="font-size: 10pt"><b>(Unaudited)</b></font></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt">Cash</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">234,758</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">237,655</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total assets</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">234,758</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">237,655</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Liabilities and Members&#8217; Equity:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="width: 46%; padding-bottom: 1pt">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td> <td style="width: 1%; border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="width: 13%; border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><font style="font-size: 10pt"><b>August 31, 2019</b></font></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td> <td style="width: 1%; border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="width: 13%; border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><font style="font-size: 10pt"><b>May 31, 2019</b></font></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="font-weight: bold">&#160;</td> <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: center"><font style="font-size: 10pt"><b>(Unaudited)</b></font></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Payables</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right">107,661</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right">21,933</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Members&#8217; equity</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">127,097</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">215,722</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Total liabilities and members&#8217; equity</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">234,758</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">237,655</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-weight: normal">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Statements of Operations</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td colspan="6" style="text-align: center; border-bottom: Black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Three Months Ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>August 31,</b></p></td><td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2018</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="font-weight: bold">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td><td style="font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 46%">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt">Expenses</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">88,625</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">29,559</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(88,625</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(29,559</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif"><b>4</b></font><b>. Income Taxes</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 22, 2017, the United States Government passed the Tax Cuts and Jobs Act (&#8220;Tax Cuts Act&#8221;) that, among other provisions, has lowered the corporate tax rate from 35% to 21%. In addition to applying the new lower corporate tax rate in 2018 and thereafter to any taxable income we may have, the legislation affects the way we can use and carryforward net operating losses previously accumulated and results in a revaluation of deferred tax assets and liabilities recorded on our condensed consolidated balance sheet. The Securities and Exchange Commission staff issued Staff Accounting Bulletin No. 118 (&#8220;SAB 118&#8221;) which provides guidance regarding accounting for the income tax effects of the Tax Cuts Act, including the impact of the Tax Cuts Act on deferred tax assets and liabilities for financial statements issued in the reporting period that includes the enactment date of December 22, 2017. Given that our current deferred tax assets, with the exception of those representing certain refundable tax credits, are offset by a full valuation allowance, these changes had no net impact on our condensed consolidated balance sheet. However, if we become profitable, we will receive a reduced benefit from such deferred tax assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>5. Stockholders&#8217; Equity</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><u>Share-based Compensation</u></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Summary of Assumptions and Activity</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value of share-based awards to employees and directors is calculated using the Black-Scholes option pricing model, even though this model was developed to estimate the fair value of freely tradable, fully transferable options without vesting restrictions, which differ significantly from our stock options.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Black-Scholes model also requires subjective assumptions, including future stock price volatility and expected time to exercise, which greatly affect the calculated values. The expected term of options granted is derived from historical data on employee exercises and post-vesting employment termination behavior. The risk-free rate selected to value any particular grant is based on the U.S. Treasury rate that corresponds to the pricing term of the grant effective as of the date of the grant. The expected volatility is based on the historical volatilities of our common stock. These factors could change in the future, affecting the determination of share-based compensation expense in future periods.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">A summary of option activity as of August 31, 2019 and changes during the three months then ended, is presented below:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Weighted Average Remaining Contractual Term (Years)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Aggregate Intrinsic Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 40%">Options outstanding at June 1, 2019</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">1,600,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">0.03</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Options granted</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Options exercised</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Options forfeited/expired</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt; text-align: left">$</td><td style="padding-bottom: 1pt; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Options outstanding at August 31, 2019</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,600,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right">0.03</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">0.68</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Options vested and expected to vest at August 31, 2019</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,600,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right">0.03</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">0.68</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Options exercisable at August 31, 2019</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,600,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right">0.03</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">0.68</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The aggregate intrinsic value represents the differences in market price at the close of the quarter ($0.004 per share on August 31, 2019) and the exercise price of outstanding, in-the-money options (those options with exercise prices below $0.004 per share) on August 31, 2019.</p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Weighted Average Remaining Contractual Term (Years)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Aggregate Intrinsic Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 40%">Options outstanding at June 1, 2019</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">1,600,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">0.03</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Options granted</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Options exercised</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Options forfeited/expired</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt; text-align: left">$</td><td style="padding-bottom: 1pt; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Options outstanding at August 31, 2019</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,600,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right">0.03</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">0.68</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Options vested and expected to vest at August 31, 2019</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,600,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right">0.03</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">0.68</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Options exercisable at August 31, 2019</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,600,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right">0.03</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">0.68</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>6. Commitments and Contingencies </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><u>Litigation </u></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Patent Litigation </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We, TPL, and PDS (collectively referred to as &#8220;Plaintiffs&#8221;) are Plaintiffs in ongoing proceedings in the U.S. District Court for the Northern District of California where the Plaintiffs allege infringement of the US 5,809,336 patent (the &#8220;&#8216;336 patent&#8221;) by: Huawei Technologies Co. Ltd., LG Electronics, Nintendo Co. Ltd., Samsung Electronics Co. Ltd., and ZTE Corporation (collectively referred to as the &#8220;Defendants&#8221;). This litigation is proceeding in front of District Court Judge Vince Chhabria.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These ongoing proceedings relate to the proceedings filed by the Plaintiffs in February 2008 in the U.S. District Court for the Northern District of California alleging infringement of the US 5,440,749 patent (the &#8220;&#8216;749 patent&#8221;), the US 5,530,890 patent (the &#8220;&#8216;890 patent&#8221;) and the &#8216;336 patent against Amazon.com Inc., Barnes &#38; Noble Inc., Garmin Ltd., Huawei Technologies Co. Ltd., Kyocera Corporation, LG Electronics, Nintendo Co. Ltd., Novatel Wireless Inc., Samsung Electronics Co. Ltd., Sierra Wireless Inc., and ZTE Corporation. We have settled with all defendants except those named in the first paragraph to this footnote. On September 18, 2015, a Markman hearing was held before U.S. Magistrate Judge Grewal and, on September 22, 2015, he issued a claim construction report and recommendation. On September 25, 2015, as a result of the claim construction report and recommendation, Plaintiffs and defendants, with the exception of Huawei Technologies Co. Ltd., (&#8220;Huawei&#8221;) agreed to stay all proceedings pending resolution of Plaintiffs&#8217; objections to the claim construction report and recommendation. Plaintiffs further stipulated that, under the claim construction provided by the report and recommendation, defendants&#8217; products do not infringe the &#8216;336 patent, and, in the event that the Court does not materially modify the claim construction, Plaintiffs and defendants ask that the Court enter a final judgment of non-infringement. After Plaintiffs and Huawei filed opposing letter briefs with the Court, U.S. Magistrate Judge Grewal stayed the action against Huawei pending resolution of Plaintiffs&#8217; objections to the claim construction. On October 6, 2015, Plaintiffs filed objections to the claim construction with District Court Judge Chhabria. Judge Chhabria rejected those objections on November 9, 2015. Based on that order, the parties stipulated to a judgment of non-infringement as to the &#8216;336 patent and such judgment was entered on November 13, 2015.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 7, 2015, Plaintiffs filed notices of appeal with the U.S. Federal Circuit appealing the district court&#8217;s claim construction. Plaintiffs filed their opening appellate brief on March 10, 2016. Defendants filed their response brief on May 23, 2016, with Plaintiffs filing their reply brief on June 23, 2016. On March 3, 2017, the U.S. Court of Appeals for the Federal Circuit rendered its decision modifying the claim construction that was issued in September 2016 by the U.S. District Court for the Northern District of California and has remanded the matter to the District Court for further proceedings.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 23, 2017, a case management conference was held in front of District Court Judge Chhabria, who ordered that Plaintiffs amend their infringement contentions on or before June 16, 2017. Judge Chhabria further ordered that Defendants submit any motion for summary judgment based on the amended infringement contentions and the modified claim construction by August 1, 2017. On June 5, 2017, the law firm of Banys, P.C., who had served as local counsel for PDS, withdrew as counsel. PDS continued to be represented by the law firm of Nelson Bumgardner, P.C. On June 16, 2017, Plaintiffs timely amended their infringement contentions. On July 13, 2017, all remaining counsel for each of Patriot, TPL, and PDS moved to withdraw as counsel and further moved to extend all currently pending case deadlines by 60 days for Plaintiffs to seek new counsel.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On September 13, 2017, the law firm of Bunsow De Mory LLP was entered before the U.S. District Court for the Northern District of California as successor counsel in representation of Patriot, PDS, and TPL.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Defendants moved for summary judgment of non-infringement on September 29, 2017, and the Court held a hearing on Defendants&#8217; motion on November 30, 2017. The Court granted Defendants&#8217; motion and entered judgment of non-infringement on December 13, 2017.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Defendant Samsung submitted a bill of costs seeking $30,170 in taxable costs in the underlying district court proceedings; Plaintiffs filed an objection to significant portions of that request. On March 1, 2018, the Clerk of the District Court taxed costs in the amount $829.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Plaintiffs filed notices of appeal in these district court matters on January 5, 2018. The appeals were docketed and consolidated under lead case No. 18-1439, captioned as Technology Properties Limited v. Huawei Technologies Co., Ltd in the United States Court of Appeals for the Federal Circuit. Oral argument proceeded on February 4, 2019. The Court affirmed the lower court&#8217;s determination without written opinion pursuant to Federal Circuit Rule 36 on February 6, 2019.&#160; Plaintiffs filed a Petition for Rehearing En Banc on March 8, 2019 which was denied by the Court on April 10, 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 6, 2019, Plaintiffs filed a petition for a writ of certiorari with the Supreme Court of the United States as a result of the United States Court of Appeals outcome.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><u>Employment Contracts</u></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with Mr.&#160;Flowers&#8217; appointment as the Chief Financial Officer, and commencing on September&#160;17, 2007, we entered into an employment agreement with Mr.&#160;Flowers for an initial 120-day term if not terminated pursuant to the agreement, with an extension period of one year and on a continuing basis thereafter. On December 30, 2016, we entered into an amended and restated employment agreement with Mr. Flowers. Pursuant to the amended December 30, 2016 agreement, if Mr.&#160;Flowers is terminated without cause or resigns with good reason any time after two years of continuous employment, he is entitled to receive an amount equal to 1.25 times his annual base salary. Mr.&#160;Flowers is also entitled to certain payments upon a change of control of the Company if the surviving corporation does not retain him. All such payments are conditional upon the execution of a general release. Mr. Flowers resigned effective October 1, 2019 (see Note 7).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><u>Guarantees and Indemnities</u></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have made certain guarantees and indemnities, under which we may be required to make payments to a guaranteed or indemnified party. We indemnify our directors, officers, employees and agents to the maximum extent permitted under the laws of the State of Delaware. The duration of the guarantees and indemnities varies, and in many cases is indefinite. These guarantees and indemnities do not provide for any limitation of the maximum potential future payments we could be obligated to make. Historically, we have not been obligated to make any payments for these obligations and no liabilities have been recorded for these guarantees and indemnities in the accompanying condensed consolidated balance sheets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><u>Escrow Shares</u></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 31, 2009 we gave notice to the former shareholders of Crossflo and Union Bank of California (the &#8220;Escrow Agent&#8221;) under Section 2.5 of the Agreement and Plan of Merger between us and Crossflo (the &#8220;Agreement&#8221;), outlining damages incurred by us in conjunction with the acquisition of Crossflo, and seeking the return of 2,844,630 shares of our common stock held by the Escrow Agent. Subsequently, former shareholders of Crossflo representing a majority of the escrowed shares responded in protest to our claim, delaying the release of the escrowed shares until a formal resolution is reached. In the event we fail to prevail in our claim against the escrowed shares, we may be obligated to deposit into escrow approximately $256,000 of cash consideration due to the decline in our average stock price over the one year escrow period, calculated in accordance with the Section 2.5 of the Agreement. We have evaluated the potential for loss regarding our claim and believe that it is probable that the resolution of this issue will not result in a material obligation to the Company, although there is no assurance of this. Accordingly, we have not recorded a liability for this matter.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>7. Subsequent Events</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr. Clifford L. Flowers, Chief Financial Officer, Secretary, Treasurer and member of the Company&#8217;s Board of Directors, resigned his positions effective October 1, 2019. On October 3, 2019, our Board appointed Mr. Carlton Johnson Jr. as the Interim Chief Financial Officer on an interim basis. There were no known disagreements with Mr. Flowers regarding our operations, policies or practices.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with his departure, Mr. Flowers entered into a Separation Agreement and General Release of All Claims as of with the Company (the &#8220;Release&#8221;). Pursuant to the Release, Mr. Flowers is entitled to receive severance payments equal to $327,750, less all appropriate federal and state tax withholding, which will be made in seven equal installments on the 30th of each month commencing on October 30, 2019 and ending April 30, 2020. The payments under the Release are in lieu of any rights under the employment agreement between Mr. Flowers and the Company. The Release also contains a mutual general release, confidentiality, non-disparagement and other covenants and agreements.</p> 500000 0 500000 0 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Basis of Consolidation</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The condensed consolidated balance sheets at August 31, 2019 and May 31, 2019 include our accounts and those of our inactive subsidiary Patriot Data Solutions Group, Inc. (&#8220;PDSG&#8221;) which includes Crossflo Systems, Inc. (&#8220;Crossflo&#8221;). The condensed consolidated statements of operations, cash flows and stockholders&#8217; equity for the three months ended August 31, 2019 and 2018 include our accounts and those of our inactive subsidiaries: PDSG and Plasma Scientific Corporation (&#8220;Plasma&#8221;). We dissolved Plasma in March 2018. All significant intercompany accounts and transactions have been eliminated.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Liquidity and Management&#8217;s Plans</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern. At August 31, 2019, the Company has an accumulated deficit of $61,469,283, and has incurred recurring losses and used significant amounts of cash in its operations. As of August 31, 2019, the Company had cash and cash equivalents and marketable securities of approximately $1,239,000 and working capital of approximately $1,237,000. Our only significant potential source of cash is PDS. PDS has not generated significant license revenues since September 2013. Therefore, our ability to continue and expand our operations is highly dependent on the amount of cash and cash equivalents and marketable securities on hand combined with our ability to raise additional capital to fund future operations. We anticipate, based on currently proposed plans and assumptions that our cash on hand will not satisfy our operational and capital requirements through twelve months from the date of filing on this Form 10-Q.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cash shortfalls currently experienced by PDS will have an adverse effect on our liquidity. To date, we have determined that it is in the best interests of the Moore Microprocessor Patent (&#8220;MMP&#8221;) licensing program that we provide our 50% share of capital to provide for PDS expenses including legal retainers and litigation related payments in the event license revenues received by PDS are insufficient to meet these needs. We believe contributions to PDS to fund working capital may be required.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">PDS had been incurring significant third-party costs for legal fees, expert testimony, depositions and other related litigation costs. We could be required to make capital contributions to PDS for any future litigation related costs in the event that PDS does not receive sufficient licensing revenues to pay these expenses.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">PDS is currently pursuing a litigation strategy, which includes the filing, on September 6, 2019, a petition for a writ of certiorari with the Supreme Court of the United States in regards to a decision by the United States Court of Appeals for the Federal Circuit, stemming from litigation in U.S. District Court against multiple companies alleged to be infringers of the MMP portfolio. We continue to believe that the significant investment in legal effort and costs incurred to date at PDS is necessary for the protection of our interests in the MMP portfolio and its future success, although to date it has generated mixed results.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 20, 2013, TPL filed a petition under Chapter 11 of the United States Bankruptcy Code. On March 5, 2018, TPL&#8217;s Motion for Entry of Final Decree Closing Chapter 11 was granted. In the event we are required to provide funding to PDS that is not reciprocated by TPL, our ownership percentage in PDS will increase and we will have a controlling financial interest in PDS, in which case, we will consolidate PDS in our consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 12, 2019, we entered into an agreement with Artius Bioconsulting LLC, (&#8220;Artius&#8221;), to evaluate the potential of establishing a company that develops a platform that could be implemented throughout the drug development process utilizing blockchain technologies. We are anticipating receiving shortly a feasibility report with its analysis. In the event the next steps in the development of a blockchain based business are undertaken, it is expected that funding from external sources will be required.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are a number of uncertainties associated with our financial projections that could increase our projected expenses, which would further accelerate cash usage. Additionally, if we are unable to realize satisfactory cash from operations in the near future, we will be required to seek additional financing to continue our operations. We will also require additional financing to develop or acquire new lines of business. We have no current arrangements with respect to any additional financing. Consequently, there can be no assurance that any additional financing on commercially reasonable terms, or at all, will be available when needed. The inability to obtain additional capital may reduce our ability to continue to conduct business operations. Any additional equity financing may involve substantial dilution to our then existing stockholders. The above matters raise substantial doubt regarding our ability to continue as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Investment in Affiliated Companies</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have a 50% interest in PDS. We account for our investment using the equity method of accounting since the investment provides us the ability to exercise significant influence, but not control, over the investee. Significant influence is generally deemed to exist if we have an ownership interest in the voting stock of the investee of between 20% and 50%, although other factors, such as representation on the investee&#8217;s Board of Directors, are considered in determining whether the equity method of accounting is appropriate. Under the equity method of accounting, the investment, originally recorded at cost, is adjusted to recognize our share of net earnings or losses of the investee and is recognized in the condensed consolidated statements of operations in the caption &#8220;Equity in earnings (loss) of affiliated company&#8221; and also is adjusted by contributions to and distributions from PDS.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">PDS, as an unconsolidated equity investee, recognizes revenue from technology license agreements at the time a contract is entered into, the license method is determined (paid-in-advance or on-going royalty), performance obligations under the license agreement are satisfied, and the realization of revenue is assured which is generally upon the receipt of the license proceeds. PDS may at times enter into license agreements whereby contingent revenues are recognized as one or more contractual milestones are met.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We review our investment in PDS to determine whether events or changes in circumstances indicate that the carrying amount may not be recoverable. The primary factors we consider in our determination are the financial condition, operating performance and near term prospects of PDS. If the decline in value is deemed to be other than temporary, we would recognize an impairment loss.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We own 100% of the preferred stock of Holocom (see Note 3). Prior to impairment, this investment was accounted for at cost since we do not have the ability to exercise significant influence over the operating and financial policies of Holocom.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Income (Loss) Per Share</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Basic income (loss) per share includes no dilution and is computed by dividing income (loss) available to common stockholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share reflect the potential dilution of securities that could share in the earnings of an entity.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At August 31, 2019 and 2018, potential common shares of 1,600,000 related to our outstanding options were not included in the calculation of diluted loss per share as we recorded a loss. Had we reported net income for the three months ended August 31, 2019 and 2018, no shares of common stock would have been included in the calculation of diluted income per share using the treasury stock method.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with our acquisition of Crossflo, which became a part of PDSG, we issued 2,844,630 escrow shares that are contingent upon certain representations and warranties made by Crossflo at the time of the merger agreement (see Note 6). We exclude these escrow shares from the basic income (loss) per share calculations and would have included the escrowed shares in the diluted income per share calculations if we reported net income.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Income Taxes</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We follow authoritative guidance in accounting for uncertainties in income taxes. This authoritative guidance prescribes a recognition threshold and measurement requirement for the financial statement recognition of a tax position that has been taken or is expected to be taken on a tax return and also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. Under this guidance we may only recognize tax positions that meet a &#8220;more likely than not&#8221; threshold.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We follow authoritative guidance to evaluate whether a valuation allowance should be established against our deferred tax assets based on the consideration of all available evidence using a &#8220;more likely than not&#8221; standard. In making such judgments, significant weight is given to evidence that can be objectively verified. We assess our deferred tax assets annually under more likely than not scenarios in which they may be realized through future income.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With the exception for refundable alternative minimum tax (&#8220;AMT&#8221;) credits, we have determined that it was more likely than not that all of our deferred tax assets will not be realized in the future due to our continuing pre-tax and taxable losses. As a result of this determination, and with the exception for the aforementioned refundable tax credits, we have recorded a full valuation allowance against our deferred tax assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 22, 2017, the United States Government passed the Tax Cuts and Jobs Act (&#8220;Tax Cuts Act&#8221;) that, among other provisions, has lowered the corporate tax rate from 35% to 21%. In addition to applying the new lower corporate tax rate in 2018 and thereafter to any taxable income we may have, the legislation affects the way we can use and carryforward net operating losses previously accumulated and results in a revaluation of deferred tax assets and liabilities recorded on our condensed consolidated balance sheet. The Securities and Exchange Commission staff issued Staff Accounting Bulletin No. 118 (&#8220;SAB 118&#8221;) which provides guidance regarding accounting for the income tax effects of the Tax Cuts Act, including the impact of the Tax Cuts Act on deferred tax assets and liabilities for financial statements issued in the reporting period that includes the enactment date of December 22, 2017. Given that our current deferred tax assets, with the exception of those representing certain refundable tax credits, are offset by a full valuation allowance, these changes had no net impact on our condensed consolidated balance sheet. However, if we become profitable, we will receive a reduced benefit from such deferred tax assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Assessment of Contingent Liabilities</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are involved in various legal matters, disputes, and patent infringement claims which arise in the ordinary course of our business. We accrue for any estimated losses at the time when we can make a reliable estimate of such loss and it is probable that it has been incurred. By their very nature, contingencies are difficult to estimate. We continually evaluate information related to all contingencies to determine that the basis on which we have recorded our estimated exposure is appropriate.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Intellectual Property Rights</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">PDS, our investment in affiliated company, relies on a combination of patents, trademarks, copyrights, trade secret laws, confidentiality procedures and licensing arrangements to protect our intellectual property rights. We have seven U.S., nine European, and three Japanese patents all of which expired between August 2009 and October 2016. These patents, while expired, may have certain retrospective statutory benefits that will fully diminish six years after the patent expiration dates. The patent useful life for purposes of negotiating licenses is finite and these patents are subject to legal challenges, which in combination with the limited life, could adversely impact the stream of revenues. A successful challenge to the ownership of the technology or the proprietary nature of the intellectual property would materially damage business prospects. Any issued patent may be challenged and invalidated.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Recent Accounting Pronouncements </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In February 2016, the FASB issued ASU No. 2016-02, &#8220;Leases (Topic 842)&#8221;, as amended (&#34;ASC 842&#34;), which modifies lease accounting for lessees to increase transparency and comparability by recording lease assets and liabilities for operating leases and disclosing key information about leasing arrangements. ASU 2018-13 is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2018. The Company adopted ASC 842 effective June 1, 2019 using a modified retrospective method and will not restate comparative periods. As permitted under the transition guidance, the Company will carry forward the assessment of whether its contracts contain or are leases, classification of its leases and remaining lease terms. Implementation of this guidance did not have a material impact on the Company&#8217;s consolidated financial statements. We have elected the short-term lease recognition exemption for all applicable classes of underlying assets. Short-term leases include only those leases with a term greater than one month and twelve months or less. Short-term leases are not recorded on the consolidated balance sheet, and lease expense on short-term leases is recognized on a straight-line basis over the lease term. The Company elected the &#8220;practical expedient package&#8221; as permitted under ASC 842. Therefore, the Company has not reassessed whether any expired or existing contracts are, or contain, leases; the Company has not reassessed the lease classification for any expired or existing leases; and the Company has not reassessed initial direct costs for any expired or existing leases. The Company currently leases office space on a month-to-month basis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In August 2018, the FASB issued ASU No. 2018-13, &#8220;Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement&#8221; (&#8220;ASU 2018-13&#8221;), which removes, modifies, and adds various disclosure requirements on fair value measurements in Topic 820. ASU 2018-13 is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2019. The amendments on changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. Early adoption is permitted upon issuance of this update. An entity is permitted to early adopt any removed or modified disclosures upon issuance of this update and delay adoption of the additional disclosures until their effective date. The Company does not expect a significant impact from adopting this update on its consolidated financial statements.</p> 88625 29559 -88625 -29559 1600 0 1239000 1237000 -70022 -260325 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>3. Investment in Affiliated Companies</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Phoenix Digital Solutions, LLC</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 7, 2005, we entered into a Master Agreement (the &#8220;Master Agreement&#8221;) with TPL, and Charles H. Moore (&#8220;Moore&#8221;), the co-inventor of the technology which is the subject of the MMP portfolio of microprocessor patents, pursuant to which the parties resolved all legal disputes between them. Pursuant to the Master Agreement, we and TPL entered into the Limited Liability Company Operating Agreement of PDS (the &#8220;LLC Agreement&#8221;) into which we and Moore contributed our rights to certain of our technologies.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We and TPL each own 50% of the membership interests of PDS, and each member has the right to appoint one member of the three-member management committee. The two appointees are required to select a mutually acceptable third member of the management committee. There had not been a third management committee member since May 2010; however, as a result of our initiation of arbitration seeking the appointment of a third member, on December 16, 2014, an independent manager to the PDS management committee was selected by the arbitrator. Pursuant to the LLC Agreement, we and TPL initially agreed to establish a working capital fund for PDS of $4,000,000, of which our contribution was $2,000,000. The working capital fund was increased to a maximum of $8,000,000 as license revenues are achieved. We and TPL are obligated to fund future working capital requirements at the discretion of the management committee of PDS in order to maintain working capital of not more than $8,000,000. If the management committee determines that additional capital is required, neither we nor TPL are required to contribute more than $2,000,000 in any fiscal year. No such contributions were made during the three months ended August 31, 2019 and 2018. Distributable cash and allocation of profits and losses have been allocated to the members in the priority defined in the LLC Agreement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On July 11, 2012, we entered into the Program Agreement with PDS, TPL, and Alliacense, and an Agreement (the &#8220;TPL Agreement&#8221;) with TPL. Pursuant to the Program Agreement, PDS engaged Alliacense to negotiate MMP portfolio licenses and to pursue claims against violators of the MMP portfolio on behalf of PDS, TPL, and the Company. The Program Agreement continued through the useful life of the MMP portfolio patents. Pursuant to the TPL Agreement, we and TPL agreed to certain allocations of obligations in connection with the engagement of Alliacense. On July 24, 2014, the Program Agreement was amended with PDS and Alliacense entering into the Amended Alliacense Services and Novation Agreement (the &#8220;Novation Agreement&#8221;). Pursuant to the Novation Agreement certain performance goals and incentives were established for Alliacense. The Novation Agreement also provided for the addition of a second licensing company, which was engaged on October 10, 2014, to complement the MMP licensing commercialization. However, Alliacense fulfilled only a portion of its obligations under the Novation Agreement associated with the deployment of the second licensing company and on May 11, 2015, Alliacense was terminated by PDS.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 10, 2016, PDS entered into an agreement with Alliacense and MMP Licensing, LLC to settle matters relating to Alliacense&#8217;s non-performance under terms of the Novation Agreement. The August 10, 2016 agreement required Alliacense to provide PDS&#8217;s second licensing company, Dominion Harbor Group (&#8220;DHG&#8221;), with certain materials and to cooperate with reasonable discovery requests relating to infringement litigation in the U.S. District Court for the Northern District of California. MMP Licensing, LLC will provide commercialization services to PDS for the MMP portfolio with respect to certain companies. PDS and Alliacense have agreed to cause the arbitration between the parties to be dismissed with prejudice. The August 10, 2016 agreement, and the agreement retaining DHG as PDS&#8217;s second licensing company, will both expire on October 4, 2022. Terms of the settlement agreement required PDS to pay Alliacense $84,000 within 24 hours after delivery of materials to PDS&#8217;s second licensing agent and to pay Alliacense $84,000 out of subsequent recoveries. PDS paid Alliacense $84,000 on each of August 11, 2016 and October 3, 2016.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During January 2013, TPL and Moore settled their litigation. Terms of the settlement included the payment by PDS to Moore of a consulting fee of $250,000 for four years or until the completion of all outstanding MMP litigation whichever came first. Per terms of the agreement, PDS paid Moore $150,000 on the settlement date and paid Moore $16,667 per month from August 2013 through January 2014 and $20,833 per month beginning February 2014 through January 2017.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based on our analysis of current authoritative accounting guidance with respect to our investment in PDS, we continue to account for our investment in PDS under the equity method of accounting, and accordingly have recorded our share of PDS&#8217;s net loss during the three months ended August 31, 2019 and 2018 of $44,312 and $14,780, respectively, as a decrease in our investment as &#8220;Equity in loss of affiliated company&#8221; in the accompanying condensed consolidated statements of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 20, 2013, TPL filed a petition under Chapter 11 of the United States Bankruptcy Code. On March 5, 2018, TPL&#8217;s Motion for Entry of Final Decree Closing Chapter 11 was granted. In the event we are required to provide funding to PDS that is not reciprocated by TPL, our ownership percentage in PDS will increase and we will have a controlling financial interest in PDS, in which case, we will consolidate PDS in our condensed consolidated financial statements. If we determine that it is appropriate to consolidate PDS, we would measure the assets, liabilities and noncontrolling interests of PDS at their fair values at the date that we have the controlling financial interest.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">PDS&#8217;s balance sheets at August 31, 2019 and May 31, 2019 and statements of operations for the three months ended August 31, 2019 and 2018 are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Balance Sheets</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Assets:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">August 31, 2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">May 31, 2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 46%">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td> <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 13%; font-weight: bold; text-align: center"><font style="font-size: 10pt"><b>(Unaudited)</b></font></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt">Cash</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">234,758</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">237,655</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total assets</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">234,758</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">237,655</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Liabilities and Members&#8217; Equity:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="width: 46%; padding-bottom: 1pt">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td> <td style="width: 1%; border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="width: 13%; border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><font style="font-size: 10pt"><b>August 31, 2019</b></font></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td> <td style="width: 1%; border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="width: 13%; border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><font style="font-size: 10pt"><b>May 31, 2019</b></font></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="font-weight: bold">&#160;</td> <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: center"><font style="font-size: 10pt"><b>(Unaudited)</b></font></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Payables</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right">107,661</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right">21,933</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Members&#8217; equity</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">127,097</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">215,722</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Total liabilities and members&#8217; equity</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">234,758</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">237,655</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-weight: normal">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Statements of Operations</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td colspan="6" style="text-align: center; border-bottom: Black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Three Months Ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>August 31,</b></p></td><td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2018</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="font-weight: bold">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td><td style="font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 46%">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt">Expenses</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">88,625</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">29,559</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(88,625</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(29,559</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We review our investment in PDS to determine whether events or changes in circumstances indicate that the carrying amount may not be recoverable. The primary factors we consider in our determination are the financial condition, operating performance and near term prospects of PDS. If&#160;a decline in value is deemed to be other than temporary, we would recognize an impairment loss.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Holocom, Inc</i>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We currently own 2,100,000 shares of preferred stock, equivalent to an approximate 46% ownership interest on an after converted basis, in Holocom, Inc. (&#8220;Holocom&#8221;), a California corporation that manufactures products that protect information transmitted over secure networks. The shares are convertible at our option into shares of Holocom&#8217;s common stock on a one-to-one basis. The preferred stock entitles us to receive non-cumulative dividends at the per annum rate of $0.04 per share, when and if declared by the Board of Directors of Holocom, as well as a liquidation preference of $0.40 per share, plus an amount equal to all declared but unpaid dividends.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In 2010, we determined that the inability of Holocom to meet its business plan, raise capital, and the general economic environment were indicators of impairment on our investment and we wrote-off our cost basis investment in Holocom. At August 31, 2019 and May 31, 2019, our investment in Holocom was valued at $0.</p> EX-101.SCH 6 ptsc-20190831.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Consolidated Statements of Stockholders' Equity (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Statement - Reconciliation of Cash, Cash Equivalents, and Restricted Cash and Cash Equivalents link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - 1. Basis of Presentation and Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - 2. Cash, Cash Equivalents, Restricted Cash link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - 3. Investment in Affiliated Companies link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - 4. Income Taxes link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - 5. Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - 6. Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - 7. Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - 2. Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - 2. Cash, Cash Equivalents, Restricted Cash (Tables) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - 3. Investment in Affiliated Company (Tables) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - 5. Stockholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - 1. Basis of Presentation and Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - 2. Cash, Cash Equivalents, Restricted Cash (Details - Fair Value) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - 2. Cash, Cash Equivalents, Restricted Cash (Details - Maturities) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - 3. Investment in Affiliated Company (Details) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - 3. Investment in Affiliated Company (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - 5. Stockholders' Equity (Details - Option activity) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 ptsc-20190831_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 ptsc-20190831_def.xml XBRL DEFINITION FILE EX-101.LAB 9 ptsc-20190831_lab.xml XBRL LABEL FILE Equity Components [Axis] Common Stock Additional Paid-In Capital Accumulated Deficit Treasury Stock FairValueByFairValueHierarchyLevel [Axis] Fair Value Inputs Level 1 Fair Value Inputs Level 2 Fair Value Inputs Level 3 CashAndCashEquivalents [Axis] Due in three months or less Balance Sheet Location [Axis] Payables [Member] Members equity [Member] Cash [Member] Prepaid Expenses [Member] Award Type [Axis] Options [Member] Legal Entity [Axis] PDS [Member] Antidilutive Securities [Axis] Business Acquisition [Axis] Crossflo [Member] Holocom [Member] Class of Stock [Axis] Preferred Stock [Member] Due in greater than three months [Member] Income Statement Location [Axis] Expenses [Member] Net Loss [Member] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Is Entity's Reporting Status Current Entity Filer Category Entity Public Float Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Entity Small Business Entity Emerging Growth Entity file number Entity state of incorporation Shell Company Interactive Data Current Statement of Financial Position [Abstract] ASSETS Current assets: Cash and cash equivalents Restricted cash and cash equivalents Investments in marketable securities Prepaid expenses and other current assets Total current assets Property and equipment, net Deferred income taxes Investment in affiliated company Total assets LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable Accrued expenses and other Income taxes payable Total current liabilities Total liabilities Commitments and contingencies Stockholders' equity Preferred stock, $0.00001 par value; 5,000,000 shares authorized: none outstanding Common stock, $0.00001 par value: 600,000,000 shares authorized: 438,242,618 shares issued and 401,392,948 shares outstanding at August 31, 2019 and May 31, 2019 Additional paid-in capital Accumulated deficit Common stock held in treasury, at cost - 36,849,670 shares at August 31, 2019 and May 31, 2019 Total stockholders' equity Total liabilities and stockholders' equity Preferred stock, par value (in Dollars per share) Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value (in Dollars per share) Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Common stock held in treasury, at cost Income Statement [Abstract] Operating expenses: Selling, general and administrative Total operating expenses Other income (expense): Interest income Equity in loss of affiliated company Total other expense, net Loss before income taxes Provision for income taxes Net loss Basic and diluted loss per common share Weighted average number of common shares outstanding - basic Weighted average number of common shares outstanding - diluted Statement of Cash Flows [Abstract] Operating activities: Net loss Adjustments to reconcile net loss to net cash used in operating activities: Depreciation Equity in loss of affiliated company Changes in operating assets and liabilities: Prepaid expenses and other current assets Income taxes payable Accounts payable, accrued expenses and other Net cash used in operating activities Investing activities: Proceeds from sales of marketable securities Purchases of marketable securities Net cash provided by investing activities Net decrease in cash, cash equivalents and restricted cash and cash equivalents Cash, cash equivalents and restricted cash and cash equivalents, beginning of period Cash, cash equivalents and restricted cash cash equivalents, end of period Supplemental Disclosure of Cash Flow Information: Cash paid for income taxes Statement [Table] Statement [Line Items] Beginning balance, shares Beginning balance, value Ending balance, shares Ending balance, value Reconciliation of cash, cash equivalents and restricted cash and cash equivalents at end of period Cash and Cash Equivalents Restricted Cash and cash equivalents Total cash, cash equivalents and restricted cash Organization, Consolidation and Presentation of Financial Statements [Abstract] Basis of Presentation and Summary of Significant Accounting Policies Cash and Cash Equivalents [Abstract] Cash, Cash Equivalents, Restricted Cash and Marketable Securities Investments in and Advances to Affiliates, Schedule of Investments [Abstract] Investment in Affiliated Companies Income Tax Disclosure [Abstract] Income Taxes Equity [Abstract] Stockholders' Equity Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Subsequent Events [Abstract] Subsequent Events Accounting Policies [Abstract] Basis of Consolidation Financial Instruments and Concentrations of Credit Risk Fair Value of Financial Instruments Cash Equivalents, Restricted Cash, and Marketable Securities Investments in Marketable Securities Property, Equipment and Depreciation Investment in Affiliated Companies Income Taxes Assessment of Contingent Liabilities Income (Loss) Per Share Use of Estimates Intellectual Property Rights Recent Accounting Pronouncements Liquidity and Management's Plans Schedule of fair value of cash, cash equivalents and investments in marketable securities Schedule of maturities, gross unrealized gains or losses and fair value of certificates of deposit Financial Statements of Affiliates Schedule of Stock Options Activity Cash, cash equivalents and marketable securities Working capital Percentage of investment in affiliated company Common shares not included in calculation of net earnings (loss) per share Shares held in escrow Fair Value Hierarchy and NAV [Axis] Fair Value Measurement of Cash, Cash Equivalents and Investments in Marketable Securities Cash and cash equivalents: Cash Money market funds Certificates of deposit Investments in marketable securities Certificates of deposit Fair value of assets Cash and Cash Equivalents [Axis] Cost Gross Unrealized Gains/(Losses) Total fair value of investment Total assets Total liabilities and members' equity Total Expenses Net loss Equity interest percentage Equity shares owned Capital contribution to entity Litigation settlement expense Terms of settlement Number of Options Number of Options Outstanding, Beginning Number of Options Granted Number of Options Exercised Number of Options Forfeited/Expired Number of Options Outstanding, Ending Options vested and expected to vest, Ending Number of Options Exercisable, Ending Weighted Average Exercise Price Weighted Average Exercise Price Outstanding, Beginning Weighted Average Exercise Price Granted Weighted Average Exercise Price Exercised Weighted Average Exercise Price Forfeited/Expired Weighted Average Exercise Price Outstanding, Ending Weighted Average Exercise Price, Options vested and expected to vest, Ending Weighted Average Exercise Price Exercisable Weighted Average Remaining Contractual Life Weighted Average Remaining Contractual Life (in years) Outstanding Weighted Average Remaining Contractual Life (in years) Options vested and expected to vest Weighted Average Remaining Contractual Life (in years) Exercisable Aggregate Intrinsic Value Aggregate Intrinsic Value Outstanding, Beginning Aggregate Intrinsic Value Outstanding, Ending Aggregate Intrinsic Value Options vested and expected to vest Aggregate Intrinsic Value Exercisable Aggregate Intrinsic Value [Abstract] Capital contribution to entity Cash and cash equivalents: Cash and cash equivalents cash and marketable securities abstract Custom Element. Shares held in escrow Weighted Average Remaining Contractual Life [Abstract] Marketable securities, certificates of deposit fair value Working capital Assets, Current Assets Liabilities, Current Liabilities Treasury Stock, Value Stockholders' Equity Attributable to Parent Liabilities and Equity Operating Expenses Nonoperating Income (Expense) Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Income Taxes Payable Net Cash Provided by (Used in) Operating Activities Payments to Acquire Marketable Securities Net Cash Provided by (Used in) Investing Activities Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Shares, Outstanding Equity Method Investments [Policy Text Block] Income Tax, Policy [Policy Text Block] MarketableSecuritiesCertificatesOfDepositAtCarryingValue Assets, Fair Value Disclosure Equity Method Investment, Summarized Financial Information, Net Income (Loss) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value EX-101.PRE 10 ptsc-20190831_pre.xml XBRL PRESENTATION FILE XML 11 R17.htm IDEA: XBRL DOCUMENT v3.19.3
3. Investment in Affiliated Company (Tables)
3 Months Ended
Aug. 31, 2019
Investments in and Advances to Affiliates, Schedule of Investments [Abstract]  
Financial Statements of Affiliates

Assets:

 

   August 31, 2019   May 31, 2019 
    (Unaudited)      
           
Cash  $234,758   $237,655 
Total assets  $234,758   $237,655 

 

Liabilities and Members’ Equity:

 

    August 31, 2019    May 31, 2019 
    (Unaudited)      
           
Payables  $107,661   $21,933 
Members’ equity   127,097    215,722 
Total liabilities and members’ equity  $234,758   $237,655 

 

Statements of Operations

 

  

Three Months Ended

August 31,

 
   2019   2018 
   (Unaudited)   (Unaudited) 
           
Expenses  $88,625   $29,559 
Net loss  $(88,625)   (29,559)

 

XML 12 R13.htm IDEA: XBRL DOCUMENT v3.19.3
6. Commitments and Contingencies
3 Months Ended
Aug. 31, 2019
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

6. Commitments and Contingencies

 

Litigation

 

Patent Litigation

 

We, TPL, and PDS (collectively referred to as “Plaintiffs”) are Plaintiffs in ongoing proceedings in the U.S. District Court for the Northern District of California where the Plaintiffs allege infringement of the US 5,809,336 patent (the “‘336 patent”) by: Huawei Technologies Co. Ltd., LG Electronics, Nintendo Co. Ltd., Samsung Electronics Co. Ltd., and ZTE Corporation (collectively referred to as the “Defendants”). This litigation is proceeding in front of District Court Judge Vince Chhabria.

 

These ongoing proceedings relate to the proceedings filed by the Plaintiffs in February 2008 in the U.S. District Court for the Northern District of California alleging infringement of the US 5,440,749 patent (the “‘749 patent”), the US 5,530,890 patent (the “‘890 patent”) and the ‘336 patent against Amazon.com Inc., Barnes & Noble Inc., Garmin Ltd., Huawei Technologies Co. Ltd., Kyocera Corporation, LG Electronics, Nintendo Co. Ltd., Novatel Wireless Inc., Samsung Electronics Co. Ltd., Sierra Wireless Inc., and ZTE Corporation. We have settled with all defendants except those named in the first paragraph to this footnote. On September 18, 2015, a Markman hearing was held before U.S. Magistrate Judge Grewal and, on September 22, 2015, he issued a claim construction report and recommendation. On September 25, 2015, as a result of the claim construction report and recommendation, Plaintiffs and defendants, with the exception of Huawei Technologies Co. Ltd., (“Huawei”) agreed to stay all proceedings pending resolution of Plaintiffs’ objections to the claim construction report and recommendation. Plaintiffs further stipulated that, under the claim construction provided by the report and recommendation, defendants’ products do not infringe the ‘336 patent, and, in the event that the Court does not materially modify the claim construction, Plaintiffs and defendants ask that the Court enter a final judgment of non-infringement. After Plaintiffs and Huawei filed opposing letter briefs with the Court, U.S. Magistrate Judge Grewal stayed the action against Huawei pending resolution of Plaintiffs’ objections to the claim construction. On October 6, 2015, Plaintiffs filed objections to the claim construction with District Court Judge Chhabria. Judge Chhabria rejected those objections on November 9, 2015. Based on that order, the parties stipulated to a judgment of non-infringement as to the ‘336 patent and such judgment was entered on November 13, 2015.

 

On December 7, 2015, Plaintiffs filed notices of appeal with the U.S. Federal Circuit appealing the district court’s claim construction. Plaintiffs filed their opening appellate brief on March 10, 2016. Defendants filed their response brief on May 23, 2016, with Plaintiffs filing their reply brief on June 23, 2016. On March 3, 2017, the U.S. Court of Appeals for the Federal Circuit rendered its decision modifying the claim construction that was issued in September 2016 by the U.S. District Court for the Northern District of California and has remanded the matter to the District Court for further proceedings.

 

On May 23, 2017, a case management conference was held in front of District Court Judge Chhabria, who ordered that Plaintiffs amend their infringement contentions on or before June 16, 2017. Judge Chhabria further ordered that Defendants submit any motion for summary judgment based on the amended infringement contentions and the modified claim construction by August 1, 2017. On June 5, 2017, the law firm of Banys, P.C., who had served as local counsel for PDS, withdrew as counsel. PDS continued to be represented by the law firm of Nelson Bumgardner, P.C. On June 16, 2017, Plaintiffs timely amended their infringement contentions. On July 13, 2017, all remaining counsel for each of Patriot, TPL, and PDS moved to withdraw as counsel and further moved to extend all currently pending case deadlines by 60 days for Plaintiffs to seek new counsel.

 

On September 13, 2017, the law firm of Bunsow De Mory LLP was entered before the U.S. District Court for the Northern District of California as successor counsel in representation of Patriot, PDS, and TPL.

 

The Defendants moved for summary judgment of non-infringement on September 29, 2017, and the Court held a hearing on Defendants’ motion on November 30, 2017. The Court granted Defendants’ motion and entered judgment of non-infringement on December 13, 2017.

 

Defendant Samsung submitted a bill of costs seeking $30,170 in taxable costs in the underlying district court proceedings; Plaintiffs filed an objection to significant portions of that request. On March 1, 2018, the Clerk of the District Court taxed costs in the amount $829.

 

Plaintiffs filed notices of appeal in these district court matters on January 5, 2018. The appeals were docketed and consolidated under lead case No. 18-1439, captioned as Technology Properties Limited v. Huawei Technologies Co., Ltd in the United States Court of Appeals for the Federal Circuit. Oral argument proceeded on February 4, 2019. The Court affirmed the lower court’s determination without written opinion pursuant to Federal Circuit Rule 36 on February 6, 2019.  Plaintiffs filed a Petition for Rehearing En Banc on March 8, 2019 which was denied by the Court on April 10, 2019.

 

On September 6, 2019, Plaintiffs filed a petition for a writ of certiorari with the Supreme Court of the United States as a result of the United States Court of Appeals outcome.

 

Employment Contracts

 

In connection with Mr. Flowers’ appointment as the Chief Financial Officer, and commencing on September 17, 2007, we entered into an employment agreement with Mr. Flowers for an initial 120-day term if not terminated pursuant to the agreement, with an extension period of one year and on a continuing basis thereafter. On December 30, 2016, we entered into an amended and restated employment agreement with Mr. Flowers. Pursuant to the amended December 30, 2016 agreement, if Mr. Flowers is terminated without cause or resigns with good reason any time after two years of continuous employment, he is entitled to receive an amount equal to 1.25 times his annual base salary. Mr. Flowers is also entitled to certain payments upon a change of control of the Company if the surviving corporation does not retain him. All such payments are conditional upon the execution of a general release. Mr. Flowers resigned effective October 1, 2019 (see Note 7).

 

Guarantees and Indemnities

 

We have made certain guarantees and indemnities, under which we may be required to make payments to a guaranteed or indemnified party. We indemnify our directors, officers, employees and agents to the maximum extent permitted under the laws of the State of Delaware. The duration of the guarantees and indemnities varies, and in many cases is indefinite. These guarantees and indemnities do not provide for any limitation of the maximum potential future payments we could be obligated to make. Historically, we have not been obligated to make any payments for these obligations and no liabilities have been recorded for these guarantees and indemnities in the accompanying condensed consolidated balance sheets.

 

Escrow Shares

 

On August 31, 2009 we gave notice to the former shareholders of Crossflo and Union Bank of California (the “Escrow Agent”) under Section 2.5 of the Agreement and Plan of Merger between us and Crossflo (the “Agreement”), outlining damages incurred by us in conjunction with the acquisition of Crossflo, and seeking the return of 2,844,630 shares of our common stock held by the Escrow Agent. Subsequently, former shareholders of Crossflo representing a majority of the escrowed shares responded in protest to our claim, delaying the release of the escrowed shares until a formal resolution is reached. In the event we fail to prevail in our claim against the escrowed shares, we may be obligated to deposit into escrow approximately $256,000 of cash consideration due to the decline in our average stock price over the one year escrow period, calculated in accordance with the Section 2.5 of the Agreement. We have evaluated the potential for loss regarding our claim and believe that it is probable that the resolution of this issue will not result in a material obligation to the Company, although there is no assurance of this. Accordingly, we have not recorded a liability for this matter.

XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 R21.htm IDEA: XBRL DOCUMENT v3.19.3
2. Cash, Cash Equivalents, Restricted Cash (Details - Maturities) - USD ($)
Aug. 31, 2019
May 31, 2019
Cost $ 1,250,000  
Gross Unrealized Gains/(Losses) 0  
Total fair value of investment 1,250,000  
Due in greater than three months [Member]    
Cost 500,000 $ 750,000
Gross Unrealized Gains/(Losses) 0 0
Total fair value of investment 500,000 750,000
Due in three months or less    
Cost 0 500,000
Gross Unrealized Gains/(Losses) 0 0
Total fair value of investment $ 500,000 $ 500,000
XML 15 R7.htm IDEA: XBRL DOCUMENT v3.19.3
Reconciliation of Cash, Cash Equivalents, and Restricted Cash and Cash Equivalents - USD ($)
Aug. 31, 2019
May 31, 2019
Aug. 31, 2018
May 31, 2018
Reconciliation of cash, cash equivalents and restricted cash and cash equivalents at end of period        
Cash and Cash Equivalents $ 738,660 $ 787,086 $ 2,037,537  
Restricted Cash and cash equivalents 177,247 198,843 21,587  
Total cash, cash equivalents and restricted cash $ 915,907 $ 985,929 $ 2,059,124 $ 2,319,449
XML 16 R3.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares
Aug. 31, 2019
May 31, 2019
Statement of Financial Position [Abstract]    
Preferred stock, par value (in Dollars per share) $ 0.00001 $ 0.00001
Preferred stock, shares authorized 5,000,000 5,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value (in Dollars per share) $ 0.00001 $ 0.00001
Common stock, shares authorized 600,000,000 600,000,000
Common stock, shares issued 438,242,618 438,242,618
Common stock, shares outstanding 401,392,948 401,392,948
Common stock held in treasury, at cost 36,849,670 36,849,670
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Treasury Stock
Total
Beginning balance, shares at May. 31, 2018 401,392,948        
Beginning balance, value at May. 31, 2018 $ 4,382 $ 77,444,062 $ (60,327,562) $ (14,625,868) $ 2,495,014
Net loss     (212,918)   (212,918)
Ending balance, shares at Aug. 31, 2018 401,392,948        
Ending balance, value at Aug. 31, 2018 $ 4,382 77,444,062 (60,540,480) (14,625,868) 2,282,096
Beginning balance, shares at May. 31, 2019 401,392,948        
Beginning balance, value at May. 31, 2019 $ 4,382 77,444,062 (61,126,025) (14,625,868) 1,696,551
Net loss     (343,258)   (343,258)
Ending balance, shares at Aug. 31, 2019 401,392,948        
Ending balance, value at Aug. 31, 2019 $ 4,382 $ 77,444,062 $ (61,469,283) $ (14,625,868) $ 1,353,293
XML 18 R2.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Balance Sheets (Unaudited) - USD ($)
Aug. 31, 2019
May 31, 2019
Current assets:    
Cash and cash equivalents $ 738,660 $ 787,086
Restricted cash and cash equivalents 177,247 198,843
Investments in marketable securities 500,000 750,000
Prepaid expenses and other current assets 85,880 28,003
Total current assets 1,501,787 1,763,932
Property and equipment, net 692 814
Deferred income taxes 52,156 52,156
Investment in affiliated company 63,549 107,861
Total assets 1,618,184 1,924,763
Current liabilities:    
Accounts payable 19,779 8,868
Accrued expenses and other 243,512 219,344
Income taxes payable 1,600 0
Total current liabilities 264,891 228,212
Total liabilities 264,891 228,212
Commitments and contingencies
Stockholders' equity    
Preferred stock, $0.00001 par value; 5,000,000 shares authorized: none outstanding 0 0
Common stock, $0.00001 par value: 600,000,000 shares authorized: 438,242,618 shares issued and 401,392,948 shares outstanding at August 31, 2019 and May 31, 2019 4,382 4,382
Additional paid-in capital 77,444,062 77,444,062
Accumulated deficit (61,469,283) (61,126,025)
Common stock held in treasury, at cost - 36,849,670 shares at August 31, 2019 and May 31, 2019 (14,625,868) (14,625,868)
Total stockholders' equity 1,353,293 1,696,551
Total liabilities and stockholders' equity $ 1,618,184 $ 1,924,763
XML 19 R24.htm IDEA: XBRL DOCUMENT v3.19.3
5. Stockholders' Equity (Details - Option activity) - Options [Member]
3 Months Ended
Aug. 31, 2019
USD ($)
$ / shares
shares
Number of Options  
Number of Options Granted | shares 0
Number of Options Exercised | shares 0
Number of Options Forfeited/Expired | shares 0
Number of Options Outstanding, Ending | shares 1,600,000
Options vested and expected to vest, Ending | shares 1,600,000
Number of Options Exercisable, Ending | shares 1,600,000
Weighted Average Exercise Price  
Weighted Average Exercise Price Granted | $ / shares
Weighted Average Exercise Price Exercised | $ / shares
Weighted Average Exercise Price Forfeited/Expired | $ / shares
Weighted Average Exercise Price Outstanding, Ending | $ / shares 0.03
Weighted Average Exercise Price, Options vested and expected to vest, Ending | $ / shares 0.03
Weighted Average Exercise Price Exercisable | $ / shares $ 0.03
Weighted Average Remaining Contractual Life  
Weighted Average Remaining Contractual Life (in years) Outstanding 8 months 5 days
Weighted Average Remaining Contractual Life (in years) Options vested and expected to vest 8 months 5 days
Weighted Average Remaining Contractual Life (in years) Exercisable 8 months 5 days
Aggregate Intrinsic Value  
Aggregate Intrinsic Value Outstanding, Ending | $ $ 0
Aggregate Intrinsic Value Options vested and expected to vest | $ 0
Aggregate Intrinsic Value Exercisable | $ $ 0
XML 20 R20.htm IDEA: XBRL DOCUMENT v3.19.3
2. Cash, Cash Equivalents, Restricted Cash (Details - Fair Value) - USD ($)
Aug. 31, 2019
May 31, 2019
Aug. 31, 2018
Cash and cash equivalents:      
Cash $ 46,048 $ 49,149  
Money market funds 692,612 237,937  
Certificates of deposit   500,000  
Restricted cash and cash equivalents 177,247 198,843 $ 21,587
Investments in marketable securities      
Certificates of deposit 500,000 750,000  
Fair value of assets 1,415,907 1,735,929  
Fair Value Inputs Level 1      
Cash and cash equivalents:      
Cash 46,048 49,149  
Money market funds 692,612 237,937  
Certificates of deposit   0  
Restricted cash and cash equivalents 177,247 198,843  
Investments in marketable securities      
Certificates of deposit 0 0  
Fair value of assets 915,907 485,929  
Fair Value Inputs Level 2      
Cash and cash equivalents:      
Cash 0 0  
Money market funds 0 0  
Certificates of deposit   500,000  
Restricted cash and cash equivalents 0 0  
Investments in marketable securities      
Certificates of deposit 500,000 750,000  
Fair value of assets 500,000 1,250,000  
Fair Value Inputs Level 3      
Cash and cash equivalents:      
Cash 0 0  
Money market funds 0 0  
Certificates of deposit   0  
Restricted cash and cash equivalents 0 0  
Investments in marketable securities      
Certificates of deposit 0 0  
Fair value of assets $ 0 $ 0  
XML 21 R16.htm IDEA: XBRL DOCUMENT v3.19.3
2. Cash, Cash Equivalents, Restricted Cash (Tables)
3 Months Ended
Aug. 31, 2019
Cash and Cash Equivalents [Abstract]  
Schedule of fair value of cash, cash equivalents and investments in marketable securities

       Fair Value Measurements at August 31, 2019 Using 
   Fair Value at
August 31,
2019
   Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
   Significant Other
Observable
Inputs
(Level 2)
   Significant
Unobservable
Inputs
(Level 3)
 
Cash and cash equivalents:                    
Cash  $46,048   $46,048   $   $ 
Money market funds   692,612    692,612         
Restricted cash and cash equivalents   177,247    177,247         
Investments in marketable securities:                    
Certificates of deposit   500,000        500,000     
Total  $1,415,907   $915,907   $500,000   $ 

 

 

       Fair Value Measurements at May 31, 2019 Using 
   Fair Value at
May 31,
2019
   Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
   Significant Other
Observable
Inputs
(Level 2)
   Significant
Unobservable
Inputs
(Level 3)
 
Cash and cash equivalents:                    
Cash  $49,149   $49,149   $   $ 
Money market funds   237,937    237,937         
Certificates of deposit   500,000        500,000     
Restricted cash and cash equivalents   198,843    198,843         
Investments in marketable securities:                    
Certificates of deposit   750,000        750,000     
Total  $1,735,929   $485,929   $1,250,000   $ 

 

Schedule of maturities, gross unrealized gains or losses and fair value of certificates of deposit

  

August 31, 2019

(Unaudited)

 
   Cost   Gross Unrealized Gains/(Losses)   Fair
Value
 
Maturity            
Due in greater than three months  $500,000   $   $500,000 

 

 

   May 31, 2019 
   Cost   Gross Unrealized Gains/(Losses)   Fair
Value
 
Maturity            
Due in three months or less  $500,000   $   $500,000 
Due in greater than three months   750,000        750,000 
   $1,250,000   $   $1,250,000 

 

XML 22 R12.htm IDEA: XBRL DOCUMENT v3.19.3
5. Stockholders' Equity
3 Months Ended
Aug. 31, 2019
Equity [Abstract]  
Stockholders' Equity

5. Stockholders’ Equity

 

Share-based Compensation

 

Summary of Assumptions and Activity

 

The fair value of share-based awards to employees and directors is calculated using the Black-Scholes option pricing model, even though this model was developed to estimate the fair value of freely tradable, fully transferable options without vesting restrictions, which differ significantly from our stock options.

 

The Black-Scholes model also requires subjective assumptions, including future stock price volatility and expected time to exercise, which greatly affect the calculated values. The expected term of options granted is derived from historical data on employee exercises and post-vesting employment termination behavior. The risk-free rate selected to value any particular grant is based on the U.S. Treasury rate that corresponds to the pricing term of the grant effective as of the date of the grant. The expected volatility is based on the historical volatilities of our common stock. These factors could change in the future, affecting the determination of share-based compensation expense in future periods.

 

A summary of option activity as of August 31, 2019 and changes during the three months then ended, is presented below:

 

   Shares   Weighted Average Exercise Price   Weighted Average Remaining Contractual Term (Years)   Aggregate Intrinsic Value 
Options outstanding at June 1, 2019   1,600,000   $0.03           
Options granted      $           
Options exercised      $           
Options forfeited/expired      $           
Options outstanding at August 31, 2019   1,600,000   $0.03    0.68   $ 
Options vested and expected to vest at August 31, 2019   1,600,000   $0.03    0.68   $ 
Options exercisable at August 31, 2019   1,600,000   $0.03    0.68   $ 

 

The aggregate intrinsic value represents the differences in market price at the close of the quarter ($0.004 per share on August 31, 2019) and the exercise price of outstanding, in-the-money options (those options with exercise prices below $0.004 per share) on August 31, 2019.

XML 23 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.3 html 57 207 1 false 21 0 false 4 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://ptsc.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - Consolidated Balance Sheets (Unaudited) Sheet http://ptsc.com/role/BalanceSheets Consolidated Balance Sheets (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Unaudited) (Parenthetical) Sheet http://ptsc.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Unaudited) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Operations (Unaudited) Sheet http://ptsc.com/role/StatementsOfOperations Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statements of Cash Flows (Unaudited) Sheet http://ptsc.com/role/StatementsOfCashFlows Consolidated Statements of Cash Flows (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Consolidated Statements of Stockholders' Equity (Unaudited) Sheet http://ptsc.com/role/StatementsOfStockholdersEquity Consolidated Statements of Stockholders' Equity (Unaudited) Statements 6 false false R7.htm 00000007 - Statement - Reconciliation of Cash, Cash Equivalents, and Restricted Cash and Cash Equivalents Sheet http://ptsc.com/role/ReconciliationOfCashCashEquivalentsAndRestrictedCashAndCashEquivalents Reconciliation of Cash, Cash Equivalents, and Restricted Cash and Cash Equivalents Statements 7 false false R8.htm 00000008 - Disclosure - 1. Basis of Presentation and Summary of Significant Accounting Policies Sheet http://ptsc.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies 1. Basis of Presentation and Summary of Significant Accounting Policies Notes 8 false false R9.htm 00000009 - Disclosure - 2. Cash, Cash Equivalents, Restricted Cash Sheet http://ptsc.com/role/CashCashEquivalentsRestrictedCash 2. Cash, Cash Equivalents, Restricted Cash Notes 9 false false R10.htm 00000010 - Disclosure - 3. Investment in Affiliated Companies Sheet http://ptsc.com/role/InvestmentInAffiliatedCompanies 3. Investment in Affiliated Companies Notes 10 false false R11.htm 00000011 - Disclosure - 4. Income Taxes Sheet http://ptsc.com/role/IncomeTaxes 4. Income Taxes Notes 11 false false R12.htm 00000012 - Disclosure - 5. Stockholders' Equity Sheet http://ptsc.com/role/StockholdersEquity 5. Stockholders' Equity Notes 12 false false R13.htm 00000013 - Disclosure - 6. Commitments and Contingencies Sheet http://ptsc.com/role/CommitmentsAndContingencies 6. Commitments and Contingencies Notes 13 false false R14.htm 00000014 - Disclosure - 7. Subsequent Events Sheet http://ptsc.com/role/SubsequentEvents 7. Subsequent Events Notes 14 false false R15.htm 00000015 - Disclosure - 2. Summary of Significant Accounting Policies (Policies) Sheet http://ptsc.com/role/SummaryOfSignificantAccountingPoliciesPolicies 2. Summary of Significant Accounting Policies (Policies) Policies http://ptsc.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies 15 false false R16.htm 00000016 - Disclosure - 2. Cash, Cash Equivalents, Restricted Cash (Tables) Sheet http://ptsc.com/role/CashCashEquivalentsRestrictedCashTables 2. Cash, Cash Equivalents, Restricted Cash (Tables) Tables http://ptsc.com/role/CashCashEquivalentsRestrictedCash 16 false false R17.htm 00000017 - Disclosure - 3. Investment in Affiliated Company (Tables) Sheet http://ptsc.com/role/InvestmentInAffiliatedCompanyTables 3. Investment in Affiliated Company (Tables) Tables http://ptsc.com/role/InvestmentInAffiliatedCompanies 17 false false R18.htm 00000018 - Disclosure - 5. Stockholders' Equity (Tables) Sheet http://ptsc.com/role/StockholdersEquityTables 5. Stockholders' Equity (Tables) Tables http://ptsc.com/role/StockholdersEquity 18 false false R19.htm 00000019 - Disclosure - 1. Basis of Presentation and Summary of Significant Accounting Policies (Details Narrative) Sheet http://ptsc.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative 1. Basis of Presentation and Summary of Significant Accounting Policies (Details Narrative) Details 19 false false R20.htm 00000020 - Disclosure - 2. Cash, Cash Equivalents, Restricted Cash (Details - Fair Value) Sheet http://ptsc.com/role/CashCashEquivalentsRestrictedCashDetails-FairValue 2. Cash, Cash Equivalents, Restricted Cash (Details - Fair Value) Details http://ptsc.com/role/CashCashEquivalentsRestrictedCashTables 20 false false R21.htm 00000021 - Disclosure - 2. Cash, Cash Equivalents, Restricted Cash (Details - Maturities) Sheet http://ptsc.com/role/CashCashEquivalentsRestrictedCashDetails-Maturities 2. Cash, Cash Equivalents, Restricted Cash (Details - Maturities) Details http://ptsc.com/role/CashCashEquivalentsRestrictedCashTables 21 false false R22.htm 00000022 - Disclosure - 3. Investment in Affiliated Company (Details) Sheet http://ptsc.com/role/InvestmentInAffiliatedCompanyDetails 3. Investment in Affiliated Company (Details) Details http://ptsc.com/role/InvestmentInAffiliatedCompanyTables 22 false false R23.htm 00000023 - Disclosure - 3. Investment in Affiliated Company (Details Narrative) Sheet http://ptsc.com/role/InvestmentInAffiliatedCompanyDetailsNarrative 3. Investment in Affiliated Company (Details Narrative) Details http://ptsc.com/role/InvestmentInAffiliatedCompanyTables 23 false false R24.htm 00000024 - Disclosure - 5. Stockholders' Equity (Details - Option activity) Sheet http://ptsc.com/role/StockholdersEquityDetails-OptionActivity 5. Stockholders' Equity (Details - Option activity) Details http://ptsc.com/role/StockholdersEquityTables 24 false false All Reports Book All Reports ptsc-20190831.xml ptsc-20190831.xsd ptsc-20190831_cal.xml ptsc-20190831_def.xml ptsc-20190831_lab.xml ptsc-20190831_pre.xml http://fasb.org/us-gaap/2019-01-31 http://xbrl.sec.gov/dei/2019-01-31 true true ZIP 24 0001683168-19-003232-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001683168-19-003232-xbrl.zip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htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Aug. 31, 2019
Aug. 31, 2018
Operating expenses:    
Selling, general and administrative $ 303,037 $ 203,481
Total operating expenses 303,037 203,481
Other income (expense):    
Interest income 5,691 6,943
Equity in loss of affiliated company (44,312) (14,780)
Total other expense, net (38,621) (7,837)
Loss before income taxes (341,658) (211,318)
Provision for income taxes 1,600 1,600
Net loss $ (343,258) $ (212,918)
Basic and diluted loss per common share $ 0.00 $ 0.00
Weighted average number of common shares outstanding - basic 398,548,318 398,548,318
Weighted average number of common shares outstanding - diluted 398,548,318 398,548,318
XML 26 R8.htm IDEA: XBRL DOCUMENT v3.19.3
1. Basis of Presentation and Summary of Significant Accounting Policies
3 Months Ended
Aug. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation and Summary of Significant Accounting Policies

1. Basis of Presentation and Summary of Significant Accounting Policies

 

The unaudited condensed consolidated financial statements of Patriot Scientific Corporation (the “Company”, “PTSC”, “Patriot”, “we”, “us” or “our”) presented herein have been prepared pursuant to the rules of the Securities and Exchange Commission (“SEC”) for quarterly reports on Form 10-Q and do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America. These unaudited condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements and notes thereto included in our Report on Form 10-K for our fiscal year ended May 31, 2019.

 

The accompanying condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern. In the opinion of management, the interim condensed consolidated financial statements reflect all adjustments of a normal recurring nature necessary for a fair presentation of the results for the interim period presented. Operating results for the three month period ended August 31, 2019 are not necessarily indicative of the results that may be expected for the year ending May 31, 2020.

 

Basis of Consolidation

 

The condensed consolidated balance sheets at August 31, 2019 and May 31, 2019 include our accounts and those of our inactive subsidiary Patriot Data Solutions Group, Inc. (“PDSG”) which includes Crossflo Systems, Inc. (“Crossflo”). The condensed consolidated statements of operations, cash flows and stockholders’ equity for the three months ended August 31, 2019 and 2018 include our accounts and those of our inactive subsidiaries: PDSG and Plasma Scientific Corporation (“Plasma”). We dissolved Plasma in March 2018. All significant intercompany accounts and transactions have been eliminated.

 

Liquidity and Management’s Plans

 

The accompanying condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern. At August 31, 2019, the Company has an accumulated deficit of $61,469,283, and has incurred recurring losses and used significant amounts of cash in its operations. As of August 31, 2019, the Company had cash and cash equivalents and marketable securities of approximately $1,239,000 and working capital of approximately $1,237,000. Our only significant potential source of cash is PDS. PDS has not generated significant license revenues since September 2013. Therefore, our ability to continue and expand our operations is highly dependent on the amount of cash and cash equivalents and marketable securities on hand combined with our ability to raise additional capital to fund future operations. We anticipate, based on currently proposed plans and assumptions that our cash on hand will not satisfy our operational and capital requirements through twelve months from the date of filing on this Form 10-Q.

 

Cash shortfalls currently experienced by PDS will have an adverse effect on our liquidity. To date, we have determined that it is in the best interests of the Moore Microprocessor Patent (“MMP”) licensing program that we provide our 50% share of capital to provide for PDS expenses including legal retainers and litigation related payments in the event license revenues received by PDS are insufficient to meet these needs. We believe contributions to PDS to fund working capital may be required.

 

PDS had been incurring significant third-party costs for legal fees, expert testimony, depositions and other related litigation costs. We could be required to make capital contributions to PDS for any future litigation related costs in the event that PDS does not receive sufficient licensing revenues to pay these expenses.

 

PDS is currently pursuing a litigation strategy, which includes the filing, on September 6, 2019, a petition for a writ of certiorari with the Supreme Court of the United States in regards to a decision by the United States Court of Appeals for the Federal Circuit, stemming from litigation in U.S. District Court against multiple companies alleged to be infringers of the MMP portfolio. We continue to believe that the significant investment in legal effort and costs incurred to date at PDS is necessary for the protection of our interests in the MMP portfolio and its future success, although to date it has generated mixed results.

 

On March 20, 2013, TPL filed a petition under Chapter 11 of the United States Bankruptcy Code. On March 5, 2018, TPL’s Motion for Entry of Final Decree Closing Chapter 11 was granted. In the event we are required to provide funding to PDS that is not reciprocated by TPL, our ownership percentage in PDS will increase and we will have a controlling financial interest in PDS, in which case, we will consolidate PDS in our consolidated financial statements.

 

On April 12, 2019, we entered into an agreement with Artius Bioconsulting LLC, (“Artius”), to evaluate the potential of establishing a company that develops a platform that could be implemented throughout the drug development process utilizing blockchain technologies. We are anticipating receiving shortly a feasibility report with its analysis. In the event the next steps in the development of a blockchain based business are undertaken, it is expected that funding from external sources will be required.

 

There are a number of uncertainties associated with our financial projections that could increase our projected expenses, which would further accelerate cash usage. Additionally, if we are unable to realize satisfactory cash from operations in the near future, we will be required to seek additional financing to continue our operations. We will also require additional financing to develop or acquire new lines of business. We have no current arrangements with respect to any additional financing. Consequently, there can be no assurance that any additional financing on commercially reasonable terms, or at all, will be available when needed. The inability to obtain additional capital may reduce our ability to continue to conduct business operations. Any additional equity financing may involve substantial dilution to our then existing stockholders. The above matters raise substantial doubt regarding our ability to continue as a going concern.

 

Investment in Affiliated Companies

 

We have a 50% interest in PDS. We account for our investment using the equity method of accounting since the investment provides us the ability to exercise significant influence, but not control, over the investee. Significant influence is generally deemed to exist if we have an ownership interest in the voting stock of the investee of between 20% and 50%, although other factors, such as representation on the investee’s Board of Directors, are considered in determining whether the equity method of accounting is appropriate. Under the equity method of accounting, the investment, originally recorded at cost, is adjusted to recognize our share of net earnings or losses of the investee and is recognized in the condensed consolidated statements of operations in the caption “Equity in earnings (loss) of affiliated company” and also is adjusted by contributions to and distributions from PDS.

 

PDS, as an unconsolidated equity investee, recognizes revenue from technology license agreements at the time a contract is entered into, the license method is determined (paid-in-advance or on-going royalty), performance obligations under the license agreement are satisfied, and the realization of revenue is assured which is generally upon the receipt of the license proceeds. PDS may at times enter into license agreements whereby contingent revenues are recognized as one or more contractual milestones are met.

 

We review our investment in PDS to determine whether events or changes in circumstances indicate that the carrying amount may not be recoverable. The primary factors we consider in our determination are the financial condition, operating performance and near term prospects of PDS. If the decline in value is deemed to be other than temporary, we would recognize an impairment loss.

 

We own 100% of the preferred stock of Holocom (see Note 3). Prior to impairment, this investment was accounted for at cost since we do not have the ability to exercise significant influence over the operating and financial policies of Holocom.

 

Income (Loss) Per Share

 

Basic income (loss) per share includes no dilution and is computed by dividing income (loss) available to common stockholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share reflect the potential dilution of securities that could share in the earnings of an entity.

 

At August 31, 2019 and 2018, potential common shares of 1,600,000 related to our outstanding options were not included in the calculation of diluted loss per share as we recorded a loss. Had we reported net income for the three months ended August 31, 2019 and 2018, no shares of common stock would have been included in the calculation of diluted income per share using the treasury stock method.

 

In connection with our acquisition of Crossflo, which became a part of PDSG, we issued 2,844,630 escrow shares that are contingent upon certain representations and warranties made by Crossflo at the time of the merger agreement (see Note 6). We exclude these escrow shares from the basic income (loss) per share calculations and would have included the escrowed shares in the diluted income per share calculations if we reported net income.

 

Income Taxes

 

We follow authoritative guidance in accounting for uncertainties in income taxes. This authoritative guidance prescribes a recognition threshold and measurement requirement for the financial statement recognition of a tax position that has been taken or is expected to be taken on a tax return and also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. Under this guidance we may only recognize tax positions that meet a “more likely than not” threshold.

 

We follow authoritative guidance to evaluate whether a valuation allowance should be established against our deferred tax assets based on the consideration of all available evidence using a “more likely than not” standard. In making such judgments, significant weight is given to evidence that can be objectively verified. We assess our deferred tax assets annually under more likely than not scenarios in which they may be realized through future income.

 

With the exception for refundable alternative minimum tax (“AMT”) credits, we have determined that it was more likely than not that all of our deferred tax assets will not be realized in the future due to our continuing pre-tax and taxable losses. As a result of this determination, and with the exception for the aforementioned refundable tax credits, we have recorded a full valuation allowance against our deferred tax assets.

 

On December 22, 2017, the United States Government passed the Tax Cuts and Jobs Act (“Tax Cuts Act”) that, among other provisions, has lowered the corporate tax rate from 35% to 21%. In addition to applying the new lower corporate tax rate in 2018 and thereafter to any taxable income we may have, the legislation affects the way we can use and carryforward net operating losses previously accumulated and results in a revaluation of deferred tax assets and liabilities recorded on our condensed consolidated balance sheet. The Securities and Exchange Commission staff issued Staff Accounting Bulletin No. 118 (“SAB 118”) which provides guidance regarding accounting for the income tax effects of the Tax Cuts Act, including the impact of the Tax Cuts Act on deferred tax assets and liabilities for financial statements issued in the reporting period that includes the enactment date of December 22, 2017. Given that our current deferred tax assets, with the exception of those representing certain refundable tax credits, are offset by a full valuation allowance, these changes had no net impact on our condensed consolidated balance sheet. However, if we become profitable, we will receive a reduced benefit from such deferred tax assets.

 

Assessment of Contingent Liabilities

 

We are involved in various legal matters, disputes, and patent infringement claims which arise in the ordinary course of our business. We accrue for any estimated losses at the time when we can make a reliable estimate of such loss and it is probable that it has been incurred. By their very nature, contingencies are difficult to estimate. We continually evaluate information related to all contingencies to determine that the basis on which we have recorded our estimated exposure is appropriate.

 

Intellectual Property Rights

 

PDS, our investment in affiliated company, relies on a combination of patents, trademarks, copyrights, trade secret laws, confidentiality procedures and licensing arrangements to protect our intellectual property rights. We have seven U.S., nine European, and three Japanese patents all of which expired between August 2009 and October 2016. These patents, while expired, may have certain retrospective statutory benefits that will fully diminish six years after the patent expiration dates. The patent useful life for purposes of negotiating licenses is finite and these patents are subject to legal challenges, which in combination with the limited life, could adversely impact the stream of revenues. A successful challenge to the ownership of the technology or the proprietary nature of the intellectual property would materially damage business prospects. Any issued patent may be challenged and invalidated.

 

Recent Accounting Pronouncements

 

In February 2016, the FASB issued ASU No. 2016-02, “Leases (Topic 842)”, as amended ("ASC 842"), which modifies lease accounting for lessees to increase transparency and comparability by recording lease assets and liabilities for operating leases and disclosing key information about leasing arrangements. ASU 2018-13 is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2018. The Company adopted ASC 842 effective June 1, 2019 using a modified retrospective method and will not restate comparative periods. As permitted under the transition guidance, the Company will carry forward the assessment of whether its contracts contain or are leases, classification of its leases and remaining lease terms. Implementation of this guidance did not have a material impact on the Company’s consolidated financial statements. We have elected the short-term lease recognition exemption for all applicable classes of underlying assets. Short-term leases include only those leases with a term greater than one month and twelve months or less. Short-term leases are not recorded on the consolidated balance sheet, and lease expense on short-term leases is recognized on a straight-line basis over the lease term. The Company elected the “practical expedient package” as permitted under ASC 842. Therefore, the Company has not reassessed whether any expired or existing contracts are, or contain, leases; the Company has not reassessed the lease classification for any expired or existing leases; and the Company has not reassessed initial direct costs for any expired or existing leases. The Company currently leases office space on a month-to-month basis.

 

In August 2018, the FASB issued ASU No. 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement” (“ASU 2018-13”), which removes, modifies, and adds various disclosure requirements on fair value measurements in Topic 820. ASU 2018-13 is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2019. The amendments on changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. Early adoption is permitted upon issuance of this update. An entity is permitted to early adopt any removed or modified disclosures upon issuance of this update and delay adoption of the additional disclosures until their effective date. The Company does not expect a significant impact from adopting this update on its consolidated financial statements.

XML 27 R22.htm IDEA: XBRL DOCUMENT v3.19.3
3. Investment in Affiliated Company (Details) - USD ($)
3 Months Ended
Aug. 31, 2019
Aug. 31, 2018
May 31, 2019
Total assets $ 234,758   $ 237,655
Total liabilities and members' equity 234,758   237,655
Expenses [Member]      
Total Expenses 88,625 $ 29,559  
Net Loss [Member]      
Net loss (88,625) $ (29,559)  
Cash [Member]      
Total assets 234,758   237,655
Prepaid Expenses [Member]      
Total assets 0    
Payables [Member]      
Total liabilities and members' equity 107,661   21,933
Members equity [Member]      
Total liabilities and members' equity $ 127,097   $ 215,722
XML 28 R14.htm IDEA: XBRL DOCUMENT v3.19.3
7. Subsequent Events
3 Months Ended
Aug. 31, 2019
Subsequent Events [Abstract]  
Subsequent Events

7. Subsequent Events

 

Mr. Clifford L. Flowers, Chief Financial Officer, Secretary, Treasurer and member of the Company’s Board of Directors, resigned his positions effective October 1, 2019. On October 3, 2019, our Board appointed Mr. Carlton Johnson Jr. as the Interim Chief Financial Officer on an interim basis. There were no known disagreements with Mr. Flowers regarding our operations, policies or practices.

 

In connection with his departure, Mr. Flowers entered into a Separation Agreement and General Release of All Claims as of with the Company (the “Release”). Pursuant to the Release, Mr. Flowers is entitled to receive severance payments equal to $327,750, less all appropriate federal and state tax withholding, which will be made in seven equal installments on the 30th of each month commencing on October 30, 2019 and ending April 30, 2020. The payments under the Release are in lieu of any rights under the employment agreement between Mr. Flowers and the Company. The Release also contains a mutual general release, confidentiality, non-disparagement and other covenants and agreements.

XML 29 R10.htm IDEA: XBRL DOCUMENT v3.19.3
3. Investment in Affiliated Companies
3 Months Ended
Aug. 31, 2019
Investments in and Advances to Affiliates, Schedule of Investments [Abstract]  
Investment in Affiliated Companies

3. Investment in Affiliated Companies

 

Phoenix Digital Solutions, LLC

 

On June 7, 2005, we entered into a Master Agreement (the “Master Agreement”) with TPL, and Charles H. Moore (“Moore”), the co-inventor of the technology which is the subject of the MMP portfolio of microprocessor patents, pursuant to which the parties resolved all legal disputes between them. Pursuant to the Master Agreement, we and TPL entered into the Limited Liability Company Operating Agreement of PDS (the “LLC Agreement”) into which we and Moore contributed our rights to certain of our technologies.

 

We and TPL each own 50% of the membership interests of PDS, and each member has the right to appoint one member of the three-member management committee. The two appointees are required to select a mutually acceptable third member of the management committee. There had not been a third management committee member since May 2010; however, as a result of our initiation of arbitration seeking the appointment of a third member, on December 16, 2014, an independent manager to the PDS management committee was selected by the arbitrator. Pursuant to the LLC Agreement, we and TPL initially agreed to establish a working capital fund for PDS of $4,000,000, of which our contribution was $2,000,000. The working capital fund was increased to a maximum of $8,000,000 as license revenues are achieved. We and TPL are obligated to fund future working capital requirements at the discretion of the management committee of PDS in order to maintain working capital of not more than $8,000,000. If the management committee determines that additional capital is required, neither we nor TPL are required to contribute more than $2,000,000 in any fiscal year. No such contributions were made during the three months ended August 31, 2019 and 2018. Distributable cash and allocation of profits and losses have been allocated to the members in the priority defined in the LLC Agreement.

 

On July 11, 2012, we entered into the Program Agreement with PDS, TPL, and Alliacense, and an Agreement (the “TPL Agreement”) with TPL. Pursuant to the Program Agreement, PDS engaged Alliacense to negotiate MMP portfolio licenses and to pursue claims against violators of the MMP portfolio on behalf of PDS, TPL, and the Company. The Program Agreement continued through the useful life of the MMP portfolio patents. Pursuant to the TPL Agreement, we and TPL agreed to certain allocations of obligations in connection with the engagement of Alliacense. On July 24, 2014, the Program Agreement was amended with PDS and Alliacense entering into the Amended Alliacense Services and Novation Agreement (the “Novation Agreement”). Pursuant to the Novation Agreement certain performance goals and incentives were established for Alliacense. The Novation Agreement also provided for the addition of a second licensing company, which was engaged on October 10, 2014, to complement the MMP licensing commercialization. However, Alliacense fulfilled only a portion of its obligations under the Novation Agreement associated with the deployment of the second licensing company and on May 11, 2015, Alliacense was terminated by PDS.

 

On August 10, 2016, PDS entered into an agreement with Alliacense and MMP Licensing, LLC to settle matters relating to Alliacense’s non-performance under terms of the Novation Agreement. The August 10, 2016 agreement required Alliacense to provide PDS’s second licensing company, Dominion Harbor Group (“DHG”), with certain materials and to cooperate with reasonable discovery requests relating to infringement litigation in the U.S. District Court for the Northern District of California. MMP Licensing, LLC will provide commercialization services to PDS for the MMP portfolio with respect to certain companies. PDS and Alliacense have agreed to cause the arbitration between the parties to be dismissed with prejudice. The August 10, 2016 agreement, and the agreement retaining DHG as PDS’s second licensing company, will both expire on October 4, 2022. Terms of the settlement agreement required PDS to pay Alliacense $84,000 within 24 hours after delivery of materials to PDS’s second licensing agent and to pay Alliacense $84,000 out of subsequent recoveries. PDS paid Alliacense $84,000 on each of August 11, 2016 and October 3, 2016.

 

During January 2013, TPL and Moore settled their litigation. Terms of the settlement included the payment by PDS to Moore of a consulting fee of $250,000 for four years or until the completion of all outstanding MMP litigation whichever came first. Per terms of the agreement, PDS paid Moore $150,000 on the settlement date and paid Moore $16,667 per month from August 2013 through January 2014 and $20,833 per month beginning February 2014 through January 2017.

  

Based on our analysis of current authoritative accounting guidance with respect to our investment in PDS, we continue to account for our investment in PDS under the equity method of accounting, and accordingly have recorded our share of PDS’s net loss during the three months ended August 31, 2019 and 2018 of $44,312 and $14,780, respectively, as a decrease in our investment as “Equity in loss of affiliated company” in the accompanying condensed consolidated statements of operations.

 

On March 20, 2013, TPL filed a petition under Chapter 11 of the United States Bankruptcy Code. On March 5, 2018, TPL’s Motion for Entry of Final Decree Closing Chapter 11 was granted. In the event we are required to provide funding to PDS that is not reciprocated by TPL, our ownership percentage in PDS will increase and we will have a controlling financial interest in PDS, in which case, we will consolidate PDS in our condensed consolidated financial statements. If we determine that it is appropriate to consolidate PDS, we would measure the assets, liabilities and noncontrolling interests of PDS at their fair values at the date that we have the controlling financial interest.

 

PDS’s balance sheets at August 31, 2019 and May 31, 2019 and statements of operations for the three months ended August 31, 2019 and 2018 are as follows:

 

Balance Sheets

 

Assets:

 

   August 31, 2019   May 31, 2019 
    (Unaudited)      
           
Cash  $234,758   $237,655 
Total assets  $234,758   $237,655 

 

Liabilities and Members’ Equity:

 

    August 31, 2019    May 31, 2019 
    (Unaudited)      
           
Payables  $107,661   $21,933 
Members’ equity   127,097    215,722 
Total liabilities and members’ equity  $234,758   $237,655 

 

Statements of Operations

 

  

Three Months Ended

August 31,

 
   2019   2018 
   (Unaudited)   (Unaudited) 
           
Expenses  $88,625   $29,559 
Net loss  $(88,625)   (29,559)

 

We review our investment in PDS to determine whether events or changes in circumstances indicate that the carrying amount may not be recoverable. The primary factors we consider in our determination are the financial condition, operating performance and near term prospects of PDS. If a decline in value is deemed to be other than temporary, we would recognize an impairment loss.

 

Holocom, Inc.

 

We currently own 2,100,000 shares of preferred stock, equivalent to an approximate 46% ownership interest on an after converted basis, in Holocom, Inc. (“Holocom”), a California corporation that manufactures products that protect information transmitted over secure networks. The shares are convertible at our option into shares of Holocom’s common stock on a one-to-one basis. The preferred stock entitles us to receive non-cumulative dividends at the per annum rate of $0.04 per share, when and if declared by the Board of Directors of Holocom, as well as a liquidation preference of $0.40 per share, plus an amount equal to all declared but unpaid dividends.

 

In 2010, we determined that the inability of Holocom to meet its business plan, raise capital, and the general economic environment were indicators of impairment on our investment and we wrote-off our cost basis investment in Holocom. At August 31, 2019 and May 31, 2019, our investment in Holocom was valued at $0.

XML 30 R18.htm IDEA: XBRL DOCUMENT v3.19.3
5. Stockholders' Equity (Tables)
3 Months Ended
Aug. 31, 2019
Equity [Abstract]  
Schedule of Stock Options Activity
   Shares   Weighted Average Exercise Price   Weighted Average Remaining Contractual Term (Years)   Aggregate Intrinsic Value 
Options outstanding at June 1, 2019   1,600,000   $0.03           
Options granted      $           
Options exercised      $           
Options forfeited/expired      $           
Options outstanding at August 31, 2019   1,600,000   $0.03    0.68   $ 
Options vested and expected to vest at August 31, 2019   1,600,000   $0.03    0.68   $ 
Options exercisable at August 31, 2019   1,600,000   $0.03    0.68   $ 
XML 32 R19.htm IDEA: XBRL DOCUMENT v3.19.3
1. Basis of Presentation and Summary of Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended
Aug. 31, 2019
Aug. 31, 2018
May 31, 2019
Accumulated deficit $ (61,469,283)   $ (61,126,025)
Cash, cash equivalents and marketable securities 1,239,000    
Working capital $ 1,237,000    
Crossflo [Member]      
Shares held in escrow 2,844,630    
Options [Member]      
Common shares not included in calculation of net earnings (loss) per share 1,600,000 1,600,000  
PDS [Member]      
Percentage of investment in affiliated company 50.00%    
XML 33 R15.htm IDEA: XBRL DOCUMENT v3.19.3
2. Summary of Significant Accounting Policies (Policies)
3 Months Ended
Aug. 31, 2019
Accounting Policies [Abstract]  
Basis of Consolidation

Basis of Consolidation

 

The condensed consolidated balance sheets at August 31, 2019 and May 31, 2019 include our accounts and those of our inactive subsidiary Patriot Data Solutions Group, Inc. (“PDSG”) which includes Crossflo Systems, Inc. (“Crossflo”). The condensed consolidated statements of operations, cash flows and stockholders’ equity for the three months ended August 31, 2019 and 2018 include our accounts and those of our inactive subsidiaries: PDSG and Plasma Scientific Corporation (“Plasma”). We dissolved Plasma in March 2018. All significant intercompany accounts and transactions have been eliminated.

Investment in Affiliated Companies

Investment in Affiliated Companies

 

We have a 50% interest in PDS. We account for our investment using the equity method of accounting since the investment provides us the ability to exercise significant influence, but not control, over the investee. Significant influence is generally deemed to exist if we have an ownership interest in the voting stock of the investee of between 20% and 50%, although other factors, such as representation on the investee’s Board of Directors, are considered in determining whether the equity method of accounting is appropriate. Under the equity method of accounting, the investment, originally recorded at cost, is adjusted to recognize our share of net earnings or losses of the investee and is recognized in the condensed consolidated statements of operations in the caption “Equity in earnings (loss) of affiliated company” and also is adjusted by contributions to and distributions from PDS.

 

PDS, as an unconsolidated equity investee, recognizes revenue from technology license agreements at the time a contract is entered into, the license method is determined (paid-in-advance or on-going royalty), performance obligations under the license agreement are satisfied, and the realization of revenue is assured which is generally upon the receipt of the license proceeds. PDS may at times enter into license agreements whereby contingent revenues are recognized as one or more contractual milestones are met.

 

We review our investment in PDS to determine whether events or changes in circumstances indicate that the carrying amount may not be recoverable. The primary factors we consider in our determination are the financial condition, operating performance and near term prospects of PDS. If the decline in value is deemed to be other than temporary, we would recognize an impairment loss.

 

We own 100% of the preferred stock of Holocom (see Note 3). Prior to impairment, this investment was accounted for at cost since we do not have the ability to exercise significant influence over the operating and financial policies of Holocom.

Income Taxes

Income Taxes

 

We follow authoritative guidance in accounting for uncertainties in income taxes. This authoritative guidance prescribes a recognition threshold and measurement requirement for the financial statement recognition of a tax position that has been taken or is expected to be taken on a tax return and also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. Under this guidance we may only recognize tax positions that meet a “more likely than not” threshold.

 

We follow authoritative guidance to evaluate whether a valuation allowance should be established against our deferred tax assets based on the consideration of all available evidence using a “more likely than not” standard. In making such judgments, significant weight is given to evidence that can be objectively verified. We assess our deferred tax assets annually under more likely than not scenarios in which they may be realized through future income.

 

With the exception for refundable alternative minimum tax (“AMT”) credits, we have determined that it was more likely than not that all of our deferred tax assets will not be realized in the future due to our continuing pre-tax and taxable losses. As a result of this determination, and with the exception for the aforementioned refundable tax credits, we have recorded a full valuation allowance against our deferred tax assets.

 

On December 22, 2017, the United States Government passed the Tax Cuts and Jobs Act (“Tax Cuts Act”) that, among other provisions, has lowered the corporate tax rate from 35% to 21%. In addition to applying the new lower corporate tax rate in 2018 and thereafter to any taxable income we may have, the legislation affects the way we can use and carryforward net operating losses previously accumulated and results in a revaluation of deferred tax assets and liabilities recorded on our condensed consolidated balance sheet. The Securities and Exchange Commission staff issued Staff Accounting Bulletin No. 118 (“SAB 118”) which provides guidance regarding accounting for the income tax effects of the Tax Cuts Act, including the impact of the Tax Cuts Act on deferred tax assets and liabilities for financial statements issued in the reporting period that includes the enactment date of December 22, 2017. Given that our current deferred tax assets, with the exception of those representing certain refundable tax credits, are offset by a full valuation allowance, these changes had no net impact on our condensed consolidated balance sheet. However, if we become profitable, we will receive a reduced benefit from such deferred tax assets.

Assessment of Contingent Liabilities

Assessment of Contingent Liabilities

 

We are involved in various legal matters, disputes, and patent infringement claims which arise in the ordinary course of our business. We accrue for any estimated losses at the time when we can make a reliable estimate of such loss and it is probable that it has been incurred. By their very nature, contingencies are difficult to estimate. We continually evaluate information related to all contingencies to determine that the basis on which we have recorded our estimated exposure is appropriate.

Income (Loss) Per Share

Income (Loss) Per Share

 

Basic income (loss) per share includes no dilution and is computed by dividing income (loss) available to common stockholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share reflect the potential dilution of securities that could share in the earnings of an entity.

 

At August 31, 2019 and 2018, potential common shares of 1,600,000 related to our outstanding options were not included in the calculation of diluted loss per share as we recorded a loss. Had we reported net income for the three months ended August 31, 2019 and 2018, no shares of common stock would have been included in the calculation of diluted income per share using the treasury stock method.

 

In connection with our acquisition of Crossflo, which became a part of PDSG, we issued 2,844,630 escrow shares that are contingent upon certain representations and warranties made by Crossflo at the time of the merger agreement (see Note 6). We exclude these escrow shares from the basic income (loss) per share calculations and would have included the escrowed shares in the diluted income per share calculations if we reported net income.

Intellectual Property Rights

Intellectual Property Rights

 

PDS, our investment in affiliated company, relies on a combination of patents, trademarks, copyrights, trade secret laws, confidentiality procedures and licensing arrangements to protect our intellectual property rights. We have seven U.S., nine European, and three Japanese patents all of which expired between August 2009 and October 2016. These patents, while expired, may have certain retrospective statutory benefits that will fully diminish six years after the patent expiration dates. The patent useful life for purposes of negotiating licenses is finite and these patents are subject to legal challenges, which in combination with the limited life, could adversely impact the stream of revenues. A successful challenge to the ownership of the technology or the proprietary nature of the intellectual property would materially damage business prospects. Any issued patent may be challenged and invalidated.

Recent Accounting Pronouncements

Recent Accounting Pronouncements

 

In February 2016, the FASB issued ASU No. 2016-02, “Leases (Topic 842)”, as amended ("ASC 842"), which modifies lease accounting for lessees to increase transparency and comparability by recording lease assets and liabilities for operating leases and disclosing key information about leasing arrangements. ASU 2018-13 is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2018. The Company adopted ASC 842 effective June 1, 2019 using a modified retrospective method and will not restate comparative periods. As permitted under the transition guidance, the Company will carry forward the assessment of whether its contracts contain or are leases, classification of its leases and remaining lease terms. Implementation of this guidance did not have a material impact on the Company’s consolidated financial statements. We have elected the short-term lease recognition exemption for all applicable classes of underlying assets. Short-term leases include only those leases with a term greater than one month and twelve months or less. Short-term leases are not recorded on the consolidated balance sheet, and lease expense on short-term leases is recognized on a straight-line basis over the lease term. The Company elected the “practical expedient package” as permitted under ASC 842. Therefore, the Company has not reassessed whether any expired or existing contracts are, or contain, leases; the Company has not reassessed the lease classification for any expired or existing leases; and the Company has not reassessed initial direct costs for any expired or existing leases. The Company currently leases office space on a month-to-month basis.

 

In August 2018, the FASB issued ASU No. 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement” (“ASU 2018-13”), which removes, modifies, and adds various disclosure requirements on fair value measurements in Topic 820. ASU 2018-13 is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2019. The amendments on changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. Early adoption is permitted upon issuance of this update. An entity is permitted to early adopt any removed or modified disclosures upon issuance of this update and delay adoption of the additional disclosures until their effective date. The Company does not expect a significant impact from adopting this update on its consolidated financial statements.

Liquidity and Management's Plans

Liquidity and Management’s Plans

 

The accompanying condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern. At August 31, 2019, the Company has an accumulated deficit of $61,469,283, and has incurred recurring losses and used significant amounts of cash in its operations. As of August 31, 2019, the Company had cash and cash equivalents and marketable securities of approximately $1,239,000 and working capital of approximately $1,237,000. Our only significant potential source of cash is PDS. PDS has not generated significant license revenues since September 2013. Therefore, our ability to continue and expand our operations is highly dependent on the amount of cash and cash equivalents and marketable securities on hand combined with our ability to raise additional capital to fund future operations. We anticipate, based on currently proposed plans and assumptions that our cash on hand will not satisfy our operational and capital requirements through twelve months from the date of filing on this Form 10-Q.

 

Cash shortfalls currently experienced by PDS will have an adverse effect on our liquidity. To date, we have determined that it is in the best interests of the Moore Microprocessor Patent (“MMP”) licensing program that we provide our 50% share of capital to provide for PDS expenses including legal retainers and litigation related payments in the event license revenues received by PDS are insufficient to meet these needs. We believe contributions to PDS to fund working capital may be required.

 

PDS had been incurring significant third-party costs for legal fees, expert testimony, depositions and other related litigation costs. We could be required to make capital contributions to PDS for any future litigation related costs in the event that PDS does not receive sufficient licensing revenues to pay these expenses.

 

PDS is currently pursuing a litigation strategy, which includes the filing, on September 6, 2019, a petition for a writ of certiorari with the Supreme Court of the United States in regards to a decision by the United States Court of Appeals for the Federal Circuit, stemming from litigation in U.S. District Court against multiple companies alleged to be infringers of the MMP portfolio. We continue to believe that the significant investment in legal effort and costs incurred to date at PDS is necessary for the protection of our interests in the MMP portfolio and its future success, although to date it has generated mixed results.

 

On March 20, 2013, TPL filed a petition under Chapter 11 of the United States Bankruptcy Code. On March 5, 2018, TPL’s Motion for Entry of Final Decree Closing Chapter 11 was granted. In the event we are required to provide funding to PDS that is not reciprocated by TPL, our ownership percentage in PDS will increase and we will have a controlling financial interest in PDS, in which case, we will consolidate PDS in our consolidated financial statements.

 

On April 12, 2019, we entered into an agreement with Artius Bioconsulting LLC, (“Artius”), to evaluate the potential of establishing a company that develops a platform that could be implemented throughout the drug development process utilizing blockchain technologies. We are anticipating receiving shortly a feasibility report with its analysis. In the event the next steps in the development of a blockchain based business are undertaken, it is expected that funding from external sources will be required.

 

There are a number of uncertainties associated with our financial projections that could increase our projected expenses, which would further accelerate cash usage. Additionally, if we are unable to realize satisfactory cash from operations in the near future, we will be required to seek additional financing to continue our operations. We will also require additional financing to develop or acquire new lines of business. We have no current arrangements with respect to any additional financing. Consequently, there can be no assurance that any additional financing on commercially reasonable terms, or at all, will be available when needed. The inability to obtain additional capital may reduce our ability to continue to conduct business operations. Any additional equity financing may involve substantial dilution to our then existing stockholders. The above matters raise substantial doubt regarding our ability to continue as a going concern.

XML 34 R11.htm IDEA: XBRL DOCUMENT v3.19.3
4. Income Taxes
3 Months Ended
Aug. 31, 2019
Income Tax Disclosure [Abstract]  
Income Taxes

4. Income Taxes

 

On December 22, 2017, the United States Government passed the Tax Cuts and Jobs Act (“Tax Cuts Act”) that, among other provisions, has lowered the corporate tax rate from 35% to 21%. In addition to applying the new lower corporate tax rate in 2018 and thereafter to any taxable income we may have, the legislation affects the way we can use and carryforward net operating losses previously accumulated and results in a revaluation of deferred tax assets and liabilities recorded on our condensed consolidated balance sheet. The Securities and Exchange Commission staff issued Staff Accounting Bulletin No. 118 (“SAB 118”) which provides guidance regarding accounting for the income tax effects of the Tax Cuts Act, including the impact of the Tax Cuts Act on deferred tax assets and liabilities for financial statements issued in the reporting period that includes the enactment date of December 22, 2017. Given that our current deferred tax assets, with the exception of those representing certain refundable tax credits, are offset by a full valuation allowance, these changes had no net impact on our condensed consolidated balance sheet. However, if we become profitable, we will receive a reduced benefit from such deferred tax assets.

EXCEL 35 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 36 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 37 R9.htm IDEA: XBRL DOCUMENT v3.19.3
2. Cash, Cash Equivalents, Restricted Cash
3 Months Ended
Aug. 31, 2019
Cash and Cash Equivalents [Abstract]  
Cash, Cash Equivalents, Restricted Cash and Marketable Securities

2. Cash, Cash Equivalents and Restricted Cash

 

We follow authoritative guidance to account for our marketable securities as held-to-maturity. Under this authoritative guidance we are required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. We determine fair value based on quoted prices when available or through the use of alternative approaches, such as discounting the expected cash flows using market interest rates commensurate with the credit quality and duration of the investment or valuations by third party professionals. The three levels of inputs that we may use to measure fair value are:

 

Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;

 

Level 2: Quoted prices in markets that are not active or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; and

 

Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e. supported by little or no market activity).

 

The following tables detail the fair value measurements within the fair value hierarchy of our cash, cash equivalents and investments in marketable securities:

 

       Fair Value Measurements at August 31, 2019 Using 
   Fair Value at
August 31,
2019
   Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
   Significant Other
Observable
Inputs
(Level 2)
   Significant
Unobservable
Inputs
(Level 3)
 
Cash and cash equivalents:                    
Cash  $46,048   $46,048   $   $ 
Money market funds   692,612    692,612         
Restricted cash and cash equivalents   177,247    177,247         
Investments in marketable securities:                    
Certificates of deposit   500,000        500,000     
Total  $1,415,907   $915,907   $500,000   $ 

 

 

       Fair Value Measurements at May 31, 2019 Using 
   Fair Value at
May 31,
2019
   Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
   Significant Other
Observable
Inputs
(Level 2)
   Significant
Unobservable
Inputs
(Level 3)
 
Cash and cash equivalents:                    
Cash  $49,149   $49,149   $   $ 
Money market funds   237,937    237,937         
Certificates of deposit   500,000        500,000     
Restricted cash and cash equivalents   198,843    198,843         
Investments in marketable securities:                    
Certificates of deposit   750,000        750,000     
Total  $1,735,929   $485,929   $1,250,000   $ 

 

We purchase certificates of deposit with varying maturity dates. The following tables summarize the purchase date maturities, gross unrealized gains or losses and fair value of the certificates of deposit as of August 31, 2019 and May 31, 2019:

 

  

August 31, 2019

(Unaudited)

 
   Cost   Gross Unrealized Gains/(Losses)   Fair
Value
 
Maturity            
Due in greater than three months  $500,000   $   $500,000 

 

 

   May 31, 2019 
   Cost   Gross Unrealized Gains/(Losses)   Fair
Value
 
Maturity            
Due in three months or less  $500,000   $   $500,000 
Due in greater than three months   750,000        750,000 
   $1,250,000   $   $1,250,000 

 

XML 38 R23.htm IDEA: XBRL DOCUMENT v3.19.3
3. Investment in Affiliated Company (Details Narrative) - USD ($)
3 Months Ended
Aug. 31, 2019
Aug. 31, 2018
May 31, 2019
Investment in affiliated company $ 63,549   $ 107,861
Equity in loss of affiliated company $ (44,312) $ (14,780)  
PDS [Member]      
Equity interest percentage 50.00%    
Capital contribution to entity $ 0 0  
Equity in loss of affiliated company $ (44,312) (14,780)  
Holocom [Member]      
Equity interest percentage 46.00%    
Investment in affiliated company $ 0 $ 0  
Holocom [Member] | Preferred Stock [Member]      
Equity shares owned 2,100,000    
XML 39 R5.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Aug. 31, 2019
Aug. 31, 2018
Operating activities:    
Net loss $ (343,258) $ (212,918)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 122 122
Equity in loss of affiliated company 44,312 14,780
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (57,877) (55,813)
Income taxes payable 1,600 1,600
Accounts payable, accrued expenses and other 35,079 (8,096)
Net cash used in operating activities (320,022) (260,325)
Investing activities:    
Proceeds from sales of marketable securities 500,000 0
Purchases of marketable securities (250,000) 0
Net cash provided by investing activities 250,000 0
Net decrease in cash, cash equivalents and restricted cash and cash equivalents (70,022) (260,325)
Cash, cash equivalents and restricted cash and cash equivalents, beginning of period 985,929 2,319,449
Cash, cash equivalents and restricted cash cash equivalents, end of period $ 915,907 $ 2,059,124
XML 40 R1.htm IDEA: XBRL DOCUMENT v3.19.3
Document and Entity Information - shares
3 Months Ended
Aug. 31, 2019
Oct. 10, 2019
Document And Entity Information    
Entity Registrant Name PATRIOT SCIENTIFIC CORP  
Entity Central Index Key 0000836564  
Document Type 10-Q  
Document Period End Date Aug. 31, 2019  
Amendment Flag false  
Current Fiscal Year End Date --05-31  
Is Entity's Reporting Status Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Common Stock, Shares Outstanding   401,392,948
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2020  
Entity Small Business true  
Entity Emerging Growth false  
Entity file number 000-22182  
Entity state of incorporation DE  
Interactive Data Current Yes